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Background: Vascular services is changing rapidly, having emerged as a new specialty with its own
training and specialised techniques. This has resulted in the need for reconfiguration of services to
provide adequate specialist provision and accessible and equitable services.
Objectives: To identify the effects of service configuration on practice, resource use and outcomes.
To model potential changes in configuration. To identify and/or develop electronic data collection tools
for collecting patient-reported outcome measures and other clinical information. To evaluate patient
preferences for aspects of services other than health-related quality of life.
Design: This was a multiple methods study comprising multiple systematic literature reviews; the
development of a new outcome measure for users of vascular services (the electronic Personal
Assessment Questionnaire – Vascular) based on the reviews, qualitative studies and psychometric
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evaluation; a trade-off exercise to measure process utilities; Hospital Episode Statistics analysis; and
the development of individual disease models and a metamodel of service configuration.
Setting: Specialist vascular inpatient services in England.
Data sources: Modelling and Hospital Episode Statistics analysis for all vascular inpatients in England
from 2006 to 2018. Qualitative studies and electronic Personal Assessment Questionnaire – Vascular
evaluation with vascular patients from the Sheffield area. The trade-off studies were based on a
societal sample from across England.
Interventions: The data analysis, preference studies and modelling explored the effect of different
potential arrangements for service provision on the resource use, workload and outcomes for all
interventions in the three main areas of inpatient vascular treatment: peripheral arterial disease,
abdominal aortic aneurysm and carotid artery disease. The electronic Personal Assessment Questionnaire
– Vascular was evaluated as a potential tool for clinical data collection and outcome monitoring.
Main outcome measures: Systematic reviews assessed quality and psychometric properties of published
outcome measures for vascular disease and the relationship between volume and outcome in vascular
services. The electronic Personal Assessment Questionnaire – Vascular development considered face and
construct validity, test–retest reliability and responsiveness. Models were validated using case studies
from previous reconfigurations and comparisons with Hospital Episode Statistics data. Preference
studies resulted in estimates of process utilities for aneurysm treatment and for travelling distances to
access services.
Results: Systematic reviews provided evidence of an association between increasing volume of activity
and improved outcomes for peripheral arterial disease, abdominal aortic aneurysm and carotid artery
disease. Reviews of existing patient-reported outcome measures did not identify suitable condition-
specific tools for incorporation in the electronic Personal Assessment Questionnaire – Vascular. Reviews
of qualitative evidence, primary qualitative studies and a Delphi exercise identified the issues to be
incorporated into the electronic Personal Assessment Questionnaire –Vascular, resulting in a questionnaire
with one generic and three disease-specific domains. After initial item reduction, the final version has
55 items in eight scales and has acceptable psychometric properties. The preference studies showed
strong preference for endovascular abdominal aortic aneurysm treatment (willingness to trade up
to 0.135 quality-adjusted life-years) and for local services (up to 0.631 quality-adjusted life-years).
A simulation model with a web-based interface was developed, incorporating disease-specific models
for abdominal aortic aneurysm, peripheral arterial disease and carotid artery disease. This predicts the
effects of specified reconfigurations on workload, resource use, outcomes and cost-effectiveness. Initial
exploration suggested that further reconfiguration of services in England to accomplish high-volume
centres would result in improved outcomes, within the bounds of cost-effectiveness usually considered
acceptable in the NHS.
Limitations: The major source of evidence to populate the models was Hospital Episode Statistics data,
which have limitations owing to the complexity of the data, deficiencies in the coding systems and
variations in coding practice. The studies were not able to address all of the potential barriers to
change where vascular services are not compliant with current NHS recommendations.
Conclusions: There is evidence of potential for improvement in the clinical effectiveness and
cost-effectiveness of vascular services through further centralisation of sites where major vascular
procedures are undertaken. Preferences for local services are strong, and this may be addressed
through more integrated services, with a range of services being provided more locally. The use of a
web-based tool for the collection of clinical data and patient-reported outcome measures is feasible
and can provide outcome data for clinical use and service evaluation.
Future work: Further evaluation of the economic models in real-world situations where local vascular
service reconfiguration is under consideration and of the barriers to change where vascular services
do not meet NHS recommendations for service configuration is needed. Further work on the electronic
Personal Assessment Questionnaire – Vascular is required to assess its acceptability and usefulness in
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clinical practice and to develop appropriate report formats for clinical use and service evaluation.
Further studies to assess the implications of including non-health-related preferences for care
processes, and location of services, in calculations of cost-effectiveness are required.
Study registration: This study is registered as PROSPERO CRD42016042570, CRD42016042573,
CRD42016042574, CRD42016042576, CRD42016042575, CRD42014014850, CRD42015023877
and CRD42015024820.
Funding: This project was funded by the National Institute for Health Research (NIHR) Programme
Grants for Applied Research programme and will be published in full in Programme Grants for Applied
Research; Vol. 9, No. 5. See the NIHR Journals Library website for further project information.
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Plain English summary
Vascular services deal with people who have circulation problems. These problems include varicoseveins or poor circulation in the legs, bleeding from burst blood vessels and disease in the neck
arteries that may cause strokes.
Services have changed in recent years owing to new treatment methods and increased specialisation.
This has resulted in the need for reorganisation of services. Our research programme has studied the
aspects of services that are important to patients, how they may be best organised to provide better
outcomes and how the results of treatment can be assessed.
We have reviewed the published evidence to see how a difference in the way that services are
organised can affect results. This shows that some centralisation of services is likely to produce better
outcomes. However, we have carried out a study to measure the importance that people attach to the
location of services and the method of treatment, which has shown that these are highly valued and
may be important in planning services.
Information from patients and doctors relating to their experience of the conditions and treatments has
been used to develop an electronic questionnaire (the electronic Personal Assessment Questionnaire –
Vascular) to collect and record information to help doctors and patients decide on the best treatment
and monitor the results. This has been tested in a sample of NHS patients using vascular services.
An adapted version is being used to collect data relating to aneurysm screening.
Finally, we have used the information that is routinely collected about patients with vascular conditions
to develop computer models of the effects of rearranging services. This helps predict the best way to
organise services and the impact that this is likely to have on the kind of treatment used, the number
of patients treated and the outcomes. The model is available online and is already being used to help
inform local service reconfiguration.
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There have been extensive changes in the delivery of vascular services over the past 20 years. New
technologies have been introduced that cross traditional disciplinary boundaries and a new specialty of
vascular surgery has been created that deals with a range of complex and often urgent or emergency
procedures. This has significant implications for workforce planning and training arrangements and has
resulted in the need for service reconfiguration. The planning, monitoring and evaluation of such changes
requires the availability of suitable information on the effects that this has on practice and outcomes.
Objectives
The overarching aim for the programme was to develop data sets, outcome measures and
cost-effectiveness models that inform the development and evaluation of high-quality subspecialist
vascular services. To achieve this, substudies were carried out to identify the features that are
important to patients, clinicians and commissioners, and to address these through the use of existing
or new outcome measures and through developing methods to analyse routine data sources. Further
objectives of these studies were to inform the development of a new electronic tool for the collection
of clinical information and patient-reported outcomes and the development of computer models that
could be used to predict the effects of organisational changes.
Methods
The programme was divided into four main workstreams that were closely linked and used a range
of methods.
Workstream 1: the identification of current service arrangements and analysis of Hospital
Episode Statistics
Systematic literature reviews were carried out to evaluate published evidence relating to the
relationship between hospital or surgeon volume of activity and outcomes for people with vascular
disease. A single search strategy was developed and subsequently divided into three main areas of
interest: abdominal aortic aneurysm, peripheral artery disease and carotid artery disease. Standard
review methods using a published risk-of-bias tool were used following a published protocol (Phillips P,
Shackley P, Kaltenthaler E, Poku E, Essat M, Woods H. Volume-outcome Relationships in Peripheral
Vascular Surgery: A Systematic Review. PROSPERO 2014 CRD42014014850. URL: www.crd.york.ac.uk/
prospero/display_record.php?ID=CRD42014014850; accessed 1 December 2020).
An analysis of a Hospital Episode Statistics extract of linked data for all patients who had a vascular
inpatient episode between 2002/3 and 2017/18 was subsequently limited to index episodes since
2008/9. The analysis included detailed mapping of data based on diagnostic, procedural and other codes
to classify episodes relevant to vascular services and identify potential outcome measures, comorbidities
and measures of resource use. This was carried out through an iterative process with a clinical consensus
group, developing coding algorithms in R (The R Foundation for Statistical Computing, Vienna, Austria) to
develop clinically meaningful categories of vascular activity and measures of outcome and to identify
aspects of a service configuration, such as changes in site and travelling distance.
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Further analysis compared Hospital Episode Statistics details with publications from the National
Vascular Registry concerning activity and service configuration and a case study of known service
reconfiguration.
Workstream 2: the identification and development of outcome measures
Systematic literature reviews assessed psychometric evidence of existing patient-reported outcome
measures for conditions managed by vascular services and reviewed published qualitative research to
identify aspects of vascular disease that are relevant to patients. For all systematic reviews, protocols
were registered prior to their conduct. Reviews were carried out in line with the recommendations made
by the Preferred Reporting Items for Systematic Reviews and Meta-Analysis, the Oxford system and
the Consensus-based Standards for the selection of health Measurement Instruments, as appropriate.
For the reviews of existing outcome measures, a two-stage search procedure was developed in which
preliminary searches identified potential generic and disease-specific outcome measures for each area of
vascular disease and subsequent secondary searches included more detailed searching on the measures
that had been identified as potentially relevant. The reviews were split into five key clinical areas:
peripheral artery disease, abdominal aortic aneurysm, carotid artery disease, varicose veins and venous
leg ulcers.
An electronic, web-based data collection tool for use with patients with vascular disease (the electronic
Personal Assessment Questionnaire – Vascular) was developed and evaluated using an established
process through four stages. In stage 1, the systematic reviews mentioned above and a primary
qualitative study using semistructured interviews with patients living with a range of vascular conditions
identified the main areas of quality of life affected by vascular disease and developed key themes for
consideration in the electronic Personal Assessment Questionnaire – Vascular. A consensus exercise
with vascular clinicians considered these initial themes and assessed their importance from the clinician’s
perspective. In stage 2, the evidence from the systematic reviews, qualitative study and clinicians’
consensus study was used to develop the items for inclusion in the questionnaire, which were tested in
a face validity exercise with clinicians and patients. In stage 3, a survey was carried out to reduce the
number of items and confirm the domain structure of electronic Personal Assessment Questionnaire –
Vascular. Finally, in stage 4, an additional survey was carried out to evaluate the psychometric properties
of the instrument, including test–retest reliability, known groups validity and responsiveness.
Workstream 3: the evaluation of non-health service attributes
The third workstream evaluated societal preferences for aspects of service other than clinical
outcomes that were important to decision-making. Two key issues were identified as important to the
modelling of service configuration, the travelling distance to access vascular services and the choice
between minimally invasive and open surgery, as exemplified by the difference between endovascular
aneurysm repair and open surgical repair. A trade-off exercise was carried out using written scenarios
describing the potential outcomes and visual aids to describe the possible choices. Participants were
asked which of the specific scenarios they would prefer and an iterative process was used to establish
the additional risk they would accept for their preferred option.
Workstream 4: the development of vascular service models
The modelling of vascular services was carried out by using a simulation based on three main areas
of vascular disease: abdominal aortic aneurysm, carotid artery disease and peripheral artery disease.
For each of these a simulation model was developed with the main inputs derived from an analysis of
Hospital Episode Statistics, which were used to generate regression models to predict the hospital
costs and outcomes after vascular treatment. Data that were not available from Hospital Episode
Statistics were identified from additional searches of published sources. All statistical analyses were
carried out in R and the simulation was also developed in R with an interactive user interface that
could be deployed as a web-based application. All costs were reported in Great British pounds at
2017/18 prices, and costs and outcomes were discounted at 3.5% per year.
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The systematic reviews of the relationship between activity and outcome suggested that increasing
hospital volume was associated with reduced mortality for both carotid artery disease and abdominal
aortic aneurysm repair. For peripheral artery disease, the evidence suggested that an increase in
hospital volume was associated with a higher rate of repeated treatments and a lower rate of
post-operative amputations.
Hospital Episode Statistics data demonstrate several trends in practice and workload. Both emergency
and elective abdominal aortic aneurysm treatments are declining, with an increasing proportion of
endovascular aneurysm repairs, although there is substantial regional variation in practice. Overall
mortality and length of stay are declining for most patient groups. For peripheral artery disease, the
number of admissions is falling, apart from minor amputations, which have increased substantially
over the period of the study. There is considerable local variation, particularly in relation to the use of
endovascular treatments and inpatient investigations. Carotid artery disease admissions have fallen,
with an increasing proportion of emergency admissions.
Varicose vein treatments fell rapidly in 2011/12, but have subsequently increased again, with the modalities
of radiofrequency ablation and endovascular laser therapy having largely replaced open surgery.
Comparisons of Hospital Episode Statistics data and National Vascular Registry publications
demonstrated similar findings regarding the configuration of services but highlighted some of the
potential pitfalls in the different ways in which mortality is recorded and reported and the limitations
of a procedure-based registry without data linkage.
Workstream 2
The reviews of patient-reported outcome measures showed that Short Form questionnaire-36 items and
EuroQol-5-Dimensions were the most widely used generic measures with some evidence of acceptability
but poor evidence of responsiveness and little full psychometric evaluation. For most conditions there was
an absence of well-validated disease-specific questionnaires. For varicose veins the Aberdeen Varicose
Vein Questionnaire was the most extensively validated but had questionable content validity. Overall, the
systematic reviews did not identify appropriate disease-specific questionnaires that were well validated
and could be directly incorporated into the electronic Personal Assessment Questionnaire – Vascular.
Framework analysis on the primary qualitative data identified six overarching themes relating to the
impact of the conditions. These were symptoms, impact on physical function, social impact, psychological
impact, financial impact and lifestyle. These conditions were mapped and tabulated and those areas
common to multiple conditions were identified. The synthesis of published qualitative data identified a
number of overlapping domains and confirmed many of the findings of the primary research. The domains
and themes identified from these studies were used to inform the development of the questions for the
electronic Personal Assessment Questionnaire – Vascular.
The electronic Personal Assessment Questionnaire – Vascular development process used the primary
qualitative and systematic review evidence to generate 168 items, of which 59 were initially eliminated
because of repetition. The instrument was divided into one generic and three disease-specific sections
for abdominal aortic aneurysm, carotid artery disease and lower limb conditions, and grouped across
eight scales. These were assessed for usability, accessibility and appropriateness. Confirmatory factor
analysis using data from 628 patients revealed eight distinct scales and the results were used to
reduce the items that exhibited local dependence. A second quantitative survey, carried out in a sample
of 721 patients with a range of vascular conditions, was used to further evaluate the psychometric
properties of the 55-item electronic Personal Assessment Questionnaire – Vascular. The results
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showed good known group validity in line with prespecified hypotheses, acceptable test–retest
reliability (n = 181) and good responsiveness (n = 55) with moderate to large effect sizes.
Workstream 3
For the study of process utilities relating to abdominal aortic aneurysm repair, a total of 209 participants
were recruited and overall results suggested that a majority would prefer endovascular aneurysm
repair and would be prepared to trade expected quality-adjusted life-years for the less invasive process.
Those who were willing to trade were estimated to be willing to give up, on average, 0.135 expected
quality-adjusted life-years for the preferred treatment.
For the questions relating to location of services, a total of 608 patients were recruited across the
three diagnostic areas of abdominal aortic aneurysm, carotid artery disease and peripheral artery
disease. In summary, for the various scenarios the results showed that 55.5–66.2% would require some
compensation for increased travel distance. For example, the magnitude of the required compensation
for travelling an additional 30 miles ranged from 0.2 quality-adjusted life-years for carotid artery
disease treatment to 0.63 quality-adjusted life-years for peripheral artery disease.
Workstream 4
Three separate simulation models were developed for abdominal aortic aneurysm, carotid artery
disease and peripheral artery disease. These were combined to develop a single holistic model to
simulate previous, current and predicted activity, costs, resource use and outcomes for any subset of
hospital sites in England. The model allows various assumptions and configurations to be chosen via
a web-based interface and will provide predicted results with the overall workload and outcome
estimates and evaluation of the cost-effectiveness for the chosen models of configuration.
The model performance was validated through comparison of the simulated and actual data and by
comparing actual and predicted effects of known reconfigurations, during the period for which Hospital
Episode Statistics data were available. In both of these investigations, the model performed well.
Conclusions
The programme of research has developed a broad range of evidence regarding the current
arrangements of vascular services, the nature and quality of current outcome measures and the
current trends and variation in practice that relate to particular aspects of service configuration.
The programme has gone on to develop two major tools that may be of value in planning, delivering
and evaluating future vascular services. The electronic Personal Assessment Questionnaire – Vascular
is a web-based tool for the collection and evaluation of patient-reported outcome measures and other
information of relevance to clinical management and service evaluation. The second is a web-based
simulation model that predicts the effects of service reconfiguration.
The data analysis suggests that there is considerable variation in practice with regard to vascular
services, with variable uptake of new technologies, such as the use of minimally invasive treatment
for abdominal aortic aneurysm and peripheral artery disease, and new modalities for the treatment
of varicose veins. In addition, there is confirmatory evidence of the potential benefits of service
reconfiguration to create larger centres with the critical mass and volume of activity necessary to
achieve optimum results. Although the recommendations of the NHS service specification and the
provision of vascular services document suggest that centres should be large enough to carry out a
minimum of 60 aneurysm procedures per year, the evidence from the analysis suggests that further
gains may be achieved by increasing this threshold further to levels of around 100 cases per year.
The analysis of activity data suggests that, although some smaller centres have merged to attain
the necessary activity levels, there remain many areas in which further gains may be achieved by
similar reconfiguration.
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One of the main limitations of the study is the nature of the data available for the evaluation of services.
One key implication for the delivery of high-quality services is that there is an urgent need to develop
systems that allow the collection of richer clinical data and its linkage to administrative data sets.
Although the National Vascular Registry is collecting high-quality clinical information, this is a procedure-
based registry relating to a number of selected procedures. Data attainment is incomplete and the lack
of linkage to administrative data sets means that it is not possible to obtain clear follow-up information
regarding repeat procedures, re-admissions, late complications or mortality.
Another key implication of the research findings is the need for individual regions to consider options
for reconfiguration, where small units continue to offer services that are below the recommended
threshold for activity level, and to identify the existing barriers to reconfiguration. Improvements in
cost-effectiveness that may be attained by reconfiguration need to be considered in the context of
evidence for strong preferences for local treatments. The results suggest that there may be considerable
opportunity for more integrated services in which major vascular procedures are carried out at a single
site, but collaborative working arrangements allow those patients who can safely be treated with minor
procedures, investigations or rehabilitation services, to be managed at a more local site.
In terms of recommendations for further research, the electronic Personal Assessment Questionnaire –
Vascular tool has been developed and shown to have good psychometric properties. However, further
work is required to evaluate its usefulness in wider clinical practice and its potential for monitoring
service outcomes.
A second research recommendation relates to the linkage of clinical data from the National Vascular
Registry and routinely collected patient-reported outcome measures to administrative data from
Hospital Episode Statistics to attain a more accurate picture of clinical outcomes, resource use and
patient pathways.
Study registration
This study is registered as PROSPERO CRD42016042570, CRD42016042573, CRD42016042574,
CRD42016042576, CRD42016042575, CRD42014014850, CRD42015023877 and CRD42015024820.
Funding
This project was funded by the National Institute for Health Research (NIHR) Programme Grants for
Applied Research programme and will be published in full in Programme Grants for Applied Research;
Vol. 9, No. 5. See the NIHR Journals Library website for further project information.
DOI: 10.3310/pgfar09050 Programme Grants for Applied Research 2021 Vol. 9 No. 5
Copyright © 2021 Michaels et al. This work was produced by Michaels et al. under the terms of a commissioning contract issued by the Secretary of State for Health and
Social Care. This is an Open Access publication distributed under the terms of the Creative Commons Attribution CC BY 4.0 licence, which permits unrestricted use,
distribution, reproduction and adaption in any medium and for any purpose provided that it is properly attributed. See: https://creativecommons.org/licenses/by/4.0/.




This section provides some background regarding the changes in vascular services in recent yearsthat have arisen from technological developments and the introduction of a new specialty,
which have led to the need for reconfiguration. An overview is given of the programme aims and
objectives, the structure of the workstreams and the changes from the original protocol. The main
components of each study are described, followed by a brief comment on patient and public
involvement in the programme.
Background
In providing any clinical service, there is tension between maximising efficiency, cost-effectiveness
and other desirable features of the service. Financial pressure on providers encourages efficiency,
maximising activity for the minimum possible cost. Commissioners wishing to maximise cost-effective
use of resources are interested in wider outcomes. However, they are limited in their ability to identify
clinically meaningful outcome measures or validated proxy measures and process attributes that
adequately reflect service quality and can be derived from currently available data sources. Other
service attributes of importance to service users and wider society, such as equity, processes of care
and dignity, are not routinely assessed but may be significantly affected by service reconfiguration.
For example, when considering potential models for devolved or centralised services, the need for
providers to maximise efficiency may produce adverse incentives that encourage smaller independent
units to increase activity by treating cases where effective management could be better provided by
a larger unit. However, the same drivers may cause centralised units to consolidate on a single site,
reducing patient choice and accessibility and potentially reducing equity. It is thus vital that in planning
services the key desirable attributes are identified, their relative importance is understood and there is
a means available to monitor the effects of any changes.
There is currently enormous pressure for the reconfiguration of vascular services due to many
conflicting requirements. Vascular surgery has separated from general surgery, progressing from a
situation in the late 1990s with only a handful of centres with sufficient specialist clinicians to offer
separate emergency vascular services1 to the situation when the programme was planned, when
about half of vascular surgeons had no general surgical practice.2 In July 2011 the four Departments
of Health and Social Care in the UK agreed to the formation of a new specialty of vascular surgery,
and a Specialist Advisory Committee was established and began specialty training year 3 in
October 2013. Since then, most vascular and general services have separated completely, with
< 10% of vascular services providing any general surgical cross-cover in 20153 and only 5% of
vascular surgeons providing any general surgery in a 2018 vascular workforce survey.4
These changes, and similar subspecialisation in vascular radiology, are driven partly by technological and
clinical developments, such as new minimally invasive treatments for peripheral arterial disease (PAD),
endovascular stent grafts for abdominal aortic aneurysms (AAAs), new treatments for varicose veins
(VV) and new imaging methods, such as magnetic resonance angiography (MRA) and computerised
tomography angiography (CTA).
Other drivers for service change have been the implementation of screening for AAAs (see www.gov.uk/
topic/population-screening-programmes/abdominal-aortic-aneurysm; accessed 1 December 2020),
scarcity of expertise in vascular interventional radiology,5 changes in training and working hours related
to the European Working Time Directive and recognition of the need for sustainable out-of-hours
specialist service provision.3
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Research carried out for the National Institute for Health Research (NIHR) Health Technology
Assessment (HTA) programme 20 years ago in a single region highlighted conflicting pressures:6
l the need to optimise health gains by planning activity in centres with access to specialist expertise, the
provision of emergency vascular and interventional radiology services and multidisciplinary working
l workforce planning, staffing and training needs
l improving equity of access and outcome between socioeconomic and geographic groups
l patient preferences for attributes, such as location, travelling times, waiting times and processes of
care (including the availability of newer, minimally invasive techniques)
l links to other services, such as diabetes, general surgery, leg ulcer, cardiothoracic, stroke and
renal services
l resource availability and the capital and recurrent costs associated with reconfiguration.
Overview of the programme
The overarching aim of the research programme is to identify and draw together existing evidence
regarding vascular service configuration; to develop the tools necessary to plan and assess existing
services; and to predict and evaluate the results of reconfiguration. In the original application, the
programme was divided into four main workstreams that are closely inter-related and include a
number of substudies. Figure 1 provides an overview of the workstreams, the links between them and
the relevant outputs and appendices.
The main outputs of the programme are a new electronic Personal Assessment Questionnaire –
Vascular (ePAQ-VAS) to facilitate the collection of patient-reported outcome measure (PROM) data,
and a series of economic and decision analytic models that incorporate all of the current evidence to
allow the characterisation of current services and prediction of the effects of any reconfiguration at
either a local or a national level.
An interactive demo version of the ePAQ-VAS, a copy of a sample report and a demonstration of the
management’s site are available at www.epaq.co.uk/Demo/VascularDemo (accessed 1 December 2020).
The web-based interface for the organisational model can be accessed at https://modellers.sheffield.ac.uk/
vascularmodel/ (accessed 1 December 2020).
To develop these, separate strands of the research have involved a thorough evaluation of existing
outcome measures used in vascular services, collection of published and primary qualitative data about
vascular outcomes and developing and testing the ePAQ-VAS. This has been validated as a tool to
monitor clinical outcomes and is intended to be used on an individual patient basis in clinical practice,
and to provide aggregate data for assessing and monitoring the effectiveness of clinical services.
Further work has developed algorithms to produce consistent analysis of practice and outcomes from
routinely collected hospital data, which may be used in the future to evaluate the effects of reconfiguration.
Report outline
The following is a brief overview of each of the workstreams, as originally envisaged in the application,
describing the component studies and how these are incorporated into the report. The appendices
provide additional details of published papers and unpublished methods and results.
Objective 1: current service arrangements
The first objective was to characterise the existing arrangements for vascular services and to establish the
relationship between workload, case-mix and outcome and service configuration through an analysis of
routinely collected hospital data and existing published literature. This workstream comprised four substudies.
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Study 1a was the analysis of Hospital Episode Statistics (HES) to identify trends and variation in activity
and aspects of case-mix and outcome that can be established from routinely collected data sources.
This study depended on the analysis of HES; some initial problems were encountered in obtaining the
data from NHS Digital, which resulted in some delays in undertaking this aspect of the work. The task
also proved to be considerably more complex than what was originally envisaged. There were a variety
of reasons for this, including the lack of consistency in coding, with changes in both the coding systems
and the practices over the period of the study. There were also some difficulties encountered in
classifying cases with multiple and often conflicting codes and ambiguities.
Classification systems and algorithms were established that enabled consistent case-mix groups and
adjustment for comorbidities allowing comparisons to be made between workload, working practices,
resource use and outcomes that could be compared between centres based on service configuration
and used to identify trends over time (see Vascular activity and outcomes from routine data, Appendix 1
and Report Supplementary Materials 2–11).
These classification systems and algorithms were used to populate the modelling that was carried
out in workstream 4 to predict the effects of service reconfiguration on workload and outcome
(see Modelling the effects of service reconfiguration). Several publications and presentations arose from
this work that reported specific aspects of the trends and variations in workload, including a study of
the outcomes of aortic aneurysm surgery; papers on sex differences in rates of repair of emergency
AAA; papers on risk adjustment and trends in aortic aneurysm treatment; and a contribution towards
another NIHR-funded project7 that examined the potential cost-effectiveness of screening women
for AAA.8–12
This proposed workstream included a survey of current working arrangements for the provision of vascular
services. The intention was to carry out a survey in vascular centres in England to understand the current
working arrangements. However, prior to this study commencing, the Vascular Society of Great Britain and
Ireland (VSGBI) carried out a large survey of its members that covered most of the same subject matter.3
In view of this, a decision was made that it would not be helpful to carry out a further survey because it
would add little to the available information and would probably have a poor response rate from following
so soon after the audit. Instead, the results of the audit were reviewed and compared with the evidence
that was available from the analysis of HES to characterise working practices and identify geographical
areas in which some planned reconfiguration of vascular services had taken place in recent years or was
currently being planned (see Vascular activity and outcomes from routine data).
The third study that was included in workstream 1 related to an analysis of the practical effects of
organisational change on activity and identifiable outcomes. This aspect of the work is included in the
validation of the modelling (see Modelling the effects of service reconfiguration).
Finally, workstream 1 included a systematic review of the relationship between service configuration
and clinical outcomes (see Reviews of published literature). Considerable evidence was identified in the
literature and has resulted in a number of peer-reviewed publications in three separate areas: AAA
repair,13 lower limb vascular surgery14 and carotid artery disease (CAD) procedures.15
Objective 2: development of the electronic Personal Assessment Questionnaire – Vascular
The second objective of the programme was to develop, validate and implement condition-specific
and generic outcome measures that could be collected in electronic form and used in clinical practice,
as well as in aggregate form for the evaluation and monitoring of services. This workstream represented
a considerable proportion of the total work of the programme, and included an extensive evaluation of
existing outcome measures and a rigorous process for the development and implementation of a new
tool for measuring outcome in vascular services. The workstream consisted of a number of related
studies. The first of these was a systematic review of existing outcome measures (see Reviews of
published literature). This involved an extensive set of systematic literature reviews that identified
relevant outcome measures in each of the major disease areas dealt with by vascular services.
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The purpose of these studies was to identify any existing measures that could be incorporated into the new
electronic tool and to inform its development. These reviews resulted in publications and presentations
covering separate disease areas of AAA,16 PAD,17 CAD,18 VV19 and venous leg ulcers (VLUs).20
The second planned aspects of workstream 2 were a Delphi exercise and qualitative studies to identify
relevant symptoms, signs and impacts that should be included in the electronic outcome tool. In practice,
this included several different aspects of the outcome tool development. Systematic reviews of qualitative
evidence regarding issues that were important to patients resulted in several presentations and further
publications relating to PAD,21 CAD,22 VV23 and VLUs.24
Further primary qualitative research was carried out to identify additional themes from patients with
vascular disease and a Delphi exercise was carried out with health-care professionals, both of which
were used to inform the development of the new outcome measurement tool.
The third planned study in workstream 2 that was described in the original protocol related to the
evaluation of existing identified measures and domains identified from the literature reviews and qualitative
work to incorporate existing measures or develop new preference-based measures for the evaluation of
vascular services. Careful reviewing of the existing measures found that, other than the generic EuroQol-5
Dimensions (EQ-5D), none of these was considered to be suitable to be incorporated in the new instrument.
Therefore, a new preference-based measure, incorporating all of the necessary domains for the evaluation
of vascular services, was developed based on the literature reviews and qualitative studies. This is described
fully in Development of the electronic Personal Assessment Questionnaire – Vascular.
The final study of workstream 2 relates to the validation and evaluation of psychometric properties
of the ePAQ-VAS. The final version of the ePAQ-VAS was developed following a similar process and
subjected to a rigorous psychometric evaluation (see Development of the electronic Personal Assessment
Questionnaire – Vascular).
Objective 3: other service attributes
The workstream that related to the third objective was designed to establish the relative value that
society places on attributes other than health-related quality of life (HRQoL), such as travelling
distance and treatment processes. This was carried out using a trade-off methodology, and two key
areas were investigated in detail: those relating to process utility, specifically the difference between
endovascular and open techniques for the repair of AAA, and the travelling distances to a local or
central provider of vascular services (see Evaluation of non-health outcomes).
Objective 4: model development
The final workstream was related to the objective of developing models of service configuration. This was
carried out in two parts. The initial work involved the development of three separate models that covered
the clinical areas of AAA, PAD and CAD. Specific models for VV and other venous diseases were not
considered necessary because the clinical consensus was that these services would not be significantly
affected by reconfiguration of major arterial services.
Each of the models was developed using a conceptual framework based on clinical consensus
representing the pathways of care, characterised through the analysis of HES. These were populated
with data from the analysis of HES records and systematic literature reviews, and primarily used a
discrete event simulation. Models were calibrated using the HES data, and the potential effects on
workload and activity were validated using case studies identified from the HES statistics.
These models of individual disease areas were brought together in an interactive web-based model
that enables users to identify potential reconfiguration of services within particular geographical areas
and to predict the overall effects of potential service reconfiguration in terms of workload, resource
use, outcomes and cost-effectiveness (see Evaluation of non-health outcomes).
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Summary of changes from the proposal
Workstream 1: Hospital Episode Statistics data and service configuration
The survey of national current practice was not conducted because a survey of practice was completed
at the same time by the Vascular Society.
No other changes were made to this workstream. An extension to the programme grant was approved,
largely because of delays in obtaining the HES data from NHS Digital.
Workstream 2: reviewing
No changes were made to this workstream.
Workstream 2: development of the electronic Personal Assessment Questionnaire – Vascular
l Recruitment was restricted to a single centre because of delays and complexity in gaining the
necessary approvals and limitations in staff resources.
l The results from the Delphi exercise were of limited value with regard to item reduction because of
lack of agreement and a low response rate in the second round.
l For face validity, only face-to-face interviews were carried out and no focus group was organised.
This decision was taken because of the difficulty in recruiting a sufficient number of participants for
a focus group in a timely manner without delaying the factor survey.
l Rasch analysis was performed for certain sections of the ePAQ-VAS, but this was not possible for
sections completed by only a small group of patients. Additional item response test analysis
was performed.
Workstream 3: patient preference
Following further discussions with clinicians and modellers, it became apparent that there was a need
to expand the scope of the study to look at different organisational models with follow-up locally or at
the central hospital. In addition, as AAA treatment is the main driver for centralisation, it was felt that
there was a need to look in more detail at preferences for endovascular and surgical treatment options
per se. Finally, further developments were also required in the light of evidence of links between
centralisation and outcome for certain vascular treatments. On the advice of the clinicians, VV and
VLUs were dropped from the conditions to be included. This left three clinical areas to include: AAA,
CAD and PAD.
The method was revised to accommodate the changes by altering some of the details of the trade-off
choices, as described in Evaluation of non-health outcomes.
The initial proposal was for 200 interviews in each of the five clinical areas. With three clinical areas
looking at the travel distance to hospital and one area looking at the treatment process for AAA, this
initial target was revised down to 800 (i.e. four telephone surveys with 200 interviews in each).
Workstream 4: modelling
Based on clinical advice regarding the likely changes that would drive reconfiguration, the individual
disease models that informed the overall model of service configuration were limited to the three
clinical areas of AAA, CAD and PAD.
Patient and public involvement
The Sheffield Teaching Hospitals NHS Foundation Trust Online Public Advisory Panel provided
feedback on the study materials throughout the development of the study. In the summer of 2016,
the patient and public involvement (PPI) panel reviewed study documents, including the participant
SYNOPSIS
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information sheet and invitation letter, and feedback was used to revise the wording of these documents.
Moreover, members of the PPI panel participated in mock interviews using the AAA interview schedule.
The overall aim was to test the language, structure and comprehension of the study materials to gather
feedback and refine the survey. The feedback obtained included suggestions on the wording and design
of study materials and the need to present risk (percentages) in an understandable way. All of the
feedback was incorporated into the final version of the study materials. In particular, while presenting
risk, a simple diagram was designed to explain what was meant by ‘chance of success’. This was included
in the interview booklet and was used as a guide to decision-making during the telephone interview.
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Reviews of published literature
This section reports the results of the systematic literature reviews that were carried out as partof the programme. The first section deals with the systematic reviews of published literature
regarding the relationship between service configuration and outcome, which focused on three main
areas of lower limb vascular disease, AAA and CAD. The subsequent sections report the results of a
series of reviews to identify existing PROMs in each of the main disease areas (AAA, PAD, CAD, VV
and VLU) and separate reviews to identify qualitative evidence regarding the issues of importance to
patients with these conditions.
The effects of reconfiguration on practice and outcome
The relationship between the number of invasive procedures (volume) conducted by health-care
institutions or individual clinicians and the outcomes, such as mortality, has been discussed and
investigated in multiple conditions since the 1980s.25,26
Although evidence of an inverse relationship between the volume of vascular procedures performed and
the adverse outcomes is presented in previous systematic reviews and meta-analyses,27–37 the included data
are dated. The evidence primarily represents populations in the USA38 and is, therefore, of questionable
value in relation to contemporary UK practice. In the context of ongoing reconfiguration of vascular
services in the UK and recent technological advances in the treatment of vascular conditions, a series of
systematic reviews were conducted to evaluate the relationship between mortality and the volume of
vascular procedures undertaken by individual clinicians and/or hospitals in European populations.
Methods
In general, the reviews were conducted in four stages:
1. A protocol was developed with input from clinicians, information specialists and academics and
registered on PROSPERO (www.crd.york.ac.uk/PROSPERO/display_record.php?ID=CRD42014014850;
accessed 1 December 2020) prior to the conduct of each review.
2. A single search strategy39 that combined search terms for all vascular conditions was developed
and electronic searches were conducted in databases including MEDLINE, EMBASE™ (Elsevier,
Amsterdam, the Netherlands), Cumulative Index to Nursing and Allied Health Literature (CINAHL)
and PsycInfo® (American Psychological Association, Washington, DC, USA). Additional hand-searches
and citation searches were also conducted.
3. An overview of existing systematic reviews38 was undertaken. However, no relevant current
systematic review of high quality was identified that answered the research question.
4. Three systematic reviews relating to three discrete conditions, PAD, AAA and CAD, were
conducted. Systematic reviews were subsequently presented at international conferences and
published in peer-reviewed journals (see Appendices 2–4).13–15
Standard systematic review methods,40 in line with the Preferred Reporting Items for Systematic
Reviews and Meta-Analysis (PRISMA) recommendations,40 were followed and are detailed in the
published papers.13–15 A decision to focus on European populations was made because the organisation
and delivery of ‘socialised’ health care in these countries is similar, but not identical, to the UK NHS.
This is in contrast to the USA, where a market-led model is the norm.
The ideal method of identifying a causal relationship between an exposure or intervention (in this case,
volume) and an outcome is to conduct a randomised controlled trial; however, the studies included in
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these reviews were expected to be observational rather than experimental because of the practical and
ethics difficulties of randomising participants to high- or low-volume clinicians or institutions. It was,
therefore, judged to be important to evaluate studies on the effects of volume in accordance with
principles that would avert any understimation of the risk of bias or attribution of an inflated level of
certainty to any measure of effect size. A Cochrane Risk of Bias Assessment Tool for Non-Randomised
Studies of Interventions was considered to be appropriate for this reason and, therefore, was used to
assess the methodological quality of the included studies. Meta-analyses, although planned, were
judged to be inappropriate because of clinical and methodological heterogeneity and the risk of
selection, reporting and publication bias. Narrative syntheses were, therefore, conducted, with tabulation
of results reflecting the different clinical and procedural groupings presented in individual studies.
Results
Lower limb vascular disease14
Nine studies41–49 including 67,445 patients who had undergone diverse lower limb vascular surgery
were eligible for inclusion in the review: three from the UK, one from the UK and Ireland, two from
Sweden, two from Finland and one from Denmark. The evidence for an association between hospital/
surgeon volume and mortality was contradictory, but the findings suggest that high-volume hospitals
may undertake more repeated surgeries/revascularisations and limb salvage. An increase in hospital
volume was associated with a decrease in post-operative amputations at 30 days and 1 year, and,
similarly, an inverse relationship was identified between surgeon volume and amputation at 30 days.
There were insufficient data on other variables to draw firm conclusions.
Abdominal aortic aneurysm13
Sixteen studies50–65 evaluating the volume–outcome relationship in AAA patients were included in the
review: 11 studies from the UK, three from Germany, one from Norway and one from a combined UK
and Swedish population. Data for 237,074 individual participants were collected from administrative
databases and clinical registries incorporating a variety of clinical (elective, emergency and ruptured)
and procedural (open and endoscopic repair) groups. The study quality was affected by the reliance
on observational study designs. The evidence suggests that there is an inverse relationship between
hospital volume and short-term mortality in AAA repair. Insufficient evidence was available to reach
conclusions on the relationship between clinician volume and outcome and between hospital or
clinician volume and secondary outcomes, including complications and length of hospital stay.
Furthermore, clear guidance on volume thresholds for practice was not identified.
Carotid artery disease15
Eleven studies61,66–76 investigating the volume–outcome relationship met the review eligibility criteria: five
from the UK, two from Sweden, one each from Germany, Finland and Italy, and a study of a combined
German, Austrian and Swiss population. Data from 233,411 participants were included. Two large studies
(179,736 patients) suggested that increased hospital volume was associated with reduced mortality in
carotid endarterectomy (CEA), with the number needed to treat as small as 165 and for combined
mortality and stroke as small as 93. The evidence was less clear for carotid artery stenting (CAS):
multiple analyses in three studies did not identify convincing evidence of an association.67,68,70,71 Limited
evidence is available on the relationship between clinician volume and outcome in CAS and CEA.
Discussion
The hypothesis that individual and institutional volumes are inversely related to adverse outcomes seems
plausible, and these reviews, based on the largest and highest-quality studies included, found evidence
that this is the case for CEA and AAA procedures. However, volume is a convenient but potentially
imprecise proxy for quality. The mechanisms by which any benefits are produced were not investigated
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in this review. For this reason, subsequent benefits are potentially difficult to replicate. It is questionable
whether or not simply centralising vascular procedures to be conducted by high-volume clinicians in
high-volume institutions will replicate the outcomes associated with a high volume of procedures.
The list of potential confounders is extensive, but includes patient age and sex, surgeon caseload,
hospital volume, comorbidities, surgical variables, American Society of Anesthesiologists grade,
vascular risk factors, type of hospital, day of procedure, transfer between hospitals, social deprivation,
staffing levels (medical and nursing), teaching hospital status, level of research activity and ratio of
high-dependency/intensive therapy unit beds to hospital beds. Any of these could be responsible for
some or all of the identified volume–outcome effect, either alone or in combination with other known or
unknown variables, and it is possible that interventions aimed at manipulating these variables could be
effective at improving outcomes for which a wholesale reconfiguration of vascular services might not.
Existing high-volume hospitals have infrastructure and human elements that differentiate them from
low-volume hospitals, and potentially from any new institution that is developed to tap into or benefit
from such an assumed relationship. It could be that increased volume may be necessary, but not
sufficient, to replicate the outcomes already achieved at existing high-volume hospitals. New high-
volume hospitals will need to recreate the conditions prevalent in existing high-quality, high-volume
hospitals if they are to achieve results comparable to the highest achieving high-volume hospitals.
The authors intended to determine the minimum procedure thresholds that doctors and institutions
should practise at to achieve acceptable outcomes; however, this was complicated by the range of
clinical and procedural categories that were assessed by the individual studies and it was inappropriate
to make definitive recommendations on the basis of the findings.
In addition, attempts to quantify the relationship between volume and outcome do not account for
the role of preference. The provision of centres that provide high enough volumes to meet minimum
volume criteria might be achievable and convenient in high-density populations, such as London and
other major conurbations. However, in more sparsely populated regions the provision of high-volume
centres would certainly mean an additional burden of travel to access health care, which could affect
patients’ decisions to access treatment. Parallel research conducted as part of this Programme Grant
does consider the role of preference.
Reviews of existing patient-reported outcome measures
Methods
The aim of the reviews of PROMs was to identify primary studies reporting psychometric properties of
PROMs in the relevant populations of English-speaking patients. The reviews were conducted in line with the
PRISMA recommendations,40 the Oxford system77 and the Consensus-based Standards for the selection of
health Measurement Instruments (COSMIN) recommendations.78 Protocols for the reviews are available in:
l Patient-reported Outcome Measures in Patients with Peripheral Artery Disease: Protocol for a
Systematic Review79
l Patient Reported Outcome Measures in Patients with Abdominal Aortic Aneurysms: A Systematic
Review Protocol80
l Systematic Review of Patient-reported Outcome Measures in Patients with Chronic Venous Insufficiency
(www.crd.york.ac.uk/PROSPERO/display_record.php?ID=CRD42015024820; accessed 1 December 2020)
l Patient Reported Outcome Measures in Patients with Carotid Artery Disease: A Systematic Review
(www.crd.york.ac.uk/prospero/display_record.php?RecordID=23877; accessed 1 December 2020).
In summary, a two-stage search was conducted in MEDLINE and MEDLINE In-Process & Other
Non-Indexed Citations to identify potentially relevant studies. The search strategy was further
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translated across selected major databases. Related outputs from literature searching were presented
at conferences.39,81 Supplementary literature searches were also undertaken. Randomised studies and
non-randomised studies were included if they reported the development and/or validation of generic
and condition-specific PROMs in participants with AAA, CAD, PAD, VLU or VV. Owing to issues
with language and cultural adaptations, PROMs administered only as original English-language
questionnaires were considered eligible for inclusion. Study selection, data extraction and quality
assessment were carried out independently by a minimum of two researchers. Discrepancies were
checked and resolved by discussion and, if needed, by referral to a third researcher.
Study-specific criteria for assessing the methodological quality of the included studies were adapted
from the COSMIN checklist, University of Oxford PROMs development criteria and other sources.82–87
The psychometric performance of PROMs, according to population of interest, were then summarised
as follows: 0, not reported; –, evidence not in favour; +/–, conflicting evidence; and +, evidence in
favour. Findings were analysed and presented narratively.
Results
Details of the published systematic reviews of PROMs, with further details of the review results, are
provided in Duncan et al.,16 Poku et al.,17 Essat et al.,18 Aber et al.19 and Poku et al.20
Peripheral arterial disease17
Psychometric evaluation of six generic and seven condition-specific PROMs reported in 14 studies90–103
contributed data to the review. The most frequently reported measure was the Short Form questionnaire-36
items (SF-36) (n = 11 studies); others included the Walking Impairment Questionnaire (n = 8 studies),
EQ-5D (n = 5 studies) and the Vascular Quality of Life Questionnaire (n = 3 studies). Studies included
a diverse PAD population and varied in methodology, including approach to validation of PROMs.
Substantial variations in the reporting of clinical presentation of PAD, management strategies and
administration of instruments were noted. Evidence of superiority in the psychometric performance of a
single PROM could not be established. Furthermore, no study provided evidence of a full psychometric
evaluation in the patient population.
Abdominal aortic aneurysm16
Four PROMs from three studies104–107 were identified in the psychometric review of PROMs in AAA:
the SF-36, the Australian Vascular Quality-of-Life Index (AUSVIQUOL), Aneurysm Dependent Quality
of Life (AneurysmDQoL) and the Aneurysm Symptoms Rating Questionnaire (AneurysmSRQ). The
SF-36 showed good evidence of internal consistency, construct validity and responsiveness, but
did show some floor and ceiling effects in one of the studies. There was evidence to suggest low
acceptability, especially in older patients. The AUSVIQUOL showed good content validity because it
was developed by interviewing patients with an AAA as well as other conditions. The responsiveness
and internal consistency of the AUSVIQUOL have not been assessed. The AneurysmDQoL and
AneurysmSRQ are both condition-specific measures of health and HRQoL, and have comparable trend
scores, but a conventional psychometric evaluation has not yet been performed. None of the identified
PROMs has undergone a rigorous psychometric evaluation in the AAA population.
Carotid artery disease18
Five studies108–112 were included that reported on six PROMs: the SF-36, the EQ-5D, the Hospital
Anxiety and Depression Scale (HADS), the Dizziness Handicap Inventory, the quality of life (QoL)
for CAD scale and a disease-specific PROM for CAS. The rigour of the psychometric assessment
of the PROMs was variable, with most attempting to assess only a single psychometric criterion.
No study reported evidence on construct validity and test–retest reliability. Evidence for acceptability
for the use of the SF-36, the EQ-5D and the disease-specific PROM was rated good in most studies.
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Only one study reported a Cronbach’s alpha score of > 0.70 as evidence of internal consistency.
Overall, the psychometric evaluation of all included PROMs was rated as poor in the CAS population
undergoing revascularisation.
Varicose veins88
Nine studies113–121 reported on aspects of the development and/or validation of one generic (SF-36)
and three disease-specific [Aberdeen Varicose Vein Questionnaire (AVVQ), Varicose Veins Symptoms
Questionnaire (VVSymQ) and Specific Quality of Life and Outcome Response – Venous] PROMs.
The evidence from the included studies provided data to support the construct validity, test–retest
reliability and responsiveness of the AVVQ. However, its content validity, including weighting of the
AVVQ questions, was biased and based on the opinion of clinicians, and the instrument had poor
acceptability. The VVSymQ displayed good responsiveness and acceptability rates. The SF-36 was
considered to have satisfactory responsiveness and internal consistency.
Venous ulcers20
Ten studies122–131 with data for four generic PROMs and six condition-specific measures were identified.
No generic PROM showed adequate content and criterion validity; however, the EQ-5D, Nottingham
Health Profile (NHP) and the Short Form questionnaire-12 items (SF-12) had good acceptability.
In general, the EQ-5D showed poor responsiveness in patients with VLUs. Most condition-specific
PROMs demonstrated poor criterion and construct validity. Overall, there was some evidence of internal
consistency for the Venous Leg Ulcer Quality of Life (VLU-QoL) and the Sheffield Preference-based
Venous Ulcer questionnaire. Test–retest reliability was satisfactory for the Venous Leg Ulcer Self-Efficacy
Tool. The NHP and VLU-QoL questionnaire seemed to be the most suitable PROMs for use by clinicians.
However, a valid condition-specific PROM is still required.
Discussion
All of the systematic reviews contribute to the growing evidence of psychometric performance of
PROMs in patients with vascular conditions, although a majority of the included studies (n = 41) did
not report a complete psychometric evaluation of a single PROM. Widespread heterogeneity in the
study methodology, patient population and treatment pathway could, in principle, limit the conclusions
of the individual reviews. Therefore, these are important considerations in future research.
Reviews of qualitative evidence of vascular outcomes
Methods
The aim of the qualitative literature reviews was to examine the symptoms and quality-of-life domains
that are important from the perspective of patients with PAD, AAA, CAD, VV and VLUs. Searches were
conducted in CINAHL [via EBSCOhost (EBSCO Information Services, Ipswich, MA, USA)], MEDLINE and
MEDLINE In-Process & Other Non-Indexed Citations [via Ovid® (Wolters Kluwer, Alphen aan den Rijn,
the Netherlands)], EMBASE (via Ovid), Psycinfo (via Ovid), Social Science Citation Index™ (Clarivate
Analytics, Philadelphia, PA, USA)/Science Citation Index [via the Web of Science™ (Clarivate Analytics,
Philadelphia, PA, USA) and Dissertation Abstracts (ProQuest LLC, Ann Arbor, MI, USA) and theses. To
identify relevant evidence for the qualitative literature review, a search strategy was developed to
include condition terms, terms for patient-reported outcomes/patient views and terms for qualitative
studies. Free text and thesaurus terms, such as medical subject heading (MeSH) terms, were combined
using Boolean operators. The search was based on the search strategy created for the related reviews of
PROMs for each condition.16–20 A qualitative study filter was used and combined with relevant thesaurus
terms for qualitative studies.132 Further details of the condition inclusion and exclusion criteria are listed
in Table 1. The protocol for these reviews was published.133
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Qualitative studies were included if they reported on people’s health, QoL or experience of living with
one of the five vascular conditions. Studies were included if the population was people with PAD, AAA,
CAD, VV or VLUs and included semistructured interviews, descriptions, focus groups as standalone
studies or those embedded in a quantitative study.
Framework analysis was used for the analysis of the data for each review.16,21,23 The PROM domains
were used as the initial framework for the data analysis. The method of best fit was used to code text
into domains.134
TABLE 1 Summary of the inclusion and exclusion criteria for the qualitative reviews of five vascular conditions
Inclusion criteria Exclusion criteria
Patient’s health, HRQoL or experience of one of the five
vascular conditions listed below
Studies not in English
Clinicians’ views Studies with participants aged < 16 years
PAD
A defined population of participants with a diagnosis
of PAD, also described as peripheral vascular disease,
peripheral obliterate arteriopathy or peripheral arterial
occlusive disease or patients with clinical evidence of
any or a combination of the following, where PAD is
the confirmed or stated underlying cause: rest pain,
claudication, vascular spasms, ischaemic ulceration, necrosis
or gangrene of the limb, amputation
Undefined population of PAD patients and patients
with lower limb ulcers or amputations because of any
cause other than PAD
AAA
A defined population of participants with a diagnosis
of AAA
Patients with pseudoaneurysms
Patients with thoracic aortic aneurysms, involving
the aortic root, ascending aorta, aortic arch or
descending aorta
Patients with thoracoabdominal aneurysms
CAD
A defined population of participants with a diagnosis of
CAD who need, have had or are undergoing invasive
procedures. Participants undergoing treatment for stroke or
TIA secondary to a diagnosis of CAD
Unspecified or mixed populations that include CAS
patients. Patients with stroke or TIA not related to CAS
VV
A defined population of participants with a diagnosis of CVI
presenting with VV
An undefined population of CVI patients or patients
with acute venous obstruction, such as acute deep-vein
thrombosis
VLUs
A defined population of participants with a diagnosis of CVI
presenting with VLUs, oedema or skin discoloration
An undefined population of CVI patients or patients
with acute venous obstruction, such as acute deep-vein
thrombosis
Studies that include semistructured interviews, descriptions,
focus groups either as standalone studies or embedded in a
quantitative study. Must include both data collection and
data analysis
Quantitative studies with no primary qualitative data
reported
Published or unpublished
Full-text or structured abstract with all the relevant
information
Full-text or structured abstract with incomplete or
unclear evidence
CVI, chronic venous insufficiency; TIA, transient ischaemic attack.
REVIEWS OF PUBLISHED LITERATURE
NIHR Journals Library www.journalslibrary.nihr.ac.uk
14
The domains from the identified PROMs in the previous section were used for a triangulation exercise.
The domains from PROMs were mapped against the themes from the qualitative review synthesis
for each condition to explore which PROM items/domains captured the themes deemed to be most
pertinent to patients. A triangulation approach was followed whereby the researchers evaluated
whether the concepts were the same (agreement), offered similar concepts (partial agreement), were in
contradiction (dissonance) or were not present (silence).
Results
Five systematic reviews of qualitative evidence were completed to understand and summarise the
impact that PAD, AAA, CAD, VV and VLU have on the daily living of patients.16,21–24 The characteristics
and main findings of the studies included in these five qualitative evidence syntheses systematic
reviews are summarised in Table 2.
Peripheral arterial disease21
Eight papers135–142 fulfilled the inclusion criteria and were included in the qualitative evidence synthesis.
The mean age of the participants in the included studies ranged from 64 to 77 years, and the percentage
of male participants was 50–79%. The included studies reported the views of 186 patients with PAD
including patients with intermittent claudication (IC), chronic limb ischaemia (CLI) and amputation of lower
limbs as a result of PAD. The framework analysis of the primary and secondary data in the included papers
identified six main issues: symptoms, physical functioning, impact on social functioning, psychological
impact, financial impact and process of care. In total, 35 themes were identified.21
Abdominal aortic aneurysm16
Four studies were included;105,143–145 three of these four studies were conducted in Sweden in Swedish,
although the publications were in English. Two of the four studies carried out semistructured interviews
with patients who had an AAA identified by screening and were treated conservatively, one focused on
patients who received open surgery for the AAA and the final study presented a mix of patients being
treated conservatively and patients being treated with open repair (OR) or endovascular aneurysm
repair (EVAR). Four overarching themes were identified from the four studies included in the qualitative
synthesis: symptoms, functional outcomes, psychological outcomes and social outcomes.16
Carotid artery disease18,23
Only four papers146–149 fulfilled the inclusion criteria and were included in the qualitative evidence
synthesis: three of the included studies were from the UK and one from Sweden. The studies were
published between 2002 and 2013; the age of patients who had CAD in the included studies ranged
from 50 to 80 years and the percentage of male participants was 50–65%. The included studies





included studies Key themes
AAA 315 4 Anxiety and lack of physical symptoms
CAD 964 4 Symptoms, psychological and social impact, risk and service experience
PAD 973 8 Pain, compromised physical function, impact on social life
VV 1804 3 Adaptation – coping strategies employed to limit various impacts,
appearance of VV
VLU 1804 13 Pain, odour and exudate – impact on sleep, mobility and mood
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reported the views of 62 patients with symptomatic CAS; 24 of the patients were awaiting assessment
for surgery, 26 had undergone surgery and 12 were turned down for intervention and received best
medical therapy. The framework analysis of the primary and secondary data of the included papers
identified 18 themes. These were divided into five main domains comprising anxiety, impact on
personal roles and activities, effect on independence, psychological impact, and symptoms.22
Varicose veins23
Three independent studies150–152 that met the inclusion criteria were identified. The studies were
published between 2004 and 2016 and two were conducted in the UK and the other in Sweden.
Five overarching themes were identified: physical impact of VV, psychological impact, social impact,
adapting to VV and reasons for seeking treatment. Within these main themes, further subthemes
were identified: symptoms, symptom management, physical function, worry/anxiety, appearance, social
restrictions and relationships.88
Venous leg ulcers21
Thirteen studies reported in 16 papers153–168 met the inclusion criteria and were included in the review.
The studies were published between 1995 and 2014, with eight being conducted in the UK, three in
the USA, one in South Africa and one in Ireland. Following analysis of the included papers, the number
of main themes was reduced from five to four: physical impact, psychological impact, social impact and
treatment. Ulcer and treatment-related pain, as well as odour and exudate, appeared to have significant
and direct negative effects on QoL, with additional and cumulative effects on sleep, mobility and mood.
The range of reported symptoms was broad, unique to individuals and reflected the complexity of
developing instruments to measure the effects of this condition on patients’ symptoms and QoL
(see Poku et al.20).
Discussion
A total of 32 studies were included across the five reviews of existing qualitative research. The qualitative
evidence from these reviews identified major themes and several subthemes within each disease
area. There was some overlap between these themes. These qualitative data were used to develop the
conceptual framework for the new electronic PROM developed as part of this NIHR programme grant.
The evidence from the triangulation helped to identify where previous disease-specific PROMs fell
short in covering issues that were deemed to be important to patients with vascular disease. Further
detail about the use of these qualitative data in developing the new outcome measure is provided in
Development of the electronic Personal Assessment Questionnaire – Vascular.
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Vascular activity and outcomes from
routine data
This section provides a descriptive summary of the various categories of inpatient activity that arerelated to vascular services, based on a detailed analysis of HES data. The analysis is primarily
descriptive, but more detailed statistical analysis is included in the regression modelling of the key
diagnostic areas that is provided in Modelling the effects of service reconfiguration.
The methods developed for classifying admissions into appropriate clinical categories of vascular
activity are described, followed by the processes that were established for the identification of
measures of case mix, comorbidities, complications and outcomes. Data regarding changes and
variation in practice are reported, with additional detail included in Report Supplementary Materials 2–11.
A further analysis considers the process of reconfiguration of services over the past 12 years and
compares evidence from HES data with reports from the National Vascular Registry (NVR) and the
recommendations of the NHS service specification for vascular services.
Analysis of Hospital Episode Statistics data: general methods
A major part of the first workstream of the programme was the analysis of HES data to characterise
the workload of vascular services; identify trends in activity, working practices and outcomes; and
relate these to service configuration. This section outlines the processes involved in this analysis,
with further details given in the published papers and additional material provided in the appendices
and supplementary material. The section starts with a brief description of the nature of HES and
the process of obtaining the appropriate extract. Following this, there are sections relating to
the process for establishing consistent and clinically relevant groupings of vascular activity, the
identification of the sites at which the activity was carried out, methods for obtaining valid measures
of outcome from the data, and distinguishing comorbidities and complications.
The subsequent section provides some descriptive material regarding the services that are provided,
the trends in practice and configuration of services and outcomes. Further details of these analyses are
provided in Appendix 1 and published papers. The detailed risk models that were derived from HES
data to populate the economic models are described, along with other aspects of the modelling process,
in Modelling the effects of service reconfiguration.
Data extract
The main analysis of hospital activity case-mix, resource use, working practices and outcomes was
carried out based on an extract of HES data supplied by NHS Digital, and included all relevant fields
in an extract of inpatient episodes covering all likely vascular procedural and diagnostic codes (see
Report Supplementary Material 1). Further data extracts included linked records for all other inpatient
episodes, critical care episodes and death certification records from the Office for National Statistics
(ONS) for the cohort of episodes identified in the initial extract. The original data request was made
in July 2013; however, because of considerable delays and changes in procedure at NHS Digital, the
original data extract was not obtained until May 2015. When an extension request for the programme
was made in the autumn of 2017, a further request was made for an updated HES extract to include
the most recent years, but further delays resulted in the extract not being received until February
2019, leaving little time for further detailed analysis.
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The initial categorisation of data, as described below, was based on the first data set and revised and
updated following the receipt of additional data. However, because of the changes in coding and
limited resources, a decision was made to limit the final analysis base to the 12-year period from
April 2006 to March 2018, which was the most recent 12-year period that was available.
Hospital Episode Statistics data analysis
The process of analysing the HES data was largely carried out using custom-built programmes written
in the R software package (The R Foundation for Statistical Computing, Vienna, Austria) (see Appendix 1).
The following is a brief summary of the issues that were addressed for each of these stages of data analysis.
Cleaning of data
The HES data included a number of inconsistent, ambiguous, incomplete or duplicate records.
The initial stage of ‘cleaning’ involved the removal of duplicate records or records missing critical
information. Attempts were made to ensure that best use was made of the available data, for example
by combining information from duplicate records if one copy was missing a piece of information, such
as discharge date, that was included in another copy of the record. Thus, incomplete, overlapping or
duplicate records were merged where possible to produce valid data.
The development of vascular case-mix categories
To characterise admissions, a set of case-mix categories was defined to cover the majority of vascular
activity. This was an iterative process using a set of assignment rules based on procedural and diagnostic
codes and other fields of the HES records, where necessary. A clinical consensus group developed
an initial categorisation that included five main categories: AAA, PAD, CAD, VV and complex venous
disease including VLUs. Initial categorisation was carried out and aggregate data were tabulated and
considered by the clinical consensus group.
Where there were ambiguities or potential misclassification, the categories were refined using
different mapping algorithms or other fields within the HES data, resulting in significant modifications
of the mapping algorithms. In particular, venous ulceration was found to be largely indistinguishable
from mixed arterial and venous disease or ulceration due to arterial disease, so these were combined
in a single category of peripheral arterial and complex venous disease. There was also found to be a
significant vascular workload outside these categories, which varied between different centres based
on local practices. An additional category of ‘other vascular procedures’ was introduced to include
miscellaneous upper limb, visceral vessel, arterial venous malformations and vascular access procedures.
All cases were assigned to specific case-mix groups that fell within one of five final categories: AAA, PAD,
CAD, VV and ‘other’ vascular procedures. Where there were remaining ambiguities or contradictions within
the data set, specific algorithms were developed for the categorisation of cases that may lead to confusion,
such as where multiple conflicting codes were present or non-specific codes failed to distinguish between
activities that may be relevant to vascular or other services. Decision rules were developed by the clinical
consensus group for categorising such cases to relevant groups.
Examples of specific situations that required additional information for categorisation were (1) the
categorisation of emergency, ruptured and elective aortic aneurysm repair; (2) the identification of
amputations due to vascular disease as opposed to other causes, such as cancer or trauma; and (3) the
distinction between endovascular treatments for cardiac and non-cardiac arterial disease. In addition to
the categorisation based on procedural and diagnostic codes, it was necessary to develop a hierarchy
of procedures to allocate cases where multiple codes relating to the same admission may result in
conflicting categorisation (see Report Supplementary Material 2).
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Episodes and admissions
The HES records relate to individual episodes of treatment, but a stay in hospital may generate multiple
records relating to simultaneous, overlapping or sequential episodes. To provide clinically relevant
categorisation and accurate estimates of length of stay, resource use and procedure-related events, all
episodes were combined into continuous inpatient spells (CISs). These included all relevant information
from first admission to last discharge from hospital. A ‘key’ episode was identified as the first episode
that included the procedure determining the main categorisation of the hospital admission. This was
merged with further information from other episodes related to that same admission, including potential
indicators of comorbidity; outcome and resource use, such as secondary procedures; associated critical
care episodes; and diagnostic information relating to comorbidities or complications.
Having identified relevant admissions, one or more index admission was identified for each patient
using algorithms, as described in Appendix 1. For example, for AAA repair the index admission was
the first one in which an aneurysm repair procedure was recorded, whereas for PAD a more complex
algorithm was required. This was necessary, for example, to distinguish between amputations that were
carried out as a primary procedure and amputations that might be considered an adverse outcome of a
prior vascular reconstruction (see Modelling the effects of service reconfiguration).
Identification of treatment sites
To consider the effects of reconfiguration it was necessary to identify the sites at which procedures
were carried out. This was found to be a complex exercise owing to the ambiguities and contradictions
between the use of provider and the use of site codes within the HES record, the changes in coding,
inconsistent use of particular codes and organisational mergers or other changes in providers.
Further mapping was carried out to categorise all pairs of provider and site codes based on the geographical
location at which treatment took place through the identification of individual postcodes. In addition,
sites and place of residence [based on lower-layer super output area (LSOA) data] were mapped to
aneurysm screening areas for some of the geographical analysis (see Report Supplementary Material 3).
Identification of outcome measures
There are several potential outcome measures that can be identified from within the HES data and
different outcome measures are relevant to specific case-mix categories. This section deals briefly with
some of the issues in identifying outcome measures from the routine data set.
Mortality
For some high-risk procedures within vascular surgery, mortality is an important outcome measure but
raises a number of issues regarding the different potential ways to measure this and the ability to
correct for differences in case-mix.
The HES records include a field for discharge method, which identifies episodes that ended with the death
of the patient. A single hospital admission or spell of treatment may include multiple episodes, and this
is particularly true if a patient suffers a complication and is transferred to another specialty or hospital.
The use of a crude assessment of mortality based on discharge method of individual episodes is likely to
underestimate overall mortality. For this analysis, episodes were combined into CISs and in-hospital death
was identified if any of the merged episodes included a discharge method indicating that the patient had
died. An alternative for describing procedure-related mortality is to include deaths within 30 days of
the procedure. Some ambiguity may be created in defining 30-day mortality where there are multiple
procedures or no operative procedure during an admission. In these cases, the 30-day mortality was
defined from the date of admission for unoperated cases and from the date of the first index procedure
where there were multiple procedures. A patient admitted as an emergency may undergo investigative
procedures followed by one or more major vascular reconstructions; in such a case, the index date
would be taken as the date of the first major procedure.
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Both in-hospital death and 30-day mortality were potential outcome measures and may produce
different results (see Abdominal aortic aneurysm).
Re-admissions
The linkage of data allowed identification of patient pathways and re-admissions to hospital.
In particular, the NHS measure of re-admission to hospital within 30 days of discharge was identified
for all case-mix groups. In some cases, a further categorisation was required, as, for example, it is not
uncommon for a patient to be admitted for investigation and then undergo a further subsequent
planned admission for further treatment. The nature and type of re-admission were, therefore,
considered on a case-by-case basis for the different categories of admission. Re-admissions for repeat
procedures were identified within the full data set, and specific groups were identified that were
relevant to particular diagnostic categories. Examples include re-admissions for repeat of the same
procedure, further operative or endovascular procedures following treatment of peripheral arterial
disease, or admissions with a stroke diagnosis following CEA. These categories are dealt with under
the discussion of the results for the individual conditions.
Complications and comorbidities
Although HES records provide a rich source of diagnostic and procedural information, it can be difficult
to distinguish conditions that may be pre-existing comorbidities from those that occur as complications
of a treatment. A detailed piece of work was carried out to consider complications and comorbidities for
different conditions based on existing published categorisation.169 This was modified in the light of advice
from the clinical consensus group and making use of evidence from linked episodes prior to the index
admission to attempt to separate complications from comorbidities (see Report Supplementary Material 4).
The relevance of particular comorbidities or complications varies between the different diagnostic
categories and is described in more detail below. For example, in the case of the treatment of CAD,
although cerebrovascular accidents (CVAs) are an important complication of the treatment, they may
also be a pre-existing condition and indication for the treatment. In the latter case, they are likely to
indicate a higher-risk group of patients. By identifying those patients in whom a CVA was identified in
a prior admission or the same admission as a cause for emergency admission, some separation of these
groups is possible.
Cost analysis
A Healthcare Resource Group (HRG) code was assigned to each episode using the NHS Grouper algorithm
and a year-specific reference cost data set was used to cost the episode based on its HRG code, financial
year and other classification characteristics, such as mode of admission (elective, emergency or day case),
treatment specialty, excess bed-days and other unbundled procedures. Descriptive statistics, univariate
analyses and multiple regression models were used to investigate the costs and their variation. The R
software (version 3.4.1) was used for all data manipulation and statistical analyses (see Modelling the effects
of service reconfiguration and Report Supplementary Material 5).
Trends in case-mix, practice and outcome
Introduction
The following sections describe the overall trends in the activity carried out by vascular services over
the past 12 years. Each of the following sections deals with the main trends that have been observed
in the specific areas of AAA, PAD, CAD, VV and the miscellaneous ‘other’ category. For each of these
categories, the individual case-mix groups are considered in terms of the demographics, the variations
in practice, the introduction of new technologies and the information that is available regarding
outcomes. Detailed regression analysis of the factors determining short- and long-term outcomes is
provided in Appendix 6, and the relationships between hospital configuration, activity levels, practice
and outcome are discussed in the next section.
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Abdominal aortic aneurysm
Over the past 12 years, there have been considerable changes in AAA management, with the introduction
of a screening programme for men aged 65 years and the introduction of endovascular repair for
elective and, increasingly, emergency aneurysm repair. The overall number of elective aneurysm repairs
in England increased to a maximum of 4889 in 2011/12 and has been declining gradually since, although
the proportion of endovascular repairs has risen to a steady level of approximately 70% for the most
recent 3 years. Emergency procedures have declined steadily, from 3411 procedures in 2006/7 to 2302
in 2017/18, with the proportion of EVARs increasing steadily to 36.1% (Figure 2).
There is considerable variation in practice with regard to the use of EVAR. The proportion of patients
treated by EVAR varies between ≈ 30% and > 90% of elective cases, with similar variation for emergency
admissions. Over 25% of centres do not appear to offer any emergency EVAR service (Figure 3).
An increasing proportion of aneurysms treated by EVAR are classified as complex, being coded as
juxtarenal or suprarenal aneurysms, increasing from 8.1% in 2011/12 to 18.1% in 2017/18 (see
Discussion for a comparison with the estimates in the NVR report).
Table 3 provides summary data regarding the number and demographics, length of stay, critical care
usage, re-admission rates and mortality for each of the categories of aneurysm repair, averaged over
the most recent 3 years, and Figure 4 provides further details of the critical care usage for those
emergency and elective AAA admissions that necessitated a critical care stay.
Overall, mortality from elective AAA treatment has declined steadily, from 5.6% in 2006/7 to 2.7% in
2017/18, while mortality from emergency treatment fell from 32.2% to 22.3% over the same period.
This was partly because of an increase in endovascular treatment, although there has been a reduction
in mortality in all treatment categories (Table 4). The interpretation of mortality for emergency repair
is confounded by the difficulty in distinguishing between emergency and ruptured cases. In addtion,
the number of patients who die after being admitted with a ruptured aneurysm, but before undergoing
repair, may not be included in the figures. When considering these issues, both the mortality and the





































































FIGURE 2 Number of AAA admissions by year and category of admission.
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Based on linked data with repeat admission and ONS mortality data, Kaplan–Meier analysis of
long-term survival was carried out for some of the key diagnostic groups. Kaplan–Meier plots for
overall survival (OS) following AAA repair are provided in Figure 5, and show that OR is associated
with higher initial mortality but better long-term survival. These differences persist after correction for
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FIGURE 3 Proportion of elective AAA admissions treated by EVAR by year and volume of activity at treating centre
(box plot showing median, interquartile range and 10th and 90th centiles).
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TABLE 3 Demographics, resources use and outcomes for AAA admissions in England in 2015–18
Demographics Elective EVAR Elective open Emergency EVAR Emergency open Unoperated
Number 10,670 4307 2811 2989 1763
Age (years), median (IQR) 76.0 (70.0–81.0) 70.0 (65.0–75.0) 76.0 (70.0–82.0) 75.0 (68.0–79.0) 85.0 (79.0–89.0)
Age (years), mean (SD) 75.1 (7.7) 69.4 (9.0) 74.0 (12.1) 73.0 (9.9) 83.6 (8.1)
Proportion male (%) 86.8 87.0 79.7 82.1 63.1
Proportion diabetic (%) 18.2 13.2 15.1 11.8 14.3
Proportion elective (%) 100.0 100.0 0.0 0.0 1.1
LOS (days), median (IQR) 3.0 (2.0–5.0) 8.0 (6.0–11.0) 10.0 (5.0–19.0) 12.0 (6.0–23.0) 1.0 (0.0–3.0)
LOS (days), mean (SD) 5.1 (10.9) 11.6 (17.3) 17.9 (24.9) 20.2 (27.7) 3.4 (8.1)
Wait (days), median (IQR) 34.0 (16.0–62.0) 29.0 (14.0–52.0)
Wait (days), mean (SD) 48.3 (55.5) 40.8 (41.3)
Number admitted to critical care, n (%) 4805 (45.0) 3828 (88.9) 1905 (67.8) 2563 (85.7) 93 (5.3)
Hours in critical care, median (IQR) 27.3 (22.0–52.3) 70.1 (42.8–118.3) 66.0 (27.8–145.0) 98.0 (48.0–216.0) 32.7 (11.4–88.9)
Hours in critical care, mean (SD) 57.8 (147.8) 115.8 (232.2) 140.0 (229.7) 195.3 (297.7) 134.9 (389.7)
In-hospital death rate (%) 1.4 5.1 13.2 31.9 100.0
30-day mortality (%) 1.4 4.5 12.2 29.8 98.5
Combined post-operative mortality (%) 1.7 5.2 14.1 32.2 100.0
Second procedure (%) 0.3 0.6 1.7 1.1 0.0
Re-admission rate of survivors within 30 days of
discharge (%)
15.1 11.6 21.8 17.4

















































































































































































































































































































































































































The total number of vascular reconstructions (including all surgical and endovascular procedures) in
England increased from about 25,000 in 2006/7 to a maximum of nearly 33,000 in 2013/14, decreasing
to 29,000 in 2017/18. Over the same period, there was a gradual increase in the proportion that were
emergency admissions, from 27.7% to 31.1%. For elective admissions, the proportion that underwent
endovascular treatments remained constant at around 70%, whereas the proportion for emergency
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FIGURE 4 Length of critical stay for those emergency and elective admissions for AAA repair who were admitted to
critical care.
TABLE 4 Mortality for AAA admissions in England 2006–18 (death in hospital or within 30 days of procedure)
Year
Elective admissions (%) Emergency admissions (%)
EVAR Open Overall Ruptured Non-ruptured All (including unoperated)
2006/7 2.4 6.0 5.6 41.9 8.6 54.0
2007/8 2.9 6.2 5.4 39.3 8.0 51.2
2008/9 2.1 6.8 5.1 39.4 9.0 49.9
2009/10 2.3 6.1 4.2 36.7 9.3 48.2
2010/11 1.5 5.7 3.5 36.4 8.7 47.0
2011/12 1.8 6.0 3.6 37.3 8.3 45.6
2012/13 1.4 5.3 3.1 35.4 8.5 42.8
2013/14 1.6 4.8 3.1 36.2 9.5 43.2
2014/15 1.6 4.6 2.9 38.4 10.9 42.5
2015/16 1.2 5.7 2.7 38.2 9.4 40.2
2016/17 1.3 4.3 2.5 37.4 13.1 40.9
2017/18 1.4 4.4 2.6 34.9 9.9 40.1
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The number of major amputations fell from a peak of 5851 in 2008/9 to 5522 in 2017/18, with
approximately two-thirds being admitted as an emergency. Over the same period, the number of minor
amputations increased from 5410 to 8280.
All procedures for PAD are more common in men but the proportion varies by category, being highest,
at > 75%, for distal bypasses but just over 50% for elective minor amputations. Most patients with
PAD are aged > 60 years, with those admitted as an emergency, women and those with more distal
disease tending to be older.
Table 5 provides summary data regarding the demographics, length of stay, critical care usage and
re-admission rates and mortality for each of the categories of PAD admission, averaged over the most
recent 3 years (see Report Supplementary Material 7).
Mortality is high among patients with severe limb ischaemia (defined as emergency procedures, distal
bypasses, those with a current or preceding minor or major amputation or with a diagnosis of ulcer).
The median OS following angioplasty is just under 3 years and just over 6 years for open procedures,
with similar differences for amputation-free survival (AFS) (Figure 6).
Leg ulcers
Although the original intention was to consider those with VLUs as a separate group, it proved difficult
to reliably distinguish those with an arterial and venous diagnosis. This group, therefore, includes all of
those admitted with a diagnosis of leg ulcer, but no other vascular procedure including some arterial,
diabetic and venous diagnostic groups (see Appendix 1).
The total number of such admissions has risen steadily, from 5184 to 7659, with about 75% being
emergency admissions; the median age of such patients is 73 years, and 60% are men. Approximately
70% of the episodes relate to ulcers (with no recorded procedures) and have diagnostic codes relating
to diabetes and/or arterial disease, 10% have a varicose vein diagnosis, and the remainder have no
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FIGURE 5 Kaplan–Meier survival estimates for elective infrarenal EVAR and open AAA repair.
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Number 78,976 29,211 16,461 24,035 37,552 20,217 10,482 20,202
Age (years), median (IQR) 67.0 (52.0–77.0) 71.0 (59.0–80.0) 66.0 (54.0–76.0) 67.0 (56.0–77.0) 69.0 (61.0–76.0) 74.0 (64.0–82.0) 69.0 (62.0–76.0) 69.0 (58.0–77.0)
Age (years), mean (SD) 63.6 (17.8) 68.6 (15.1) 63.8 (15.9) 66.1 (14.5) 67.9 (11.6) 71.7 (13.3) 68.4 (10.7) 66.6 (14.9)
Proportion male (%) 53.2 62.0 71.0 68.0 66.8 60.1 76.3 67.0
Proportion diabetic (%) 21.5 44.8 46.2 64.4 30.9 49.5 28.3 27.6
Proportion elective (%) 42.7 38.9 34.7 50.2 100.0 32.5 100.0 36.9
LOS (days), median (IQR) 0.0 (0.0–7.0) 3.0 (0.0–12.0) 23.0 (9.0–48.0) 5.0 (0.0–15.0) 0.0 (0.0–1.0) 7.0 (1.0–17.0) 4.0 (2.0–6.0) 10.0 (5.0–20.0)
LOS (days), mean (SD) 8.4 (27.9) 11.3 (22.8) 35.2 (50.7) 13.2 (38.9) 1.4 (26.4) 15.0 (26.5) 6.2 (9.7) 17.7 (24.3)
Wait (days), median (IQR) 29.0 (14.0–49.0) 41.0 (15.0–84.0) 23.0 (7.0–60.0) 22.5 (8.0–55.0) 30.0 (15.0–55.0) 22.0 (12.0–40.0) 34.0 (14.0–64.0) 26.0 (11.0–55.0)
Wait (days), mean (SD) 40.7 (74.3) 61.5 (90.5) 46.2 (66.2) 41.8 (56.3) 44.1 (73.7) 31.5 (38.9) 48.0 (52.9) 41.8 (47.5)
Number admitted to
critical care, n (%)
12,077 (15.3) 1356 (4.6) 3177 (19.3) 623 (2.6) 548 (1.5) 1649 (8.2) 1772 (16.9) 7336 (36.3)
Hours in critical care,
median (IQR)
74.0 (38.0–165.2) 74.5 (32.9–159.3) 69.9 (25.3–166.3) 87.8 (33.7–206.1) 38.8 (22.1–74.6) 71.6 (32.5–156.9) 29.3 (21.0–65.3) 52.4 (24.0–114.8)
Hours in critical care,
mean (SD)
160.6 (314.3) 158.6 (378.4) 162.2 (311.2) 197.8 (394.3) 74.2 (133.2) 151.8 (251.6) 61.0 (127.3) 115.8 (232.8)
In-hospital death rate (%) 4.9 5.2 8.3 2.2 0.2 4.4 0.8 6.4






































































The number of CAD procedures increased to a maximum of 6299 in 2011/12, decreasing to 4711 in
2017/18, with the proportion of endovascular procedures increasing gradually to 10.4% in 2017/18 and
the proportion of patients who were emergency admissions increasing from 14% in 2006/7, to ≈ 35%,
where it has remained over the past 5 years. Approximately 66% of those patients undergoing surgery
are men with an average age of 71 years; those undergoing endovascular treatment were slightly
younger and including a higher proportion of women (Table 6 and Report Supplementary Material 8).
The median survival, free of re-admission with stroke, following a CAD procedure is 8.1 years for those
patients without a prior stroke and 6.2 years for those with a prior stroke (Figure 7).
Varicose veins
The total number of admissions for treatment of VV fell substantially between 2009/10 and 2012/13,
from nearly 40,000 to a low of just over 25,000 cases per year. The number of open procedures (high tie,
stripping, etc.) has continued to fall and been largely replaced by the new modalities of endovenous
laser treatment (EVLT) and radiofrequency ablation (RFA), with the total number of VV procedures
rising again in recent years.
The demographics of the treated population has altered over the past 12 years, with an increasing
proportion of men and an older population. Those treated by avulsions tend to be younger and include
a higher proportion of women (Table 7).
The different treatment modalities resulted in differences in re-admission rates for further VV
interventions. Within 5 years of the first recorded treatment, 40% of those treated by sclerotherapy
had been re-admitted, compared with ≈ 15% of those treated by open surgery, 20% treated with RFA
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FIGURE 6 Kaplan–Meier estimates for OS and AFS following open surgery and angioplasty for severe limb ischaemia.
OS, overall survival.
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TABLE 6 Demographics, resources use and outcomes for CAD admissions in England in 2015–18
Demographics Endovascular Endarterectomy
Number 880 12,819
Age (years), median (IQR) 66.0 (56.0–74.0) 72.0 (65.0–79.0)
Age (years), mean (SD) 63.9 (13.6) 70.9 (10.8)
Proportion male (%) 59.8 66.4
Proportion diabetic (%) 21.0 25.0
Proportion elective (%) 59.0 66.4
LOS (days), median (IQR) 3.0 (1.0–14.0) 3.0 (2.0–6.0)
LOS (days), mean (SD) 16.5 (39.6) 7.5 (17.6)
Wait (days), median (IQR) 13.0 (5.5–34.0) 7.0 (4.0–15.0)
Wait (days), mean (SD) 26.5 (37.0) 16.7 (41.9)
Number admitted to critical care, n (%) 286 (32.5) 5288 (41.3)
Hours in critical care, median (IQR) 47.7 (22.9–137.3) 24.0 (20.1–45.5)
Hours in critical care, mean (SD) 156.1 (257.6) 43.8 (86.4)
In-hospital death rate (%) 5.9 1.1
30-day mortality (%) 5.2 1.2
Combined post-operative mortality (%) 6.4 1.5
Second procedure (%) 1.5 0.2
Re-admission within 30 days (%) 12.5 10.9
Proportion with prior stroke (%) 9.2 17.0
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FIGURE 7 Kaplan–Meier survival estimates free of stroke re-admission following carotid treatment for those with and
without a prior stroke diagnosis.
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TABLE 7 Demographics, resources use and outcomes for VV admissions in England in 2015–18
Demographics RFA EVLT High tie, etc. Sclerotherapy Avulsions
Number 35,495 16,831 16,495 16,947 5398
Age (years),
median (IQR)
54.0 (42.0–67.0) 53.0 (42.0–66.0) 51.0 (40.0–63.0) 57.0 (45.0–69.0) 49.0 (39.0–60.0)
Age (years),
mean (SD)
54.3 (15.5) 53.8 (15.7) 51.6 (14.7) 56.6 (15.5) 50.1 (14.3)
Proportion
male (%)
44.4 43.6 46.0 37.6 29.3
LOS (days),
median (IQR)
0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.0 (0.0–0.0)
LOS (days),
mean (SD)
0.1 (6.7) 0.081 (3.3) 0.79 (6.7) 0.15 (12.9) 0.078 (0.82)
Wait (days),
median (IQR)
74.0 (42.0–121.0) 72.0 (42.0–112.0) 69.0 (37.0–116.0) 74.0 (41.0–120.0) 71.0 (38.0–116.0)
Wait (days),
mean (SD)
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FIGURE 8 Re-admission rates for VV treatments by modality of original treatment.
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Other diagnostic groups
A number of other diagnostic groups were identified that represent less common or more specialist
procedures that may, in some circumstances, be included in the vascular services workload. Less
common procedures include approximately 750 upper limb procedures per year, 250 visceral vessel
procedures and 300 procedures for arteriovenous malformations. An increasing proportion of these
are endovascular. Vascular services may also be involved in vascular access work for people with renal
failure or other diagnoses. This may represent a large workload and local arrangements vary, with an
increasing proportion involving endovascular procedures (see Report Supplementary Material 10).
Discussion
Hospital Episode Statistics provides a rich source of data regarding hospital activity but the data are
complex and can be difficult to interpret. There are a number of limitations in the coding systems
and other pitfalls in interpreting the data that are particularly relevant to understanding the nature
of vascular services. Specific issues that are important are the lack of detailed diagnostic codes for
distinguishing between important subgroups of vascular patients, such as those with critical ischaemia
and intermittent claudication. There are also difficulties in distinguishing between procedures or
diagnoses that may be either complications of treatment or comorbidities, for example stroke can be
both a complication of and an indication for carotid surgery and amputation can be a primary event
or the result of a complication of failed treatment. These problems are compounded by the lack of
adequate coding for laterality, which makes it impossible to distinguish between two procedures on
the same leg or separate procedures on both legs.
Another difficulty in interpretation arises from the nature of the data set, which is based on episodes
of treatment rather than admissions or patients; therefore, complex procedures of data linkage and
identification of overlapping and repeated episodes are necessary to understand pathways of care.
Where differences are identified, these may relate to real variations in clinical treatment or
inconsistencies in coding practice.
Although these limitations are recognised, HES provides a very rich source of data and is the only
complete database that will allow linkage of episodes throughout a patient pathway, which can also be
linked to data regarding mortality.
The detailed analysis of HES data that has been carried out for this programme of research has
addressed a number of the potential issues within the data through the methods developed for
cleaning and linking data and modifying algorithms for identifying case-mix, comorbidities and
complications, which take into account previous diagnoses and re-admissions. Although it is not
possible to address all the inconsistencies in coding, some attempt can be made to produce consistent
figures by identifying clinical groupings from within the data that are a proxy for certain subgroups,
such as those with severe or moderate limb ischaemia and those who are admitted with a ruptured
aortic aneurysm and die without vascular intervention.
Taken as a whole, the analysis of HES data demonstrates a number of trends. Overall outcomes,
particularly mortality related to AAA, appear to be improving over time. Although the reduction in
mortality is partly because of the move towards EVAR, there has also been mortality improvement
in each of the subgroups of treatment. Overall, there is a trend towards a reducing number of AAA
repairs, whereas for other diagnostic groups the overall levels appear to be relatively constant, apart
from a shift towards endovascular treatment, with an older population having greater comorbidity.
However, it is difficult to know whether the trend towards higher comorbidity is real or the result of
an increasing depth of coding in recent years, possibly related to the introduction of HRG groupings
that provide higher tariff rates for patients with additional comorbidities.
VASCULAR ACTIVITY AND OUTCOMES FROM ROUTINE DATA
NIHR Journals Library www.journalslibrary.nihr.ac.uk
30
In the treatment of VV, there was a considerable reduction in the number of procedures carried out
around 2011/12, but this has now gradually returned to the original rate.
There is considerable variation in practice, which is particularly notable with the adoption of new
technologies. In the case of aneurysm repair, the proportion of patients treated by EVAR varies
between providers from 30% to > 90%. There is also considerable variation in the proportion of AAA
cases classified as complex in the use of endovascular treatments for PAD and of endovenous
treatments (EVLT and RFA) for VV.
There are also marked variations in practice with regard to the use of inpatient or outpatient investigations,
with some providers appearing to carry out large numbers of investigations, including duplex ultrasound as
day-case admissions, whereas others appear to carry out investigations as outpatient procedures. This has
considerable implications for the difference in income that may be generated from treating similar conditions.
There are a number of potential areas for further research regarding HES data, which were not within
the remit of this programme. Further work is needed to identify the extent to which differences in
workload and cost represent differences in coding or reflect clinical practice. There may be a potential
for better classification algorithms, possibly through the use of machine-learning techniques, and
linkage of HES data to other sources with richer clinical information may allow better algorithms to be
developed for classification of case-mix.
The methods of classification of HES data do, however, provide a useful basis for comparison
between centres and over time. This is explored further in the modelling in Modelling the effects of
service reconfiguration.
Changes in working arrangements
Methods
The original protocol described a survey of working arrangements for centres undertaking the
management of vascular disease. During the planning stage of this aspect of the research it became
evident that the Vascular Society was carrying out an organisational audit of NHS hospital vascular
services that would duplicate much of the intended survey. The results of this organisational audit
were published as part of The National Vascular Registry: 2015 Annual Report10 and the audit has
subsequently been repeated with details of reported configuration of vascular services included in
the 2018 annual reports.3
In view of this, a decision was made not to carry out the survey, but to carry out further work to
analyse working arrangements that were evident from the HES data regarding hospital activity and to
compare these with the results of the published NVR audit.
The NVR audit is commissioned by the Healthcare Quality Improvement Partnership and carried out
by the VSGBI. It collects data regarding a variety of index procedures carried out by vascular specialists
in the UK.These include AAA repair, peripheral arterial surgery and endovascular treatments, amputations
and procedures for the treatment of CAD. Annual reports are prepared by the Vascular Society, and the
2015 and 2018 reports included the results of organisation audits of NHS vascular services that provided
information regarding service configuration, the range of facilities available at each site carrying out
treatment and the resources and staffing available. As part of the programme of research and the
validation exercise, the analysis of HES data has been compared with some of the details contained in
the NVR audit reports. This section of the report looks at the trends in vascular activity and makes a
comparison in three main areas: the organisational arrangements, the activity and the measures of
outcome used.
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The NVR audit was based on the criteria set out in the various versions of the provision of vascular
services document produced by the VSGBI and the National Service Specification for vascular services
published by NHS England.170
A detailed analysis was carried out of the trends in vascular activity. Sites were identified following the
processes described in Appendix 1. Vascular activity at these sites was summarised over the 12-year
period from 2006/7 to 2017/18 and sites were classified on the basis of the mix of procedures
available and the levels of activity (see Report Supplementary Materials 6–11).
Sites were initially classified based on the level of AAA surgery, and further analyses considered the
number of CAD admissions for this group.
There are a number of differences between the data collected by NVR and the data collected by HES,
as analysed in this programme, and it is important to take these into consideration when comparing
results. The NVR includes data from all four countries of the UK, whereas the HES data are restricted
to England. For this reason, we used only the subset of NVR data relating to trusts in England and
the corresponding data from HES. Although the NVR collects more complete clinical data, it is, a
procedure-based registry without data linkage and it is, thus, impossible to distinguish between
multiple procedures on the same individual and procedures on separate individuals. The analysis of
HES data enabled record linkage, and thus the identification of index procedures and re-admissions,
which is important when calculating mortality. The data sets may also differ because of coding errors
or ambiguities in the HSE data and because some cases may be missing from the NVR.
Another issue relates to the definition of sites in NVR. These are currently classified by the three-digit
provider code and providers may offer services on multiple sites. This issue becomes important,
particularly when considering ‘hub and spoke’ arrangements as discussed in Organisational arrangements.
Results
Organisational arrangements
The data included in the 2018 report from the organisational survey included responses from 83 out
of 89 organisations contributing to the NVR, of which 70 out of 73 were from England. Of these,
49 were hub hospitals, 11 were spoke hospitals and 10 were not part of a network. Of the 49 hub
hospitals, 47 provided details of the number of spokes that they operated, which gave a total number
of 131 spoke hospitals. It is not clear from the report if this number includes 11 spoke hospitals
contributing to the NVR or if these are additional sites operated by the same trust or separate trusts.
There are also different potential definitions of spoke hospitals, depending on the range of services
that are offered, which could include outpatient clinics, day-case services, investigations, angioplasty
or some inpatient surgical procedures.
For comparison, HES data identified 69 sites as carrying out elective AAA repair in 2017 (excluding those
with fewer than five cases recorded). There was one additional site in which there were > 40 peripheral
arterial reconstructions, a further 25 sites with > 40 angioplasties and 28 sites at which there were
> 40 vascular admissions for investigations per year.
Abdominal aortic aneurysm
The trend in the number of sites offering AAA surgery is shown in Figure 9. The overall number of
sites offering aneurysm repair fell from 136 to 69 between 2006/7 and 2017/18. The majority of the
reduction was due to the cessation of aortic aneurysm surgery at those sites carrying out < 40 cases
per year.
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Considering the overall number of cases treated at sites with different volumes of activity, there was a
reduction in the proportion of patients treated at sites with low volumes until approximately 2011.
Since then, the figures have remained fairly stable, with approximately 20% of procedures carried out
at sites that carry out < 60 cases per year (Figure 10).
The NVR reported that the number of centres carrying out > 30 elective cases per year of infrarenal
elective AAA repair had reduced to 11, compared with 58 centres carrying out more than this number.3
For comparison, the HES data suggested that there were 12 centres in this category out of the same total
of 69. This definition of activity category differs from that reported in the specification for the provision of
vascular services,171 which suggests that the minimum number of cases for a designated aortic aneurysm
centre should be 60 cases per year of all types of aneurysm repair, averaged over 3 years. By this













































































































































FIGURE 10 Proportion of AAA admissions by total number of AAA cases per year at treating site.
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Peripheral arterial disease
Many admissions for PAD appear to have been centralised, along with the centralisation of aneurysm
services, over the past 12 years (Figure 11). Those centres that have a sustained aneurysm practice
undertook 96.9% of all surgical arterial reconstructions in 2017/18, compared with under 60% in
2006/7. Most other procedures have followed a similar trend, although about one-third of minor
amputations are carried out at non-vascular centres.
Carotid artery disease
The most recent NVR data show that 65 English trusts carry out carotid surgery, of which 23 have
activity levels below the recommendation of 40 per year. In comparison, HES data analysis for the
most recent year shows 74 sites, of which 26 are below the threshold. As expected, the AAA volume
correlates with CAD volume, but there are a small number of sites carrying out CAD but not AAA


















































































































FIGURE 11 Trends in the proportion of categories of PAD admissions treated at sites with a current AAA practice.
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Approximately 16% of CAD procedures are carried out at sites with volumes below the recommended
volume, and the postoperative mortality at these sites is significantly higher than at sites that reach
the recommended volume (Table 8).
Varicose veins
Although VV procedures are not included in the NVR reports, they constitute a significant workload
for vascular clinicians and the reconfiguration of vascular services may affect the place or method of
treatment. Between 2006/7 and 2012/13 there was a substantial reduction in the overall number
of admissions related to VV procedures and an increase in the proportion treated by endovascular
methods (EVLT and RFA) and at vascular centres (Figure 13). Table 9 provides details of the features
of VV admissions based on the method of treatment and proportion treated at current vascular sites
(those with a current AAA practice).
Discussion
To understand the current arrangements for the provision of vascular services and the way that these
may be affected by any future reconfiguration, a detailed analysis was carried out of the current sites at
which vascular services are delivered. This was compared with data from an organisational audit carried
out by VSGBI and the data on activity from the NVR. These sources of data provide rich information,
but each has limitations and drawbacks. The organisational audit relies on voluntary submission of data.
TABLE 8 Number of CAD procedures and mortality by site: annual volume of procedures 2015/16 to 2017/18
CAD procedures
CAD annual volume
Under 40 40 and over Overall
Number of cases 2174 11,525 13,699


















































































FIGURE 13 Trends in the number of VV admissions treated by open and endovenous procedures at sites with and
without a current AAA practice.
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The NVR is a procedure-based registry that does not link to long-term re-admission and outcome data,
whereas the HES data have the limitations described in the previous section relating to the coding systems
and accuracy. There is, however, reasonable agreement between the sets of data in most respects.
The main findings with regard to the configuration of vascular services are that there has been a move
towards centralisation of complex arterial cases, including AAA, CAD and major vascular reconstructions.
As a result of the centralisation of AAA services, the number of sites at which aneurysm surgery is
carried out has halved in the last 10 years. However, despite this, over the most recent 5-year period
approximately 20% of aneurysm repairs are still carried out at centres with an annual volume below the
60 cases recommended in the provision of vascular services document.171 Consideration of the distances
between centres that have already amalgamated their aneurysm service and those that continue to carry
out small numbers suggests that, with few exceptions, the geographical distances are not a major barrier
to further centralisation.
There has been much discussion of hub-and-spoke arrangements, with various documents providing
advice regarding such arrangements.172 The organisational survey regarding such arrangements is
limited in the detail that it provides. One issue in this respect is that the survey is carried out on the
basis of providers, and a single provider may deliver vascular services at multiple sites. The HES data
suggest that, where aneurysm services have been consolidated on a single site, many other aspects of
the vascular service have followed suit, resulting in centralisation of many services rather than a hub-
and-spoke arrangement. The HES data relate to inpatient activity only, so there may be hub-and-spoke
arrangements with regard to outpatient clinics. However, the number of services that appear to offer
day-case investigations, minor procedures or rehabilitation following amputation at satellite units
appears to be limited.
Even in the case of VV surgery, which is largely carried out as a day-case procedure, there appears to
be a significant degree of centralisation, with the VV activity following other major vascular services.
These results suggest that further research may be useful in identifying the drivers for and barriers
to service reconfiguration and particularly to the provision of hub-and-spoke arrangements that may
allow the local delivery of those aspects of patient care that can safely and appropriately be delivered
at spoke sites.
TABLE 9 Trends in the site and mode of treatment of varicose veins
Year
Non-vascular sites Vascular sites
Proportion at
vascular site (%)Number EVLT (%) RFA (%) Number EVLT (%) RFA (%)
2006/7 18,309 5.6 0.3 15,649 6.6 0.1 46.1
2007/8 16,670 11.7 1.2 17,048 12.1 1.6 50.6
2008/9 16,091 16.8 5.1 17,171 14.2 4.7 51.6
2009/10 15,390 18.2 14.2 17,146 18.3 10.7 52.7
2010/11 14,334 16.3 18.5 15,849 21.1 14.9 52.5
2011/12 11,586 15.8 20.8 13,126 20.9 20.2 53.1
2012/13 10,127 16.2 24.7 11,741 24.3 21.4 53.7
2013/14 10,731 16.0 31.6 12,614 25.5 25.1 54.0
2014/15 12,843 14.7 41.9 16,219 24.7 30.9 55.8
2015/16 12,047 15.7 47.0 17,481 23.7 33.2 59.2
2016/17 11,354 17.4 51.0 17,090 23.4 35.9 60.1
2017/18 10,341 14.5 55.9 15,578 21.3 40.6 60.1
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Comparison between the activity and the outcomes reported from NVR and HES data suggest a
number of issues that may be worthy of further investigation. The mortality estimates from NVR
appear to be consistently lower than those obtained from the HES data, and there are a number of
possible explanations for this. Although NVR would appear to have quite high acquisition rates, if the
returns are selectively omitting cases in which there was mortality, this may result in underestimation
of the mortality rate. This may occur because notes may be unavailable following deaths, so records
remain incomplete, or because patients may be recorded as having survived a procedure when they
have been transferred to another unit, even though they subsequently die without leaving hospital.
Another possible cause of distortion is that patients who are turned down for emergency surgery may
not be recorded in the NVR. The patients identified in HES as having died with a primary diagnosis of
aortic aneurysm include some such patients, although some of these underwent procedures, such as
laparotomy, and, thus, should be included in the NVR data.
Another discrepancy between the HES data and the NVR relates to complex aortic aneurysm repair.
Both NVR and HES suggest that there was a substantial increase in the number of EVAR procedures
carried out for complex AAA, including branched and fenestrated endovascular grafts. However, the
number identifiedas such in NVR is larger than the number with the relevant codes in HES data. It is
not possible to distinguish between patients undergoing these complex procedures who would
previously have undergone infrarenal open or endovascular procedures and patients who would not
previously have been considered suitable for treatment. The distribution of such cases is uneven, with
a small number of centres carrying out a higher proportion of these procedures. Considering the
declining total number of AAA procedures and the absence of evidence of a large number of tertiary
referrals, it seems more likely that this represents a different method of treatment of existing patients
rather than a previously untreated population.
Further research may be justified to understand the appropriate place of such treatments, particularly
in the light of the recent draft National Institute for Health and Care Excellence (NICE) guidance.173
Conclusions
The detailed analysis of HES underpins the modelling that is described in Modelling the effects of service
reconfiguration. The key findings in relation to service configuration are that, despite considerable
centralisation of major procedures, there are still several centres that do not meet recommendations
regarding activity levels and that, in most cases, this does not appear to relate to geographical limitations.
Furthermore, the centralisation has been accompanied by significant changes in practice, particularly
in relation to the implementation of less invasive treatments. Considerable variation in practice has been
identified, some of which correlates with the degree of service centralisation. An additional finding has been
the trend for centralisation of investigations and minor procedures, along with the emergency and major
vascular workload.
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Development of the electronic Personal
Assessment Questionnaire – Vascular
In the UK, most patients with AAA, PAD, CAD, VLU and VVs are treated by the NHS’s secondary careservices. Decisions on how and when to treat patients with these vascular conditions are subject to
variation across the UK. Understanding the impact that the disease has on the quality of life (HRQoL)
of patients can help both clinicians and patients to make treatment decisions. HRQoL is central to the
individual patient’s experience of health and disease; measures of HRQoL must do more than describe a
patient’s health in terms of what health professionals and society believe constitutes health.174
One method of collecting data about HRQoL is using PROMs. PROMs are made of structured
questions that ask patients about their health and HRQoL from their point of view.175 PROMs provide
information about the impact of a disease, or its associated treatment, from a patient’s perspective.
A key objective of the research programme was to identify or develop PROMs that could be collected
from users of vascular services in an electronic form, to improve and monitor their treatment and to
evaluate the services that they receive. This section describes an overview of the development of the
ePAQ-VAS that consisted of four key stages and followed the process recommended in the US Food
and Drug Administration (FDA)’s framework for PROM development.176 A substudy was also
undertaken to generate utility values of vascular patients from the EQ-5D.
Methods
Stage 1: themes generation
The various themes for the ePAQ-VAS were generated from systematic literature reviews of existing
outcome measures and qualitative evidence (see Reviews of published literature).
Qualitative interviews with vascular patients
In addition, semistructured interviews were conducted with five vascular patient groups: patients with
PAD, AAA, CAD, VLU and VVs. Users of vascular services attending the vascular department, Sheffield
Vascular Institute (SVI) at the Sheffield Teaching Hospitals were recruited using purposive sampling
techniques to ensure a range of participants at different ages, sex and stages of treatment. A clinician
approached each patient and, following informed consent, a date and time were agreed for one of three
researchers to visit the participant at home to carry out an interview [ethics approval: Yorkshire and
Humber – Bradford Leeds Research Ethics Committee (REC) number 14/YH/1117 on 25 September
2014; an amendment to the interview schedule was approved on 18 June 2015]. The interview protocol,
informed by the prior literature reviews, explored the signs, symptoms and impact that the condition had
on function and the lifestyle (see Appendix 2).
Field notes were taken to aid interpretation and each interview was recorded and transcribed verbatim.
Anonymised transcripts were entered into NVivo 10 (QSR International, Warrington, UK) for management
and analysis using standard framework analysis techniques.177 Between 10% and 20% of the interviews
were double coded by a second researcher in NVivo 10. Inter-rater comparisons were calculated using
Cohen’s kappa. Regular meetings were set up with an experienced qualitative researcher (AT) to review
the frameworks and guide the analysis.
Consensus exercise with clinicians
Clinicians involved in the care of vascular patients were invited to list the key issues, the symptoms
and the impact that AAA, PAD, CAD, VLU and VV had on patients suffering with these conditions.
The evidence from this initial round was used to inform the qualitative evidence synthesis.
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Stage 2: item generation and scale development
Items under the themes above were generated by a new PROMs Steering Committee (SCR, GJ, PP, EL and
AA) to establish the initial version of the ePAQ-VAS. Face validity was assessed by separate exercises
with clinicians and patients.
A different group of clinicians involved in the care of vascular patients were invited to score the relevance
of items (questions) in the provisional version of the ePAQ-VAS. Participants were invited to rate the
appropriateness of each question on a five-point Likert scale of ‘strongly disagree’ (0) to ‘strongly agree’ (4).
This process was repeated, with members of the clinicians’ panel being presented with the aggregate
findings of the previous round and again asked to score each question. This process examined the relevance
of each item from the clinicians’ perspective and identified new items suggested by the clinicians.178
Based on the work reported above, the Steering Committee employed an iterative process to
incorporate evidence from the systematic reviews of qualitative studies, the qualitative study and
the clinicians’ consensus study, as recommended by the FDA,176 to develop the initial item pool for the
ePAQ-VAS.179 A draft instrument was then adjusted based on further service users’ input and review
by the steering committee.
Face validity of the electronic Personal Assessment Questionnaire – Vascular
Semistructured interviews were conducted with 19 patients, purposefully sampled from the five key
clinical areas identified in workstream 2. A paper and/or electronic ePAQ-VAS (version 1) was presented
to participants and a focused interview was conducted to investigate vascular patients’ perceptions of
the whole questionnaire and individual items. Questions were asked under the headings of overall
impressions, clarity, relevance and emotional response. Interviews were audio-taped, transcribed and
analysed. A pragmatic approach was used for the analysis, with comments collated and presented back
to the Steering Committee, which made consensus decisions on revisions to the ePAQ-VAS.
Stage 3: reducing the items, confirming the domain structure and scoring algorithms
of the electronic Personal Assessment Questionnaire – Vascular
Participant recruitment
To reduce the items and confirm the conceptual framework of the ePAQ-VAS generated in stage 1,
a quantitative survey was undertaken. Consecutive patients attending outpatient clinics run by SVI
between June 2017 and June 2018 were invited to complete the questionnaire online before their
clinic appointment using an established encrypted voucher system. Patients who had not completed
the questionnaire online, and inpatients, had the option to complete the questionnaire using electronic
tablet computers or computer terminals on site. The five key vascular conditions that had been
identified (AAA, CAD, PAD, VLU and VV) were all represented in the sample.
Statistical analyses
The sample size calculation was based on previous studies suggesting that a ratio of at least
4–10 respondents per item would enable factor analysis and internal reliability calculations.180,181
Because 55 items in the ePAQ-VAS contributed to eight scales, up to 550 patient completions were
considered necessary.
A one-factor confirmatory factor analysis model for ordinal data182 was fitted to each of the eight scales
to identify their structure and enable item reduction. Ordinal items were regressed on the domain
factor by regressions estimated by a robust weighted least squares estimator with mean and variance
adjustment.183 Appropriateness of the confirmatory factor analysis model for each domain was assessed
by examining the comparative fit index (CFI) and the root-mean-square error of approximation (RMSEA),
where CFI of > 0.95 and RMSEA of < 0.08 were regarded as an appropriate fit.184 Furthermore, items
factor loadings (> 0.4), model residual correlations and modification indices were considered to examine
local dependence within domains.184 The magnitude of these three indices was evaluated in comparison
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with other items in the scale. When the modification indices (MI) were > 100 and residual correlations
(RCs) were > |0.10| this was taken as the indicator of lack of fit and items were removed from the
scale.184 Following confirmatory factor analysis, redundant items were removed. Mplus version 8.2
(Muthén & Muthén, Los Angeles, CA, USA) was used for the statistical analyses.
Internal consistency reliability measurement was used to investigate the reliability of the remaining
items in each domain. The Cronbach’s alpha coefficient was calculated for each domain to measure
internal reliability. A Cronbach’s alpha score of ≥ 0.70 was considered acceptable; however, scores
exceeding 0.92 were taken to indicate that items in the scale may be redundant.82,185,186
Stage 3: further psychometric testing of the electronic Personal Assessment
Questionnaire – Vascular
To further establish the psychometric properties of the ePAQ-VAS, the results of relevant items from a
previous survey and an additional survey were used to assess test–retest reliability, construct validity
and the responsiveness of the measure186 (see Report Supplementary Material 12).
Participants’ recruitment
All consecutive patients invited to outpatient clinics run by SVI from June 2018 to January 2019 were
asked to participate in this study using the same voucher arrangements as for the conceptual framework
analysis (CFA) study. For test–retest reliability, patients were asked to complete a second questionnaire
3–7 days later, provided that there was no change to their health status. Only patients with AAA, PAD,
VLU and VV were included in this survey because CAD patients were available around the time of
admission for treatment only. For responsiveness testing, patients completed the ePAQ-VAS before and
6 weeks after PAD and VV procedures. The second survey for test–retest reliability and responsiveness
was administered by telephone by one of the researchers.
Statistical analyses
Scoring
Summated rating was used to score the results of the eight scales in the ePAQ-VAS and was standardised to
a 0–100 scale, where 0 indicates the best HRQoL and 100 the worst HRQoL. Skipped items were allocated
a score of 0; the electronic format of the instrument allows patients to skip items that are not relevant to
them, so it was assumed that patients skipping any items have no problems relating to these items.
Test–retest reliability
Intraclass correlation coefficients (ICCs) were used to assess test–retest reliability. ICCs exceeding 0.7
are generally regarded to indicate reliability for population-based research and ICCs exceeding 0.9 are
considered to indicate reliability for use clinically with individuals.15,84,187
Known group validity
Known group validity was examined using hypothesis testing to examine whether or not the scales
correlate well with expected clinical group differences. Correlations are considered low if r is < 0.3,
moderate if r lies between 0.30 and 0.49 and high if r is > 0.5.188 Hypotheses were stated a priori,
including the postulated direction.78,188
Responsiveness
Responsiveness was measured using standardised effect size, calculated as the change in score
between post intervention and baseline divided by the standard deviation (SD) at baseline. An effect
size of 0.30–0.49 is regarded as ‘small’, an effect size of 0.50–0.79 as ‘moderate’ and an effect size
of ≥ 0.80 as ‘large’.188 The standardised response mean was also calculated by measuring the mean
difference between baseline and post intervention divided by the SD of the change. Similar cut-off
points as for the standardised effect size above were used. Statistical analyses were performed using
SPSS version 24 (IBM Corporation, Armonk, NY, USA).
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Substudy EuroQol-5 Dimensions, five-level version, utility values
The purpose of this substudy was to generate utility values for use in economic evaluation models.189
The EuroQol-5 Dimensions, five-level version (EQ-5D-5L), was incorporated into the ePAQ-VAS and
participants were asked to complete an electronic version of the EQ-5D and the EQ-5D visual
analogue scale. A series of clinical health states were identified by the steering group, in each
of the five vascular categories, as being representative of specific vascular conditions and identifiable
from the ePAQ-VAS responses. Utility values based on the EQ-5D-5L responses were calculated for
each of these clinical states using the van Hout et al.190 mapping function.
Results
Stage 1: themes generation
Overlapping themes were identified from the literature reviews for the various vascular conditions.
For PAD, there were six main themes: symptoms, physical functioning, impact on social functioning,
psychological impact, financial impact and process of care. For AAA, the four overarching themes
identified were symptoms, functional outcomes, psychological outcomes and social outcomes. For CAD,
the five main themes were anxiety, impact on personal roles and activities, effect on independence,
psychological impact and symptoms. For VV, the five main themes were physical impact of VV,
psychological impact, social impact, adapting to VV and reasons for seeking treatment. For VLU,
the main themes were physical impact, psychological impact, social impact and treatment.16,19,21–24
Qualitative primary study with vascular service users
Out of 111 patients invited to participate in the primary qualitative study, 56, aged 35–77 years,
were interviewed to explore the impact of vascular disease on daily living: 13 patients with AAA,
nine with CAD, 14 with PAD, 10 with VLU and 10 with VV. The framework analysis of the primary
data identified six overarching themes relating to the impact of these five vascular conditions. These
were symptoms, impact on physical function, social impact, psychological impact, financial impact and
lifestyle. Identified signs, symptoms and impact of the conditions were then mapped and tabulated
to see which themes were relevant to which condition and where the similarities and differences lay.179
Pain and mobility were the most commonly reported domains by participants with PAD. The extent to
which they had an impact on HRQoL was associated with the severity, age expectations and social
support. Fear of the symptoms worsening and amputation were also reported. Most participants with
AAA reported no physical symptoms, with a small number reporting abdominal pain or pain in their legs.
Uncertainty, anxiety and fear of rupture and death appeared to have the greatest impact on HRQoL.
Patients with CAD had the widest range of signs and symptoms, reporting nine different issues.
The condition had the least impact on physical and social function, although some participants reported
a sense of worry and anxiety, which was most often related to fear of having a major stroke.
Most of the participants reported that VV had little impact on their overall HRQoL. Pain was reported
by 8 of the 10 participants; one reported significantly diminished HRQoL owing to reduced mobility.
The perceived unpleasant appearance of the VV had the greatest psychological impact and was described
in detail by several of the group. Many of the participants had had their VV for very long periods of time,
often just ‘putting up with it’ for numerous years before seeking help.
The impact of VLU on HRQoL differed in the group. For some there were no major issues and having a
VLU was accepted as part of their current life, with the hope that it would heal eventually. For others,
the impact was far more significant. Pain was reported by six of the group and in some participants
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was quite severe, was quite severe, leading to a significantly reduced HRQoL. Pain also had a bearing
on people’s mobility and their ability, or desire, to go out and socialise. Sleep was also often disturbed
because of pain. The persistence of VLU had resulted in participants suffering for long periods of time.
In addition, the non-healing or recurring nature of the condition had a significant impact for many.
VLU had a significant psychological impact, causing some a high degree of distress.
There were many overlapping domains between the conditions. Pain was experienced in varying degrees
within and across the conditions. Many of the participants had more than one vascular condition that
contributed to some of the overlap in reported symptoms. For instance, many participants with AAA
reported symptoms of claudication. Comorbidities were common, particularly among patients with
PAD or VLU, who described the cumulative impact that the other conditions had on their HRQoL
and functioning. Overall, those patients with VVs were the youngest and reported the least impact
on HRQoL. Age expectations were evident in all groups; some of the older participants reported that
they expected ill health because of their age, whereas younger people often reported being much more
distressed by the condition.
In total, 13 vascular clinicians reviewed the items and they scored on the relevance of the items in a
two-round consensus exercise. Clinicians’ rating generally aligned with the issues identified by patients,
but some additional items were added, particularly relating to specific symptoms of swallowing
difficulty for CAD and abdominal pain or throbbing for AAA.
Stage 2: item generation and scale development
Based on the results above, the items of the ePAQ-VAS were arranged into four sections: generic,
AAA, CAD and lower limb vascular conditions. The generic section included the EQ-5D-5L instrument
that had been identified in the reviews (see Reviews of published literature) and through Steering Committee
discussions as being the most appropriate generic measure. A single lower limb section was developed as
common themes were identified for PAD, VLU and VVs affecting the lower limb, regardless of whether
the underlying pathology was venous or arterial. An inclusive approach to development was used and a
comprehensive questionnaire was produced with 168 questions.
Face validity of electronic Personal Assessment Questionnaire – Vascular
Overall, the response to the semistructured patient interviews was favourable, with participants
reporting that they felt that it was fit for purpose and potentially useful. There was little consistency in
items that participants found difficult. No single item was identified for which many participants had a
difficulty. Issues raised included the use of abbreviations; font size and contrast between text and
background; response options and scales; electronic format versus paper format; relevance to patients
and clinicians; use of free-text boxes and the language and wording used; when and how to use the
skip button; repetition of items and subject matter; and the possibility of emotional distress associated
with questions about the possibility of deterioration or death.
In total, 59 items were eliminated owing to overlap and five items were added, as requested by
clinicians, because they were relevant to clinical management. Generic items and the EQ-5D-5L
questionnaire were included in the first section and all respondents answered questions about pain,
altered sensation, weakness, weight/height, smoking habit, medical history and regular medication.
The subsequent three sections are condition specific and relate to CAD, AAA and lower limb vascular
disease, each of which is further divided into scales. There were 55 items in eight scales in addition to
the generic EQ-5D-5L instrument. The remainder of the questions did not contribute to scales but
were kept because of their clinical relevance. Individual items, scales and sections and the source of
the evidence for their inclusion have been detailed, along with illustration of the structure of the
questionnaire following further revisions.179
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Stage 3: reducing the items, confirming the domain structure and scoring algorithms
of the electronic Personal Assessment Questionnaire – Vascular
The first version of the ePAQ-VAS that was presented to patients had 114 items, of which 55 items
contributed to eight factors. The other questions were either clinically relevant questions (i.e. asking about
smoking, weight, etc.) or screening questions to ensure that only relevant questions are presented to the
patients based on their specific vascular complaint. The ePAQ-VAS was completed by 638 vascular patients;
159 patients (24.9% of the total) completed the questionnaire online before their clinic appointment and
the remainder were recruited face to face in the outpatient clinic and the vascular inpatient ward. The
majority (65.2%) of patients were male. All of the patients were asked to complete relevant sections of the
generic dimension. Patients were presented only with relevant disease-specific scales. In total, 49 patients
completed CAD questions, 112 respondents answered the AAA dimension, 323 completed PAD-related
questions and 117 and 172 patients completed the VLU and VV questions, respectively.
The CFA models were developed to test the a priori model for the eight-scale structure.191 In the CAD
section, two scales were modelled and all items in the ‘CAD-related anxiety’ section were relevant to
measure the latent factor. However, two items were dropped from the ‘Impact of CAD on activities of
daily living (ADL)’ domain. The first was a generic item about the impact of CAD diagnosis on enjoyment
of life, which had high MI and RCs with two other items. The other asked about the impact on mood and
had low factor loading. In the AAA section, only one item was deleted because of high MI and RCs with
two items on the same scale, as was a similar item asking about the impact that lower limb symptoms
have on the enjoyment of life. Items with a low factor loading relating to ‘cold feet’ and VLU symptoms
domain were also dropped. The opinion of clinicians was sought before deleting these items.
Following item reduction, the internal consistency of each scale was examined; all scales had a
Cronbach’s α coefficient of ≥ 0.70 but none exceeded 0.92. The results suggest that the items
in each scale measure the same latent construct. For CFA model fit statistics see Table 10
and Aber et al.186
TABLE 10 Confirmatory factor analyses of the ePAQ-VAS
Scale
CFA initial model CFA final model
Items deletedRMSEA CFI RMSEA CFI
CAD-related anxiety 0.156 0.847 0.08 0.980 None
Impact of CAD on ADL ‘Impact of CAD on enjoyment of life’ and ‘low
mood caused by CAD’ items were deleted. The
former had high MI and RCs with items in the
same domain. The latter had low factor loading
AAA-related anxiety 0.141 0.957 0.043 0.990 None
Impact of AAA on ADL ‘Impact of AAA on enjoyment of life’ had high
MI and RCs with items in the same domain
PAD symptoms 0.127 0.818 0.077 0.982 ‘Cold feet’ item was deleted because of low
factor loading
VLU symptoms 0.266 0.178 0.080 0.984 ‘Worry about leg ulcers’ had low factor
loading
VV symptoms 0.187 0.801 0.078 0.967 None
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Stage 4: further psychometric testing of the electronic Personal Assessment
Questionnaire – Vascular
In total, 721 patients completed the ePAQ-VAS. The mean age of the participants was 63.45 years
(SD 15.7 years) and 64.9% were men (n = 468). A total of 76% of patients (n = 553) completed the
questionnaire in a clinical environment (clinic or ward) and the remaining patients completed the
questionnaire online before their clinic. Scores were calculated for each scale (Table 11).
Test–retest reliability
For the test–retest survey, 150 patients (60 with PAD, 39 with VLU and 51 with VVs) completed the
relevant sections of a second questionnaire after 3–7 days. Test–retest results were calculated for the
symptom scale and the impact that lower limb vascular disease had on ADL for patients with PAD, VLU
and VVs separately. The ICC ranged from 0.59 for anxiety related to AAA to 0.94 for the impact that
VLU had on ADL.179
Known group validity
Correlations between the proposed clinical hypotheses and the CAD impact on ADL and CAD-related
anxiety scores were low, ranging from –0.089 to 0.094. The correlation between size of AAA and
AAA-related anxiety score was significant, and this scale captured this latent variable. There was no
significant correlation between size of AAA and AAA impact on ADL. There was low correlation
between AAA-related anxiety and AAA impact on ADL in preoperative patients. There was a significant
correlation between rest pain and PAD symptoms and impact of PAD on ADL. The presence of an ulcer
had a statistically significant correlation with the score of PAD impact on ADL.
Ulcer recurrence had a significant correlation with VLU symptom scale score. The correlation of ulcer
recurrence with other scales was weak. The presence of VV with VLUs had no significant correlation
with any of the scales’ correlations. The presence of VV in both legs had a significant correlation with
VV symptoms only, and the presence of VV in both legs did not have strong correlations with scores
of VV impact on ADL. Some of the results of known group validity are in line with proposed clinical
hypotheses, for instance, ‘the larger the size of AAA, the greater the anxiety caused by the condition’
and ‘the presence of rest pain or an ulcer has a significant impact on PAD scales scores’. However,
some clinical hypotheses, particularly in relation to CAD scale scores, were not in line with what was
proposed. This could be because of the small size of this disease group.
TABLE 11 Number of respondents and mean score for each scale of the ePAQ-VAS
Scale Number of respondents Mean score (out of 100) Standard deviation
AAA-related anxiety 121 23.74 21.84
AAA impact on ADL 121 17.41 20.82
CAD-related anxiety 50 44.17 29.61
CAD impact on ADL 50 32.4 30.29
PAD symptoms 308 47.08 26.86
PAD impact on ADL 308 50.28 30.88
VLU symptoms 122 34.97 24.37
VLU impact on ADL 122 55.46 30.91
VV symptoms 248 36.86 18.91
VV impact on ADL 248 28.52 26.69
PAD impact on ADL, VLU impact on ADL and VV impact on ADL was measured by the lower limb vascular disease
impact on ADL scale in the ePAQ-VAS.
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Responsiveness
In total, 55 patients with VV undergoing VV surgery and 37 patients undergoing lower limb
revascularisation procedures for PAD completed the ePAQ-VAS preoperatively and once more at least
6 weeks after their procedure. The effect size and standardised response mean were measured for all
of the relevant scales of the ePAQ-VAS (Table 12).179
Substudy: EuroQol-5 Dimensions, five-level version, utility values
The average EQ-5D-5L derived utility values ranged from 0.396 for PAD patients with a major
amputation to 0.886 for VV patients following treatment (Table 13).
Discussion
This section documents the steps undertaken to develop the ePAQ-VAS, a new tool to collect PROMs and
other clinical information from users of vascular services. This can be used as a holistic clinical assessment
tool to be completed by patients before seeing a clinician and during follow-up. The information generated
can be used to help shared decision-making and to monitor the impact of intervention on the patients’
quality of life. As an electronic online measure it can potentially be completed remotely, which facilitates
virtual clinics,192 and may contribute to electronic patient records or aggregated data for service evaluation.
A demonstration version of the final version of the web-based form is available online at www.epaq.co.uk/
Demo/VascularDemo (accessed 1 December 2020).
TABLE 12 Effect size for the ePAQ-VAS measuring responsiveness
Scale Number of patients Standardised effect size Standardised response mean
PAD symptoms 37 0.69 0.74
Impact of PAD on ADL 37 0.85 0.69
VV symptoms 55 1.48 1.60
Impact of VVs on ADL 55 0.82 0.78








CAD preoperatively 11 0.772 (0.207) 0.343–1 77.36
CAD with stroke 10 0.700 (0.261) 0.078–0.906 66.70
AAA under surveillance 85 0.711 (0.277) –0.450–1 60.55
AAA preoperatively 12 0.778 (0.178) 0.390–1 64.58
AAA post repair 3 0.771 (0112) 0.691–0.850 76.00
PAD with claudication only 22 0.676 (0.215) 0.812–1 66.38
PAD with ulcer 96 0.481 (0.315) –0.361–1 55.61
PAD with amputation 39 0.396 (0.345) –0.257–1 56.26
VLU without VV 92 0.473 (0.321) –0.445–1 53.54
VLU with VV 22 0.505 (0.315) –0.242–0.879 54.68
Postoperative VV 55 0.886 (0.181) 0.411–1 75.27
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A major strength of the work is that the instrument has been developed through a rigorous process in
line with FDA guidelines for developing PROMs.176 Evidence from this study suggests that scales in the
lower limb section of the ePAQ-VAS have good test–retest reliability, particularly the PAD and VLU
scales. The results of the known group validity show that the AAA-related anxiety scale correlates with
the size of AAA. Patients’ anxiety is increased and the impact that the disease has on patients’ daily
living is greater for preoperative patients than for those under surveillance. The instrument shows
good correlation between rest pain in PAD and increased PAD impact on ADL scores. The results of
the survey also confirmed that the presence of an ulcer with PAD diagnosis increased PAD impact on
ADL scores, and recurrent ulcer is associated with an increase in ulcer symptom scores. The results of
the responsiveness analyses show that the following scales can detect changes following intervention:
AAA-related anxiety, PAD symptoms, impact of PAD on ADL, VV symptoms scale and impact of VVs
on ADL.
Another strength of the work is the inclusion of the EQ-5D-5L alongside disease-specific scales.
This allows the generation of utility values for the different health states that can be used in
cost-effectiveness modelling, in line with NICE’s methodology.193 It may also facilitate further research
to consider the relationship between such generic measures and the more detailed symptomatic and
disease-specific description of vascular conditions provided by the new instrument.
These studies had a number of limitations. For pragmatic reasons, the development and validation
were largely based on evaluation at a single site. Sample size was small for some groups of patients,
because of resources and patient availability, particularly for patients with CAD and AAA. Access to
some patient groups before and after treatment was difficult and the fact that some forms were
completed online, some in outpatient clinics and some by telephone may have been a confounding
factor. Furthermore, the sample size for responsiveness and test–retest was small for all groups,
and future analysis with a larger sample size is desirable. The follow-up data for test–retest and
responsiveness were collected by telephone, which may have introduced some bias. Further studies
are also required to explore acceptability and completion rates, to consider the practicalities of wider
implementation and to refine aspects of the process, such as reporting formats and the analysis of
longitudinal and aggregate data.
Overall, the ePAQ-VAS provides a holistic data collection process that is relevant to most vascular
service users and has the potential to contribute to patient-focused care and the collection of
aggregate data for service evaluation.
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Evaluation of non-health outcomes
A lthough most of the previous work on the configuration of services has been driven by evidencerelating to the effect on clinical outcomes, the reconfiguration of services also affects other
aspects of the service that may be important to service users. This section reports the results of
trade-off studies to measure the strength of preference of a sample of the general population for
aspects of the process of care. Preferences for endovascular or open surgical repair for AAA are
evaluated in terms of the quality-adjusted life-year (QALY) benefit that participants would forgo for
their preferred treatment. Further studies use a similar trade-off method to evaluate the strength of
preferences for reduced travelling distances, in terms of the QALY benefit that would be forgone to
avoid the need to travel for treatment of AAA, CAD or PAD.
Trade-off study
The reorganisation of vascular services will have an impact not only in terms of health outcomes,
but also with respect to other aspects of service provision, such as travel distances and treatment
processes. The aim of the proposed research was to elicit preferences from members of the public for
the way in which vascular services could be organised in the NHS. Following qualitative work with
vascular patients, travel distance to health facilities was identified as an extremely important factor in
any reorganisation. Further work with vascular clinicians revealed a desire to elicit preferences for
alternative treatment processes for AAA, as treatment of AAA is the principal driving force behind any
potential reorganisation. The specific aims of the study, therefore, were to elicit preferences for (1) the
treatment processes associated with EVAR and open surgical repair of AAA and (2) having to travel to
specialist hospitals for treatment and follow-up for AAA, CAD and PAD.194
Method
The method involved surveying members of the UK population, through individual telephone
interviews, to elicit their preferences for treatment processes for AAA and travel distance
to specialist hospitals. At the heart of the method is the notion of opportunity cost and how this
relates to value. Fundamentally, something is of value to an individual only if they are willing to give up
(or sacrifice) something to acquire what is being valued. Without sacrifice, there is no value. What
respondents were asked to sacrifice to have their preferred treatment option or preferred hospital
was small changes in the chance of treatment being successful. From their responses it was possible to
quantify their strength of preference in terms of a QALY equivalent that allows those preferences to
be incorporated into the cost-effectiveness models. Interview booklets for the three groups are
provided in Appendices 3–5.
Participants
Participants were aged ≥ 18 years, citizens of the UK and had no previous diagnosis of a vascular condition
(self-assessed). The justification for sampling members of the public rather than patients lies in the context
of how the values are likely to be used, namely to inform national health-care priority-setting. In this
context, NICE states a preference for QALYs to be based on general population values. The total sample
size was 821 (four telephone surveys were administered, with approximately 200 participants in each).
Recruitment and consent
Participants were recruited through various NHS trusts across England. The study covered a wide
geographical area including South Yorkshire, Greater London, Kent, Staffordshire, Derbyshire, Lincolnshire,
Lancashire, Leicestershire, Cambridgeshire, Essex, Cumbria, North Devon, Tyne and Wear, and
Northumberland. A range of approaches were used to identify potential participants. These included
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approaching hospital visitors on site, having recruitment stands in dining halls, using posters around the
trusts with study details and recruiting staff via blanket e-mails. When approaching potential participants,
efforts were made to ensure that the sample was representative of the general population with regard
to age and sex. Contact details of potential participants were securely transferred to the research team,
who then contacted these participants (between September 2017 and January 2018) to arrange a date
and time for telephone interviews. Participants who agreed to be interviewed were sent an interview
booklet approximately 1 week before the interview took place. They were advised to read the interview
booklet prior to the interview to familiarise themselves with the information enclosed. Verbal consent
was obtained over the telephone prior to commencing the interview and the interview was audio-
recorded. The use of verbal consent was accepted and approved by the South East Coast – Brighton and
Sussex Research Ethics Committee, Health Research Authority (REC number 16/LO/0943), on 20 April
2017 along with all of the study documents. An amendment to the interview documents was submitted
and approved on 2 May 2017.
Results
Abdominal aortic aneurysm treatment method
A total of 209 participants completed the interview, giving a response rate of 64%. Missing data rates
were low and did not exceed 2%.
When considering simple direction of preference, 167 (79.9%) participants stated that they would
prefer EVAR, 40 (19.1%) participants indicated that they had a preference for open surgery and two
(1.0%) participants said that they had no preference for either treatment. Factors that influenced
treatment preferences for EVAR included the less invasive nature of the surgery and the quicker
recovery times associated with the procedure. For open surgery, factors included having to have only
one follow-up appointment and the feeling that the open procedure felt more permanent.
When participants were asked to make a sacrifice (trade-off) to have their preferred treatment, 45 and
22 respondents who had a stated a preference for EVAR and open surgery, respectively, indicated that
they were not willing to sacrifice anything to support their preference and, thus, were deemed to value
both treatments equally. Therefore, when strength of preference was taken into account, 122 (58.4%)
participants preferred EVAR, 18 (8.6%) participants preferred open surgery and 69 (33%) participants
had no preference. In the first year following treatment, those preferring EVAR were willing to give up
a mean of 0.135 expected QALYs to have EVAR, whereas those preferring open surgery were willing to
give up 0.033 expected QALYs to have open repair. These results indicate a clear preference for EVAR
over open surgery among the sample.
Travel distance to hospital
A total of 608 participants completed the interviews (200 for AAA, 202 for CAD and 206 for PAD).
Each respondent was asked to consider travelling one of four distances (5, 15, 30 or 60 miles) that
were distributed equally within samples. The overall response rate was 64.4%. Missing data rates were
low and did not exceed 5%.
The proportions of people willing to travel for AAA (open surgery), AAA (EVAR), CAD and PAD were
89%, 86.5%, 79.7% and 96.1%, respectively. Of these, 56.2%, 55.5%, 64.0% and 66.2% stated that they
required compensation to travel for AAA (open surgery), AAA (EVAR), CAD and PAD, respectively.
Among the remaining respondents, the main reason cited for not being willing to travel was a
preference for local services and/or a belief that all services should be available locally. Other reasons
stated were transport difficulties with making the journey, not wanting to burden family and friends,
and a concern among participants that they would feel isolated without having family and friends
around them if there was no local provision.
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Owing to the constraints of the study design, the maximum compensation that could be demanded by
those people not willing to travel was limited to that associated with the success rate at the specialist
hospital being 100%. Despite the amount of compensation required to travel by this group being
unknown, to include them in the analysis they have been assigned this maximum value. This means that
the value of the disutility of travelling reported below for the sample as a whole should be regarded as
a minimum value.
For a typical patient aged < 65 years with one of the vascular conditions considered, the expected
discounted lifetime QALYs demanded as compensation for having to travel an additional 30 miles
for treatment and follow-up are as follows: 0.3541 for AAA (open surgery), 0.3869 for AAA (EVAR),
0.2041 for CAD and 0.6310 for PAD (results for the full range of distances considered are in
Report Supplementary Material 13).
Taking AAA (open surgery) as an example, these results suggest that, if vascular services are
reorganised so that the individual must travel an extra 30 miles for treatment and follow-up, their
disutility of travelling is equal to 0.3541 QALYs. This should be netted off from any potential gain in
QALYs that is expected to arise from treatment being at a specialist rather than a local hospital.
Discussion
Our results comparing EVAR with open surgery for AAA repair suggest a clear preference for EVAR
in the sample. This suggests that patient preferences may be in conflict with the recent recommendation
by NICE195 that EVAR should not be recommended as the first-line treatment option for most people
with this condition. These findings suggest that greater consideration should be given to the value that
is placed on the treatment processes of EVAR and OR. If NICE were to find a mechanism to explicitly
incorporate such preferences in the decision-making process, it may increase the likelihood that
recommended treatment pathways align with the preferences of the UK population.173
Our results valuing the burden of travelling for treatment and follow-up clearly indicate that it is
a potentially important component of disutility in the sample for each of the three clinical areas
considered. As such, it is suggested that there is a need take this disutility into account when
considering the implications of any decision to reorganise vascular services to a more centralised
provision. To that end, the impact on cost-effectiveness of including the values placed on the disutility
of travelling has been investigated in Modelling the effects of service reconfiguration.
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Modelling the effects of service
reconfiguration
The online model can be accessed at https://modellers.sheffield.ac.uk/vascularmodel/ (accessed1 December 2020).
Summary
This section reports the evaluation of the cost and quality implications of different possible service
configurations for subspecialist vascular services. A number of techniques were used, including HES data
analysis, regression modelling, systematic literature review, preference elicitation, decision analysis and
modelling. Costs are reported in Great British pounds at year 2017/18 prices. The NHS and Personal
Social Services (PSS) perspective was adopted for the economic evaluation. Costs and outcomes are
discounted at 3.5% per year. Statistical analyses and simulation were performed in R version 3.4.3.
The modelling was carried out in two parts. First, three separate models covering the clinical areas of
AAA, PAD and CAD were developed. These models of individual disease areas were then brought
together in an interactive web-based model that enables users to identify potential reconfiguration
of services in particular geographical areas and to predict the overall effects of potential service
reconfiguration in terms of workload, resource use, outcomes and cost-effectiveness.
Results at the cohort level are reported for each vascular group (AAA, CAD and PAD) separately and for
the cohort as a whole. The incremental cost per QALY is reported for the combined cohort as a whole
to indicate how cost-effective the new configuration is compared with the baseline configuration.
The model estimates the specific results for each vascular site, before and after the reconfiguration.
Scenario analysis and one-way sensitivity analysis were conducted to see how the results were affected
by the model’s structure and key parameters. To assess the impact of parameter uncertainty on the
model’s results, 2000 Monte Carlo simulations of the model were run in a probabilistic sensitivity
analysis (PSA). Each PSA simulation ran the model with a sample of inputs for stochastic parameters.
General overview
The conceptual modelling framework was based on clinical consensus representing the pathways of care,
characterised through the analysis of HES. The aim of the model is to predict the changes in workloads,
distance from patients’ homes to hospitals, hospital costs and outcomes when vascular services are
reconfigured (i.e. merging small centres into larger centres). Our model was a patient-level simulation.
We chose a patient-level modelling approach to better utilise patient-level data from HES and to
accommodate the complexity of the decision problem, capturing both patient-level information and
hospital-level information. Our simulation used discrete time-to-event rather than time cycles in
modelling. This reduced unnecessary computer time in running the model. System dynamics was not
suitable for our modelling problem. The microsimulation models were populated with data from regression
analysis of HES records, systematic literature reviews and preference information.
Service reconfiguration
Options
The model tested two different service configurations: devolved and centralised services. Devolved
services are typically hospitals with a general surgical service that also offer vascular services and tend
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to be associated with a low volume of vascular procedures, whereas centralised services have sufficient
subspecialist staff to provide a full range of emergency and elective services and are associated with a
higher volume of procedures.
Definition of volume
‘All AAA repairs’ per year was used as the definition of volume. This is to ensure comparability with the
criteria used by NHS England170 and the VSGBI provision of vascular services document.171 The annual
volume for each specific year was used, rather than average annual volume across the years, so that
year-on-year changes could be considered.
Effects of reconfiguration
Service reconfiguration could affect clinical outcomes (e.g. mortality, length of stay, complication rate,
re-admissions and survival) and costs. Moreover, patient satisfaction may be affected if they are sent to
a service that is further from home than their usual vascular centre.
The HES data were used to estimate the relationship between volume and outcomes/costs, after
adjusting for the patient case-mix factors. The short-term outcomes included mortality, length of stay,
complication rate and re-admissions. The relationship between volume and long-term survival was also
estimated. Regression equations of the hospital admission costs as a function of volume were also
estimated from the HES data analysis (see Report Supplementary Material 5).
Conceptual model
The model aims to predict the changes in workloads, distance from patients’ homes to hospitals,
hospital costs and outcomes when vascular services are reconfigured (i.e. merging small centres into
larger centres). The model structure is similar across the three main vascular groups: AAA, CAD and
PAD (Figure 14).
Service configuration and patient cohort
The baseline configuration of services and the new configuration (reconfiguration) can be specified
for specific region(s). The aim of the evaluation is to compare the costs and outcomes between these
two options.
Given the options of service configuration, the simulation starts by simulating the patient cohort for
the region(s). First, it creates a sample of patient LSOA locations for AAA, CAD and PAD annual cases.
Second, other patient characteristics in each vascular group are simulated based on descriptive
information from HES data.
Patients are assumed to go to the nearest vascular centre (straight-line distance) and the annual AAA
volume (counting all AAA repairs) of a vascular centre is calculated accordingly for a service configuration.
It is assumed that in the base case the treatment option (e.g. EVAR vs. OR) is not affected by the
configuration (same treatment is given before and after the reconfiguration). The base case also assumed
that reconfiguration does not affect the proportion of AAA no operation deaths.
Index admission
The following outcomes were modelled for the index admission of vascular repairs: in-hospital death,
length of stay, hospital costs of the admission and major amputation in the index admission (with PAD
cases only). They were simulated using regression models that were developed from HES data. The list
of covariates considered in the regression is given in Appendix 6 and details of these regression models
are given (see Report Supplementary Material 14).
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Given the patient characteristics and the volume of procedures carried out in the vascular centre
where they receive the repair, probabilities of in-hospital death from the index admissions are
predicted using logistic regression models developed from HES data. This is then simulated to
determine whether a patient lives or dies in the index admission. Length of stay is then estimated by
generalised linear regression models. This gives the duration of the patient stay in the index admission.
The costs of index admissions are also estimated by regression models. For PAD cases, they also have
their probabilities of having a major amputation in the index admission predicted by regression models.
Post index admission
Patients who survive and are discharged from the index admission move to the post-index admission
progress/state, where their long-term survival and progression are predicted using survival models
developed from HES data. OS is estimated using time-to-death (TTD) equations for each patient given their
characteristics and centre volume. Patients also experience complications related to their index repairs.
For AAA, the complication included various re-intervention re-admissions. For CAD, the complication
was stroke-related re-admission. For PAD, the complication was major amputation re-admission.
Costs/quality-adjusted life-years
The following areas of costs are captured for the patients: costs of index admission, costs of
re-interventions/complications and long-term costs. Total costs of the index admission are predicted
for each patient by the regression models developed from HES data. The predicted costs include all
resource use during the index admission (covering main procedures, critical care and complications in
the index admission). Costs of re-admissions with major amputation were also estimated from HES
data analysis. Other long-term costs are estimated from targeted systematic literature reviews;
typically, these are presented as annual health-care costs that are combined with the OS to estimate
the overall costs.
The following utility values were captured for the patients: utility of index admission and long-term
utility with and without complications. A targeted systematic literature review was conducted to
identify sources of utility values for various health states of vascular patients. Where possible, and
where evidence allowed, utility values were estimated separately for different age groups, sex and
treatments (e.g. EVAR vs. OR).
Modelling
Methods
The HES data between 2006/07 and 2017/18 were analysed to provide the main inputs for the simulation.
First, it is the information needed to create the simulated patient cohort and vascular centres in England.
Second, HES analyses provide regression models that are used in the simulation to predict the hospital
costs and outcomes after vascular repairs. Data for utilities and other hospital costs (that are not available
from HES data) were searched and extracted from the literature (see Appendix 7).
All costs are reported in Great British pounds at year 2017/18 prices. Costs and outcomes are discounted
at 3.5% per year. All statistical analyses and simulations were performed in R. The simulation has an
interactive user interface and it can be accessed online at https://modellers.sheffield.ac.uk/vascularmodel/
(accessed 1 December 2020).
Verification and validation
The model’s conceptual structure was validated by the clinical advisory panel. The design process went
through several stages starting from the natural disease to the patterns identified from HES data.
The clinical advisory panel were involved throughout the process to come up with the final design of
the conceptual model.
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The model codes were verified internally throughout the model implementation. Simulated patients
were checked to make sure that they behaved logically as expected (i.e. their characteristics were
changing and they followed expected pathways). The model outputs at different levels (individual,
vascular centres, disease groups and whole cohort) were checked against various input combinations
to see if they agree with the input data and the conceptual model. Intermediate results were also
checked and compared for model consistency.
The regression models that were used for predicting costs and outcomes were developed through
several stages and each stage involved an assessment by the clinical advisory panel to agree the final set
of regression models to be used in the cost-effectiveness analysis (see Report Supplementary Material 14).
The model data were also compared with raw HES data to establish face validity. The outputs for
comparison include the characteristics of the cohort, the allocation of patients to vascular centres
before and after the reconfiguration, and various outcomes after vascular repairs, such as in-hospital
mortality, length of stay, costs of index admission and long-term survival. A case study of past
reconfigurations in the Yorkshire and the Humber region was conducted to validate the main
assumptions in the model (see Report Supplementary Material 15).
Abdominal aortic aneurysm model
Methods
Patient cohort
Each patient is assigned a start age, mode of admission (elective vs. non-elective), weekend or weekday
admission, comorbidities and index of multiple deprivation score. A proportion of AAA patients are
allocated to no-operation deaths (i.e. patients died in hospital with a main diagnosis of AAA and no
previous AAA repair). Among those with AAA repairs, a proportion are allocated to complex/suprarenal
repairs and the rest are allocated to infrarenal repairs. They are also assigned a ruptured status and a
type of repair (EVAR vs. OR). That is, AAA patients are classified into AAA no-operation deaths,
infrarenal repairs (EVAR vs. OR) and suprarenal repairs (EVAR vs. OR).
Index admission
The following outcomes were modelled for the index admission of vascular repairs: in-hospital death,
length of stay and hospital costs of the admission. The base case assumes that the proportion of AAA
no-operation deaths does not change with the reconfiguration.
Post index admission
The main outcome of post index admission progress for AAA cases is OS. Survival models that predict
TTD for a specific patient given their characteristics and the centre volume were fitted using HES data
for AAA repairs.
Patients with AAA can also experience re-interventions/complications related to their index repairs.
The modelling of re-interventions here is to account for their effects on the utilities (HRQoL) and costs
of AAA patients only. Six types of re-interventions/complications were modelled based on a recent
conceptual model developed by NICE196 and discussions with clinicians: life-threatening re-intervention,
serious re-intervention, hernia, lysis of adhesion, bowel resection and other laparotomy interventions
(see Appendix 8).
Costs
The costs (and utilities) were sourced from recent good-quality studies that were UK based and
had sufficient detail on both costs and utilities. For the long-term costs of AAA, the values were
sourced from the HTA report197 of cost-effectiveness analysis based on the EVAR-1 and EVAR-2 trials,
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which report costs in 2014/15 values. The cost of surveillance was reported as £227, which inflated to
2017/18 using the health services index198 is £234. EVAR patients have one surveillance visit (outpatient
attendance and ultrasound) every year and OR patients have one visit every 5 years, which results
in £234 and £47 per year for EVAR and OR patients, respectively. The cost of re-intervention was
£8670 in 2014/15 values, which inflated to year 2017/18 is £8932. For PSA, because of the lack of data,
mean values ± 10% were used.
Utilities
Without the impacts of the surgery and re-interventions, all patients are assumed to have a normal
HRQoL, which are taken from a study in 1999199 that reports the UK general population utilities
differentiated by age and sex.
Patient disutilities after AAA repair were sourced from the HTA report of cost-effectiveness analysis
based on the EVAR-1 and EVAR-2 trials197 and are summarised below in Table 14. The utility value in
the first 6 months is lower relative to baseline, with EVAR patients doing better than OR patients, and
the utility reverts to baseline after 6 months from the initial operation. However, there is a disutility
for 6 months after a re-intervention and in the 6 months prior to death.
Peripheral arterial disease model
Methods
Patient cohort
Each patient is assigned a start age, mode of admission (elective vs. non-elective), weekend or weekday
admission, comorbidities and index of multiple deprivation score. A proportion of them are assigned to
have a major amputation before the admission with the PAD repair and a proportion of them are also
assigned to have a leg ulcer. PAD patients are also assigned a type of PAD repair.
Index admission
The following outcomes were modelled for the index admission of vascular repairs: in-hospital death,
length of stay and hospital costs of the admission. The probability of having a major amputation in the
index admission is also predicted by regression models.
Post index admission
The main outcomes of post-index admission progress for PAD cases are OS and AFS. Survival models
were used for the simulation of PAD post-index admission progress: a model of OS and a model of AFS
(defined as death or major amputation).
TABLE 14 Disutility values for patients after OR and EVAR repair
Disutility Mean Standard error
OR 0–6 months disutility –0.0802 0.0119
Difference EVAR vs. OR 0–3 months 0.0599 0.0166
Difference EVAR vs. OR 3–6 months 0 –
Disutility of re-intervention (for 6 months) –0.0604 0.0258
Disutility before death (for 6 months) –0.149 0.0166
MODELLING THE EFFECTS OF SERVICE RECONFIGURATION
NIHR Journals Library www.journalslibrary.nihr.ac.uk
58
Costs and utilities
The long-term costs and utilities of PAD were sourced from the HTA report of cost-effectiveness
analysis of enhancements to angioplasty for PAD;200 and the data are presented below in Table 15.
Costs were inflated to 2017/18 values, and for PSA mean values ± 10% were used. The distributions
used for the utilities in the PSA are similar to those in the original HTA report.6
The cost of a hospital admission for major amputation was estimated from the HES data between
2008/9 and 2017/18. First, the cost of a major amputation hospital admission was summarised by
financial years. There is a steady increase in the mean cost of a major amputation admission from
£14,331 in 2008/9 to £22,135 in 2017/18. The cost data chosen for estimating individual patients’
costs of major amputation admission in the model are those for 2017/18, because this was the most
recent year for which data are available. Different distributions were fitted and compared on this
cost data using the ‘fitdistrplus’ package in R, and the best distribution was a beta distribution with the
following parameters: shape1 (alpha) = 1.024011 and shape2 (beta) = 3.400307. This distribution was
used to assign individual patient costs of major amputation admission. Its variance and covariance
matrix (Table 16) was used in PSA.
Carotid artery disease model
Methods
Patient cohort
Each patient is assigned a start age, mode of admission (elective vs. non-elective), weekend or weekday
admission, comorbidities and index of multiple deprivation score. The patients are classified according
to different types of CAD repairs (endovascular vs. OR).
Index admission
The following outcomes were modelled for the index admission of vascular repairs: in-hospital death,
length of stay and hospital costs of the admission.
Post index admission
The main outcomes of post index admission progress for CAD cases are OS and stroke-free survival.
Survival models were used for the simulation of CAD post-index admission progress: a model of OS
and a model of stroke-free survival (defined as death or major stroke re-admissions).




TABLE 15 Utility and costs by PAD health state
Health state Utility Monthly costs (£)
IC 0.7, normal(0.7, 0.23/280) 115
CLI 0.35, normal(0.35, 0.23/280) 361
Amputation 0.48, normal(0.48, 0.23/280) 2200
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Costs
The long-term costs of CAD were sourced from the HTA report of cost-effectiveness analysis based
on the International Carotid Stenting Study, which reported the costs in 2013/14 values.201 The 5-year
follow-up costs were reported as £2204 and £2563 for endarterectomy and stenting, respectively.
These costs inflated to year 2017/18 are £2292 and £2665, respectively, which results in annual costs
of £458 and £533, respectively. For PSA, the mean values ± 10% were used. Costs for stroke were also
modelled separately for endarterectomy and stenting patients. The costs for stroke patients treated by
endarterectomy were £7570 in the first year and £1770 in subsequent years. For patients treated by
stenting, the costs were £6020 in the first year and £1400 in subsequent years.
Utilities
The baseline utilities after CAD repair were also sourced from the same HTA report,201 which reports
the mean utility per patient as 0.766 for both patients treated with endarterectomy and those treated
by stenting. For PSA, the mean values ± 10% were used. The utility decrement for stroke was estimated
as 0.243 based on the meta-analysis of stroke utilities by Tengs et al.,202 and a beta distribution with
an alpha of 64 and a beta of 200 was used for PSA based on the NICE clinical guidelines for PAD.203
This was used in the model as a stroke multiplicative factor of 0.757 (i.e. 1 – 0.243) and combined with
the baseline utility of 0.766 resulted in a utility of 0.58 for patients who had stroke in the CAD model.
Combined model of service configuration
The three patient-level simulation models for the vascular groups AAA, CAD and PAD were combined
to develop an overall model. This model predicts the changes in workloads, distance from patients’
homes to hospitals, hospital costs and outcomes when vascular services are reconfigured (i.e. merging
small centres to form larger centres) taking the three main vascular groups into account. The simulation
has an interactive user interface (UI) and is deployed as a web-based application that can be accessed
online at https://modellers.sheffield.ac.uk/vascularmodel/ (accessed 1 December 2020).
The user interface (UI) allows the users to specify a particular service configuration (a list of available
vascular centres) that they want to be modelled and evaluated. It also allows the users to specify the
type of analysis (deterministic or probabilistic sensitivity analysis), number of sample iterations and
changes in inputs, such as one-off cost of the reconfiguration, probability of switching from OR to
EVAR and per cent increase (or decrease) in no-operation deaths owing to the reconfiguration.
Figure 15 illustrates these features of the UI.
The decision problem
The NHS England service specification for vascular services170 and the VSGBI171 currently recommend
an AAA volume threshold of 60 cases per year.171 This was used to define the decision problem at
the national level for service configuration: is it cost-effective to reconfigure the current landscape
of vascular services in England to achieve this threshold? The baseline option is then the current
configuration of services in 2017/18 (the latest year of the data) and the intervention option is a new
configuration of services, so that the minimum AAA volume of each vascular centre is 60.
To identify the current configuration of services in 2017/18, the total number of AAA repairs was
summarised for each vascular site in the data. Sites carrying out fewer than five AA repairs per annum
were considered non-vascular and were excluded. To identify the new configuration of services that
satisfies the AAA volume threshold of 60 cases per year for all vascular sites, an iterative process is
adopted. First, the vascular site with the minimum volume from the current configuration was identified.
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Second, this site was excluded from the current configuration and its patients re-allocated to their nearest
available sites. Third, the AAA volume for each site was recalculated and the revised values became the
current configuration (i.e. excluding the site with minimum volume). Step 1 was repeated until a
configuration with no site having a volume fewer than 60 cases per year was identified.
This method identified a baseline configuration of services that included 72 active vascular sites in
England in 2017/18 and a new configuration that met a minimum volume threshold of 60 AAA cases
per year at all sites. In this new configuration major vascular surgery was transferred from 23 vascular
centres with low volume to those with higher volumes; the final arrangement included only 49 active
centres. Figure 16 illustrates the AAA volume distribution in the baseline configuration and in the new
configuration and Table 17 describes the changes in each region.
Base-case deterministic results
Table 18 shows the results of the deterministic model for AAA patients. The reconfiguration reduced
in-hospital death (–0.75%), but it had a negative impact on the long-term survival of those who
survived the index repairs, which lead to a decrease in the total number of QALYs (–0.056 reduction
in discounted QALYs gained per patient). This is consistent with what was observed in the HES data.
The reconfiguration increased the costs of index admission (£706 per patient) and the total lifetime



























FIGURE 16 Abdominal aortic aneurysm volume distribution at baseline and the new configuration.




East Midlands 6 4 –2
East of England 11 7 –4
London 11 5 –6
North East 4 3 –1
North West 10 7 –3
South East 7 6 –1
South West 9 6 –3
West Midlands 7 6 –1
Yorkshire and the Humber 7 5 –2
Total 72 49 –23
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Table 19 shows the results of the deterministic model for CAD patients. The reconfiguration reduced
in-hospital death (–0.1%) and had a positive impact on long-term survival and stroke-related re-admission-
free survival of those who survived the index repairs, leading to an increase in the total number of QALYs
(0.078 additional discounted QALYs gained per patient) and an increase in the number of stroke-free days
(98 days per patient). The reconfiguration increased the costs of index admission (£103 per patient) but
saved resources on other longer-term costs (because there were fewer stroke-related re-admissions).
Overall, this led to an increase in the total costs (£79 undiscounted and £101 discounted per patient).
Table 20 shows the results of the deterministic model for PAD patients. The reconfiguration reduced
in-hospital death (–0.12%) and had a positive impact on long-term survival and AFS of those who
survived the index repair, leading to an increase in the total number of QALYs (0.035 additional
discounted QALYs gained per patient) and an increase in the number of amputation-free days (60 days).
TABLE 18 Deterministic base-case results for AAA
Results Baseline New configuration Incremental
Number of patients 7393 7393 0
AAA volume per site 92 135 43
Mean age (years) 74.4 74.4 0.0
Male (%) 82 82 0
Length of stay (days) 10.33 10.35 0.02
Hospital death (%) 20.49 19.74 –0.75
Life-years (undiscounted) 12.524 12.330 –0.194
QALYs (undiscounted) 9.770 9.621 –0.149
Life-years (discounted) 9.095 9.020 –0.075
QALYs (discounted) 7.068 7.011 –0.056
Costs of index admission (£) 17,021 17,727 706
Total costs (undiscounted) (£) 19,069 19,787 718
Total costs (discounted) (£) 18,614 19,343 728
TABLE 19 Deterministic base-case results for CAD
Results Baseline New configuration Incremental
Number of patients 5024 5024 0
Mean age (years) 70.5 70.5 0.0
Male (%) 66 66 0
Length of stay (days) 5.1 5.0 –0.1
Hospital death (%) 1.04 0.94 –0.11
Stroke-free days 7274 7372 98
Life-years (undiscounted) 20.480 20.696 0.216
QALYs (undiscounted) 15.585 15.760 0.175
Life-years (discounted) 13.299 13.395 0.096
QALYs (discounted) 10.139 10.217 0.078
Costs of index admission (£) 8991 9094 103
Total costs (undiscounted) (£) 19,448 19,527 79
Total costs (discounted) (£) 15,507 15,607 101
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The reconfiguration increased the costs of the index admission (£832 per patient) but saved resources on
other longer-term costs (because there were fewer amputation-related re-admissions). This led to a
reduction in the total costs (–£916 undiscounted and –£15 discounted per patient).
Table 21 shows the results of the deterministic model when the whole combined cohort of AAA, PAD
and CAD patients was considered. The reconfiguration reduced in-hospital death (–0.25%) and had a
positive impact on long-term survival of those who survived the index admission, leading to an increase
in the total number of QALYs (0.022 additional discounted QALYs gained per patient). The reconfiguration
increased the costs of index admission (£700 per patient) but saved resources on other longer-term
costs. This led to a reduction in the total costs when discounting was not included (–£424 per patient)
but an increase in the total costs when discounting was included (£160 per patient).
The new configuration was associated with an incremental cost per QALY of £7313. This is well below
the NICE cost-effectiveness threshold of £20,000 per QALY (λ). The net monetary benefit (NMB)
of the reconfiguration of vascular services was £278 per patient at the £20,000 per QALY threshold
(NMB = λ × incremental QALYs – incremental costs). Given the population size (34,712 patients), the
population NMB was £9,644,639.
Deterministic sensitivity analysis results
Table 22 shows the results from the scenario analysis (see Methods).
Figure 17 shows the results from the one-way sensitivity analysis (see Methods).
The parameters with the utilities and monthly long-term costs of PAD cases were the most influential
on the results, although none of them was sufficient to increase the incremental cost-effectiveness
ratio (ICER) to above £20,000 per QALY.
Probabilistic sensitivity analysis results
Figure 18 shows the PSA results for incremental QALYs and incremental cost of the vascular service
reconfiguration on a cost-effectiveness plane.
TABLE 20 Deterministic base-case results for PAD
Results Baseline New configuration Incremental
Number of patients 22,295 22,295 0
Mean age (years) 69 69 0
Male (%) 64 64 0
Length of stay (days) 8.7 9.1 0.4
Hospital death (%) 3.64 3.52 –0.12
Major amputation in index (%) 2.53 2.48 –0.04
Amputation-free days 5854.4 5914.8 60.4
Life-years (undiscounted) 17.277 17.380 0.103
QALYs (undiscounted) 9.861 9.939 0.078
Life-years (discounted) 11.256 11.306 0.050
QALYs (discounted) 6.369 6.404 0.035
Costs of index admission (£) 9436 10,268 832
Total costs (undiscounted) (£) 93,398 92,482 –916
Total costs (discounted) (£) 58,782 58,767 –15
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The values of the ICER of the service reconfiguration in PSA crossed into two different quadrants on the
cost-effectiveness plane: 0.25% on the south-east (SE) quadrant (dominant – less expensive and more
effective) and 0.25% on the north-west (NW) quadrant (dominated – more expensive and less effective). The
probabilistic mean ICER was £7169 per QALY (compared with £7313 per QALY in the deterministic results).
Figure 19 shows the cost-effectiveness acceptability curve together with the cost-effectiveness
acceptability frontier. At the threshold of £20,000 per QALY, the probability of the service
reconfiguration being cost-effective was 96%.
Figure 20 presents the change in individual expected value of perfect information across different
values of the cost-effectiveness threshold.
The data analysed in Vascular activity and outcomes from routine data suggests that further improvements
in outcome may be achieved by increasing the threshold of activity for AAA to 100 cases per year,
rather than the 60 cases considered in this analysis. A further exploratory analysis was, therefore,
carried out to consider the implications of a higher threshold (see Report Supplementary Material 16).
Discussion and conclusion
This study is the first model-based economic evaluation study evaluating the cost-effectiveness of a
national strategy to reconfigure the vascular services in England. The decision problem concerns the
merging of vascular centres with a low annual AAA repair volume and centres with higher volume
so that all active vascular centres would have an annual AAA repair volume of at least 60 cases,
as recommended by NHS England170 and VSGBI.171 Using HES data between 2008/9 and 2017/18,
the current baseline configuration of services in 2017/18 (72 active vascular centres) was identified.
A re-allocation algorithm identified the new service configuration that satisfied the volume threshold;
this reconfiguration required transfer of major vascular surgery from 23 vascular centres with low
volume to the remaining 49 active centres in the new configuration. The two configurations (baseline
and new) were assessed by a patient-level cost-effectiveness simulation that simulated the pathways,
costs and outcomes of three patient groups: patients with AAA, CAD and PAD.
TABLE 21 Deterministic base case results for combined cohort (60 threshold reconfiguration vs. baseline)
Results Baseline New configuration Incremental
Number of patients 34,712 34,712 0
Mean age (years) 70 70 0
Male (%) 68 68 0
Length of stay (days) 8.5 8.8 0.3
Hospital death (%) 6.85 6.60 –0.25
Travel distance (miles) 8.5 10.3 1.8
Life-years (undiscounted) 16.728 16.784 0.056
QALYs (undiscounted) 10.670 10.714 0.044
Life-years (discounted) 11.092 11.122 0.030
QALYs (discounted) 7.0631 7.0851 0.0219
Costs of index admission (£) 10,987 11,687 700
Total costs (undiscounted) (£) 66,864 66,440 –424
Total costs (discounted) (£) 43,964 44,124 160
Incremental costs per QALYs (£) 7312.90
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TABLE 22 Scenario analysis results
Scenario


















0 728 –0.056 101 0.078 –15 0.035 160 0.022 7313
1 722 –0.071 101 0.078 –15 0.035 159 0.019 8448
2 625 –0.120 96 0.075 –14 0.034 138 0.007 19,161
3 2125 0.685 147 0.110 13 0.050 482 0.194 2488
4 731 –0.027 106 0.050 248 0.023 330 0.017 19,891
5 724 –0.053 101 0.075 95 0.034 230 0.021 10,779
6 733 –0.060 100 0.081 –124 0.037 91 0.023 4014
7 721 0.059 111 0.011 875 0.003 732 0.016 45,177
ICER, incremental cost-effectiveness ratio.
Scenario:
0, base case; 1, 50% of AAA OR would be switched to EVAR after reconfiguration; 2, 1% of AAA repair cases would be switched to no-operation deaths after reconfiguration;
3, 1% of AAA no-operation deaths would be switched to repair cases after reconfiguration; 4, using 6% discounting rate instead of 3.5% in the base case; 5, setting all stochastic
parameters (from literature review) at their lower CI values; 6, setting all stochastic parameters (from literature review) at their higher CI values; and 7, removing volume effect from





































































The deterministic results suggest that this reconfiguration of vascular services is cost-effective based on
the NICE cost-effectiveness threshold of £20,000 per QALY. The incremental cost per QALY (ICER) for the
reconfiguration was £7313. This was translated to a NMB of the reconfiguration of vascular services of
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FIGURE 17 Results from the one-way sensitivity analysis. LCI, lower 95% CI; OWSA, one-way sensitivity analysis;


























FIGURE 18 The PSA results on a cost-effectiveness plane.
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However, the cost-effectiveness results were sensitive to the following assumptions in the model:
(1) the assumption about the impact that reconfiguration would have on the proportion of AAA
no-operation deaths; (2) the discount rate used in the model; and (3) the assumption about the volume
effect on long-term outcomes (i.e. survival) of survivors of the index admissions (see Deterministic
sensitivity analysis results). One-way sensitivity analysis on the model parameters on utilities and other
costs informed by the literature shows that, varying these parameters, one at a time between their
lower confidence interval (CI) value and upper CI value did not cause the cost-effectiveness to exceed
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FIGURE 20 Individual patient-expected value of perfect information.
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The main strength of the study is that it was based on a patient-level cost-effectiveness simulation that
utilised 12 years of HES data between 2006/7 and 2017/18. The richness of information from HES
data enabled us to develop a simulation describing all main vascular activities (AAA, PAD and CAD)
at three levels: (1) the individual patient level; (2) the hospital level, at which patients are treated;
and (3) the regional level, at which patients live. The model was verified and validated with the actual
observations in HES data and expert opinions from vascular clinicians. The model’s results were tested
extensively in scenario analyses and one-way sensitivity analysis, and the uncertainty with the model’s
parameters was quantified in a PSA.
However, there are limitations with the study. First, there are challenges with processing and analysing
HES data that include defining the outcome measures and predictors; identifying comorbidities; and
various aspects concerning the statistical methods for model development (modelling framework,
model fitting, assessment of model performance, recalibration, handling competing risks in survival
models, estimating hospital resources used, etc.).204
Facing the challenges raised by data quality, changes in coding across the years and past service
reconfigurations required subjective choice and judgement in the analytical decisions. Such challenges
were addressed throughout the modelling process in group discussions combining the clinical and
clinical coding, statistical and modelling expertise of the group.
The results of the analyses on the relationship between volume and in-hospital outcomes for AAA
patients generally agreed with previous volume–outcome studies;52 however, the results on the
relationship between volume and long-term outcomes for those AAA patients who survived and were
discharged from the index admissions did not agree with a previous study.52 Patients discharged from
centres with higher AAA volumes had worse long-term survival (even after case-mix adjustment),
whereas Holt et al.54 found the reverse relationship. It should be noted that Holt et al.54 used HES data
between 1 April 2000 and 31 March 2005 (before the specific procedure codes for EVAR were
introduced in HES), whereas this analysis used HES data between 1 April 2006 and 31 March 2018 and
several aspects of the methods attempted to address the limitations of the methods of Holt et al.54 In
this respect, it is of note that the HES data showed an association between higher volume and higher
rates of EVAR, and the recent modelling for the NICE guideline196 on AAA suggested that EVAR is
dominated by OR, being both more costly and less effective in the long term. This could potentially
explain the apparently poorer long-term outcomes associated with higher-volume sites.
Second, our approach in HES data analysis was relatively simplistic and pragmatic owing to time
and resource constraints. Not all possible alternative approaches were tested in developing the risk
predictive models, such as machine-learning methods or more advanced multistate survival analysis.
The outpatient data set and the accident and emergency data set in the HES analyses were not used,
owing to time and resource constraints. These data sets could improve our estimates of resources used
and costs of vascular repairs and, thus, would improve our predictive models in the cost-effectiveness
simulation.
Third, data for utilities and other long-term costs used in the model were sought from a rapid
systematic review of the literature. Values for these parameters came mainly from three UK HTA
reports for AAA, PAD and CAD. It could be argued that a more comprehensive review and data
extraction could have been carried out to improve the estimates for these parameters. Nevertheless,
the impact of changing these values between their lower and upper CI levels was tested in a one-way
sensitivity analysis and it was found that doing so did not significantly change the cost-effectiveness
results. Furthermore, the uncertainty with the model’s parameters was assessed in our PSA.
Fourth, our model is based on a fundamental assumption that the associations identified in the
regression models reflect direct or indirect causal relationships. The model does not account for many
DOI: 10.3310/pgfar09050 Programme Grants for Applied Research 2021 Vol. 9 No. 5
Copyright © 2021 Michaels et al. This work was produced by Michaels et al. under the terms of a commissioning contract issued by the Secretary of State for Health and
Social Care. This is an Open Access publication distributed under the terms of the Creative Commons Attribution CC BY 4.0 licence, which permits unrestricted use,
distribution, reproduction and adaption in any medium and for any purpose provided that it is properly attributed. See: https://creativecommons.org/licenses/by/4.0/.
For attribution the title, original author(s), the publication source – NIHR Journals Library, and the DOI of the publication must be cited.
69
complex influential factors, such as capacity constraints, linked hospital services, the experience of
individual vascular surgeons and local factors (e.g. transport links) that may influence real-world choice
and the undoubted complex disruptions associated with organisational change. Furthermore, the
method of sequentially redistributing workload from the lowest-volume site may not achieve an ideal
or optimal configuration, as there may be advantages in transferring services from several sites to one
central location. Another issue is the overall selection of procedures carried out at different sites.
For example, with appropriate collaboration many minor procedures, investigations and rehabilitation
services may be provided at sites different from those carrying out major vascular procedures.
This point may be particularly relevant in the light of the findings of the preference work described in
Evaluation of non-health outcomes, which suggests that the strength of preference for local services,
when considered in terms of the QALYs that would be traded is high when compared with the average
per-patient benefit of the effects of reconfiguration.
The overall economic benefit of reconfiguration is small and uncertain and, furthermore, is not
consistent across the three vascular conditions considered: AAA, CAD and PAD. The primary economic
benefit from reconfiguration arises from improved CAD outcomes and improved costs and outcomes
associated with amputations in PAD. There appears to be a complex trade-off between short- and
long-term outcomes in EVAR and OR in AAA that may indicate a potential for further economic gains
from reconfiguration that is worthy of further research.
Another limitation of the study is that the modelling was confined to an analysis of the effects on the
inpatient aspects of the three main diagnostic areas of AAA, CAD and PAD. Although these represent
the majority of workload that may be expected to transfer with the reconfiguration of vascular
services, vascular specialists provide services, such as VV surgery, outpatient clinics, joint diabetic foot
services and, in some areas, vascular access. It is not necessary that such services are co-located with
major vascular inpatient services, and there exist various arrangements through which some of these
may be provided in ‘non-vascular’ centres or community settings. However, the evidence in Vascular activity
and outcomes from routine data suggests that centralisation of vascular services may be accompanied by
changes in practice and relocation of some services. As the arrangements for such services may vary
depending on geography and local facilities, application of the model to a specific local reconfiguration
would require separate consideration of the intended working arrangements in these respects.
The model provides estimates of the emergency and elective workload, bed requirements and resource use
that will support the planning of reconfiguration. However, specific recommendations regarding workforce,
bed numbers and facilities in any planned reconfiguration would also require additional local adaptation to
account for intended arrangements regarding any ‘non-mandatory’ changes in configuration, such as the
location of investigative, minor procedure, rehabilitation and outpatient provision.
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Programme outcomes and conclusions
Overview of programme outcomes
The vascular research programme has resulted in the development of two major products: an electronic
web-based tool for the collection of PROMs and other clinical data (the ePAQ-VAS), and a tool for the
computer simulation of potential service reconfiguration, which can be used to estimate the effects on
workload, resource use, outcomes and cost-effectiveness of potential service reconfiguration. In the
process of developing these, there have been a number of other outputs from the programme, including
publications and analyses. These provided evidence regarding a variety of outcome measures of relevance
to vascular services, estimates of utility associated with vascular-related health states, the details of
patient preferences for aspects of service provision and the development of methods for the analysis
of workload and outcome from routine data.
The electronic Personal Assessment Questionnaire – Vascular
The ePAQ-VAS is a web-based tool for the collection of PROMs and clinical information of relevance
to patients using vascular services. It can be completed by patients from home using a web interface,
with secure access being provided through a personalised voucher code that can be distributed with an
appointment letter or by other means. It may also be completed by patients at the time of outpatient
appointments using a tablet or computer workstation. The form is divided into a number of sections
relating to generic information and specific sections relating to aneurysm, leg symptoms or CAD.
Relevant sections may be completed or skipped depending on the nature of the condition that is being
addressed. The form is designed to collect data of clinical relevance but also to produce outcome
estimates including the generic EQ-5D and specific domains related to clinical conditions. These can be
used to monitor individual patient progress or for overall service evaluation. The reliability and validity
of the tool have been established through extensive psychometric evaluation. A demonstration version
of the final version of the form is available online at www.epaq.co.uk/Demo/VascularDemo (accessed
1 December 2020).
The vascular services simulation model
A computerised simulation model has been developed with a web-based interface that allows the
modelling of potential reconfiguration of the sites providing vascular services in England. The web-based
interface allows users to select specific regions and combinations of hospital sites and allows the selection
of various parameters for sensitivity analysis. By selecting different sites for a comparison, the effects of
reconfiguration of services can be modelled, providing estimates of the overall cost-effectiveness of a
reconfiguration along with calculated estimates of the workload in the different categories and resource
use required.
Other outcomes
In addition to these two main products, the programme has generated evidence and research outputs
from a number of other aspects of the studies. Several papers describe extensive reviews of the
evidence relating to outcome measures for different aspects of vascular disease,17–24 the available
evidence relating to patient preferences,194 and to the relationship between service configuration
and outcomes.11,13–15
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The societal preference studies provide estimates of the strength of preference for EVAR compared with
OR and for the strength of preference relating to travelling distance for access to vascular services.
The algorithms developed for the analysis of HES data provide a basis for consistent evaluation of
case-mix and outcomes from this complex routine data set.
In addition to the main web-based model, the modelling has provided a detailed analysis of the
relationship between activity outcomes and resource use.
Utility values for health states related to conditions dealt with by vascular services have been obtained
from two sources: a detailed literature review to support the modelling and direct measurement in
a patient sample based on EQ-5D-5L values measured by the ePAQ-VAS. The details of these have
been added to the School of Health and Related Research Health Utilities Database (ScHARRHUD)
(see www.scharrhud.org/; accessed 1 December 2020), where they are publicly available.
Patient and public involvement
A non-disease-specific PPI group was engaged for the relevant work on the NIHR Vascular
Programme Grant.
The PPI group, recruited through the Sheffield Clinical Research Group was used on a number of
occasions, for example to review documentation that was required for ethics approval [e.g. participant
information sheets and invitation letters (see Appendix 10)].
There were two main periods of interaction with the PPI group, as detailed below:
1. In summer 2016 when the group reviewed study documents [participant information sheet and
invitation letter (see Appendix 10)] and participated in mock interviews using the AAA interview
schedule (this was relevant to workstream 3).
2. In spring 2017 when the group again participated in mock interviews (this was relevant to
workstream 3).
The feedback from the mock interviews was used to revise the interview schedule and interview
booklets to ensure that they were designed and delivered in line with the PPI panel recommendations
regarding accessibility for all readers and participants.
Appendix 9 outlines a record of the changes that were recommended by the PPI panel to ensure
maximum efficacy of the documentation shown in Appendix 10.
Details of the patient and public involvement panel
The PPI panel is a lay advisory panel that is not focused on a specific disease. Further information about
the PPI panel is available at www.sheffieldclinicalresearch.org/for-patients-public/how-to-get-involved/
(accessed 1 December 2020).
Publications
The PPI group has been acknowledged in the publications resulting from this aspect of the programme
of work. The PPI group lead was made aware of any decisions to include the PPI group in publication
acknowledgements to ensure correct reference.
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Overall, this has been a very successful programme. A good team was developed and the number
of high-quality peer-reviewed publications exceeded expectations. In many areas the work
was ground-breaking and required considerable methodological development, alongside more
established methods. Some of these are likely to be relevant to further research in other fields.
Particular examples of such methodological developments are the processes used for staged
identification of appropriate literature relating to outcomes, the methods used to identify and
classify vascular activity and outcomes from HES, the development of methods to evaluate process
utilities, and the methods used to develop a simulation model of vascular service configuration
from HES data.
The research has already had significant impact on NHS services in several areas. The analyses of HES
data were used to contribute to another NIHR-funded research project that was commissioned to
examine the potential expansion of aneurysm screening to women (the SWAN study).7
Some initial work has already been carried out in conjunction with the National Aortic Aneurysm
Screening Programme (NAASP) to develop a modified version of the ePAQ-VAS to collect additional
HRQoL data alongside the screening programme. This has led to the commissioning of further work to
pilot and roll out the electronic questionnaire.
The research group also registered as a stakeholder in the recent consultation on the NICE guideline205
on AAA and contributed to the consultation.
Limitations
The most significant problem encountered during the programme was the provision of access to
HES data. The original supply of the data extract required for the analysis took nearly 2 years and
was partly responsible for significant delays to the programme. When an extension to the programme
was granted, a further application was made to update the HES extract with the most recent data.
Once again, severe delays were encountered, resulting in a number of complaints to NHS Digital, and
the final data extract was received only in February 2019, allowing only a few months for a complex
analysis. This limited the ability of the research programme to fully explore the data and realise the
full potential from this aspect of the research. A preliminary analysis of the data is included in Vascular
activity and outcomes from routine data. A ‘no-cost’ extension to the use of data has been agreed with
NHS Digital (in response to a series of formal complaints), so there is potential for further analysis and
publications if sufficient resources and personnel can be identified.
In addition to this, the analysis of HES data proved to be far more complex than was originally
envisaged. This was largely related to the complexity of the data structures, changes in coding and
inconsistencies in the data that required numerous iterations of analysis to provide suitable algorithms
for case-mix classification purposes.
There were recruitment challenges for the study, for example in workstream 3 recruitment was slow and
difficult. Often, potential participants were called three to five times before a time to do the interview
could be arranged, and various people would commit and then not answer on the day. This made it
difficult to recruit a sample that was representative of the general population (i.e. having a 50 : 50 sex
split). Trusts were asked to provide a more balanced sample and at one point to specifically recruit male
participants in an effort to rectify this. The trusts commented that it was generally more difficult to
recruit male participants, as they were less willing to participate and less widely available.
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Implications for research
The programme has resulted in the development of two main tools that should be beneficial in the
planning and evaluation of vascular services; however, there is considerable potential for further work
to be carried out on these. The ePAQ-VAS has been developed to a stage at which it is in a useable
format and has undergone extensive psychometric evaluation, showing good validity and reliability.
The next stage in its development is the wider application in clinical practice with its evaluation both as
a clinical tool for monitoring outcomes and as a potential method for collection of data for the evaluation
of services. For this purpose, the usability and nature of report formats requires some further development
and the tool requires evaluation in different clinical settings and geographical regions.
The web-based model of service provision has considerable potential for further development both in
evaluating its usefulness in the real-world situation of regions undergoing a reorganisation of vascular
services and in considering its potential applicability to other and more widespread clinical services.
In addition to further work on the tools that have been established by the programme, there are a
number of areas that have been highlighted as worthy of further studies:
1. Studies of the drivers of and barriers to organisational change within vascular services.
It is clear from the data that have been analysed that many centres have managed to amalgamate
services for major vascular surgery and radiology on a single site. However, there are a number of
other areas in which the geographical distribution of population and services would appear to differ
little from those where there has been successful reorganisation and yet there remain services that
fail to meet the published recommendations for service configuration. It is suggested that detailed
qualitative studies with the various stakeholders in such areas may aid an understanding of the
barriers to such reconfiguration.
2. Further development of vascular registries and data linkage.
The current procedure-based NVR is an invaluable source of information regarding practice and
outcome. However, it is limited by being a procedure-based registry that does not track subsequent
procedures and outcomes, collect data relating to selection processes or collect data regarding
patients who are turned down for elective or emergency surgery. There is potential for linkage
between data sources including HES, ONS statistics and data from the NAASP. This has the
potential to provide a more complete picture of practice and outcomes in vascular services.
3. The measurement and application of process utilities.
The studies carried out in this programme suggest that society places a significant value on aspects
of the service other than HRQoL outcomes. This includes aspects of the process of care, such as the
invasive nature of an intervention and the location of services. This is a new area of research and
further investigation is warranted to further develop methods of measurement of process utilities
and to investigate the ways in which these may be incorporated into cost-effectiveness analyses.
4. Exploration of variations in practice and coding.
The data analysed for this programme demonstrate considerable variation in practice, resource use
and cost between different units. It is unclear from the data the extent to which these represent local
variations in the way that patients are managed, geographical differences in case-mix or differences
in coding practice. All of these may have significant implications for the cost-effectiveness of the
service provided.
Implications for practice and policy
This programme of research has confirmed the potential clinical effectiveness and cost-effectiveness
of consolidating services for major vascular surgery on single sites with a higher volume of activity.
Considering the existing recommendation for a minimum of 60 aortic aneurysm repairs per year,
averaged over a 3-year period,3,171,172 approximately 20% of aneurysm repairs in England continue to
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be carried out in centres that do not meet this criterion. Data analysis suggests that extending this
to a higher threshold of approximately 100 cases per year may have further advantages with regard to
clinical outcomes.
Examination of the geographical arrangements suggests that the distances involved, with a few
exceptions, are unlikely to be a barrier to such reconfiguration and consideration could be given to
how such changes may be achieved.
In considering service reconfiguration, there are a number of other issues that need to be taken into
consideration. Patient preferences for local services and the need to maintain links to other specialties
would suggest that some form of hub-and-spoke arrangement may allow some services to be provided
more locally, where it is safe to do so. Providing services, such as investigations, minor procedures,
day-case surgery and amputation rehabilitation, at a spoke site through an integrated hub-and-spoke
service would maintain a regular presence of vascular clinicians and health-care professionals and
promote linkages with other services. The evidence from the data analysed suggest that there is a
trend towards moving such procedures into the central site, rather than maintaining hub-and-spoke
arrangements. However, there would appear to be a potential for greater integration of services with
outreach or in-reach arrangements that could minimise the movement of resources, pressure on
facilities and workforce implications associated with centralisation of major operating. The potential for
such distributed services would depend on existing local staffing and facilities, and could be usefully
explored through further modelling in any further planned reorganisation of services.
In this respect, there is also a case for considering how preferences for aspects of the service that
are not included in current cost-effectiveness calculations may be more formally incorporated in
policy-making processes.
The evaluation of PROMs suggests that most of the existing measures that apply to vascular services
are poorly validated and not widely implemented, hence the development of the new ePAQ-VAS
instrument. There is a need for more widely applicable tools for the collection of such data in vascular
patients both for clinical management and for the evaluation of services. It is suggested that the
implementation of an appropriate outcome measure, such as the ePAQ-VAS, would be a potentially
beneficial development.
There is considerable variation in practice with regard to the introduction of new technology and in
coding practices. It is suggested that there is a need for standardisation of procedures for the introduction
of new technology, better monitoring of compliance with guidelines and audit of sites that appear to be
outliers, with regard to practice or coding, to address such variability.
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Appendix 1 Vascular activity and
outcomes from routine data
Analysis of Hospital Episode Statistics data: general methods
A major part of the first workstream of the programme was the analysis of HES data, as described in
summary in Vascular activity and outcomes from routine data, and in more detail in Report Supplementary
Materials 1–11, to characterise the workload of vascular services, to identify trends in activity, working
practices and outcomes and to relate these to service configuration. This appendix describes the
processes involved in this analysis.
Data extract
Hospital Episode Statistics comprises several databases containing the details of all admissions, accident
and emergency attendances and outpatient appointments at NHS hospitals in England. It is now managed
by NHS Digital and contains extensive information, as described in the HES data dictionary.206 Data from
HES are available through a data access request service that enables bespoke extracts to be obtained
from NHS Digital. For the purpose of this programme, a data extract that included all of the major
vascular procedures and diagnostic areas was requested in July 2013. The basic structure of the
requested information included the available data regarding patient characteristics, geographical
information regarding place of residence and treatment, diagnostic and procedural information, and
details of the dates and destination for admission and discharge for each episode fitting a set of criteria
that were likely to pick up the majority of vascular-related conditions and procedures. Having identified
all potentially relevant episodes, data linkage using a pseudo-anonymised identifier was used to obtain all
further episodes for the same cohort of patients, details of critical care episodes for those patients and
linked data from the ONS obtained from death certification that provided the date and cause of death
(see Report Supplementary Material 1).
Owing to numerous iterations and changes in procedure at NHS Digital, there were considerable
delays in obtaining the data, which were eventually provided in May 2015. When a request for an
extension to the programme was made in the autumn of 2017, a further request was made to update
the HES extract; however, because of further delays in changes in procedure, the final extract was not
received until February 2019, which left little time for further analysis.
Although the original data extract contained information from 1999 and the updated data extend to
March 2018, a decision was made to limit the final analysis to the 12-year period from 2006 to 2018:
the most recent 12-year period that was available. This decision was made because, owing to changes
in coding, geographical data and provider arrangements, it was felt that it would be difficult to draw
clear comparisons with data prior to 2006.
Overview of process
The analysis of HES data was an extensive and time-consuming process because of the very large data
sets and complexity of the information. The majority of analyses were carried out through custom
programmes written in the R software environment for statistical computing. The processing consisted
of a number of stages. Initially, the data were ‘cleaned’ to remove records missing critical information
or containing inconsistent data and to identify and remove duplicate records.
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The second stage was to identify and characterise individual hospital admissions. The structure of the
inpatient records is based on episodes of treatment [finished consultant episodes (FCEs)] that differ
from definitions of ‘spells’ or ‘admission’, in that multiple episodes may occur within the same period of
admission to hospital for treatment. To produce consistent data, the decision was made to consider
admissions in terms of CISs that include the full duration of a patient’s hospital journey from the date
of first admission to hospital to the last discharge, in which episodes were overlapping or sequential
without a break even if there was a transfer between specialties or hospitals during that period.
To categorise the admission, a series of case-mix categories were defined with the help of a clinical
consensus group to classify admissions into clinically meaningful groups. The case-mix groups were
ordered in a hierarchy to determine the category of those cases for which there were multiple procedural
or diagnostic codes that may assign the case to different clinical groupings. Assignment rules were also
developed to identify an index admission to categorise patients with multiple admissions and characterise
pathways of care, and to prevent double-counting of patients who may fall into several categories at
different times.
Having merged episodes into single records for admissions relating to the specific case-mix groups,
further work was carried out to identify the site of treatment to link data with critical care and ONS
mortality data. These were used to develop measures of outcome to classify those comorbidities and
complications that were identifiable from the data and to carry out an analysis of costs for specific
procedures and pathways of care.
Further details of the various process involved are provided in the following sections.
Clinical consensus group
A group of clinicians involved with the management of vascular disease assisted in the classification
of HES data. The exact composition of the group varied over the duration of the programme, but
included vascular surgeons, physicians, vascular interventional radiologists and clinical nurse specialists.
Their input was an essential part of the process in identifying the appropriate categorisation of clinical
activity. As can be seen from the detailed descriptions, there are a number of issues where ambiguities
or inconsistencies in the coding led to uncertainties in the categorisation of patient groups. Where such
difficulties arose, the clinical group considered the various options for categorisation and determined
additional information that may be of assistance in determining the optimum categorisation. For
example, where there was doubt about whether or not certain procedures were related to vascular
disease, the consensus group suggested potential tabulations of data, based on other fields in the data
set (e.g. specialty, diagnostic codes or data in linked admissions), that may help to clarify the most
appropriate categorisation. This was an iterative process in which further analyses were suggested and
data tabulated for further discussion by the clinical consensus group.
Examples of areas for which clinical input was essential in determining appropriate categorisation
are the various methods for categorising the treatment of emergency or ruptured AAAs and for
distinguishing between amputations for vascular and amputations for other conditions. These specific
issues in these cases are discussed in more detail below and in Report Supplementary Materials 2 and 4.
Definition of case-mix groups
To facilitate the analysis, and in keeping with the proposed modelling, the analysis plan involved the
development of specific categories of vascular activity for which pathways could be described. In each
of these categories, activity was divided into clinically meaningful case-mix groups. This was carried out
through an iterative process in which a group of clinicians and expert advisers provided some textual
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description of appropriate groups and categories. These were then translated into algorithms for
identification based on the Office of Population Censuses and Surveys (OPCS)’s and diagnostic codes.
Some initial identification using the categorisation was carried out, and there were several iterations
where records were sampled both from those included in the various groupings and from those that
would be excluded. These were reviewed and, where it became apparent that the categorisation was
ambiguous or unsatisfactory, further attempts were made to refine the categorisation by including
decision rules based on combinations of diagnostic and procedural codes or other fields that are
available from the HES records.






During the subsequent work, it became evident that the diagnostic codes for venous ulceration were
not sufficiently sensitive to differentiate between chronic venous disease and leg or foot ulceration
related to PAD. As a result, the PAD and venous ulcer categories were combined to make a single
category of peripheral arterial and complex venous disease.
In addition to this, there was found to be a significant vascular workload that was not directly related
to these categories, which included conditions for which there were differences in practice between
centres and some more specialist procedures. These were treated as an additional category of
‘other vascular procedures’. This category included procedures on the visceral vessels, vascular
access procedures, upper limb vascular procedures and arteriovenous malformations.
Initially, consideration was given to using existing coding systems for categorisation; the various
versions of the HRG classification were considered but suffered from a number of drawbacks. There
have been several iterations of these, with a changing categorisation over the years, and, although it
was possible to allocate using the most recent grouper, when this was attempted the expert advisory
group felt that the categorisation was not ideal for the purpose of identifying differences in practice
that may be significantly related to the service configuration. The main rationale for this was that
certain areas lacked the granularity to distinguish what were felt to be important clinical distinctions.
Therefore, it was agreed that the categorisation procedure would be undertaken from scratch based
on the OPCS and International Classification of Diseases (ICD) codes.207
As a first step, all OPCS codes relating to vascular surgical procedures (largely L codes) and those
relating to amputations (X codes) were considered individually and classified according to whether or
not they were likely to be within the remit of vascular services. Those codes that were felt to be
non-specific and may or may not relate to vascular services were identified separately. The OPCS
codes were assigned to the vascular groups as detailed in the tables in Report Supplementary Material 2.
(This gives the final categorisation following the iterative process described below.)
For each of the assigned groups, records were then sampled in two ways. Initially, random cases were
drawn from the categories and a clinician reviewed all of the HES fields including age, sex, specialty
and the text relating to OPCS, HRG and ICD coding, to establish whether or not they felt that the
cases were being correctly categorised.
The second set of checks were carried out by cross-tabulating various aspects of the identified groups,
looking at them by the most common primary diagnoses, the main specialty and treatment specialty
and any other fields that were felt to be relevant in specific cases.
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This process resulted in refinement of a number of the categories and groupings. The following
sections describe the specific issues that were encountered and the decisions that were made
regarding categorisation for each of the case-mix categories.
Abdominal aortic aneurysm
There were several issues encountered in identifying AAA surgery.
Emergency versus elective admission or procedure
In the HES data record, the OPCS data include separate codes for emergency and elective aortic
aneurysm repair (e.g. L18X vs. L19X). There are also different codes for ruptured and non-ruptured
aneurysm (e.g. I713 vs. I714) and the codes regarding the admission method distinguished between
elective and emergency admission to hospital.
Cross-tabulating the method of admission against either the diagnostic or the OPCS codes suggested
that there was considerable inconsistency in the way that the coding was carried out. Following
discussions with clinical advisors, it was decided that the best way to handle this was to divide
admissions into elective and emergency admissions, irrespective of the categorisation of the procedure
or diagnosis. Among the emergency admissions, two categories were separately identified that would
be a proxy for ruptured and non-ruptured urgent cases based on a combination of the ICD codes and
the delay between admission and first operation.
On inspecting cross-tabulation of these data, it became evident that the combination of using the code
for ruptured aneurysm with a delay between admission and surgery of < 3 days, and a code for a
non-ruptured aneurysm with surgery on the day of admission resulted in discrimination between two
groups of emergency aortic aneurysm, with a considerable difference in mortality. This was felt to
reflect a best attempt at a meaningful separation between the clinically distinct categories of ruptured
and non-ruptured urgent aneurysm repair.
Aortoiliac and aortobifemoral bypass
The OPCS procedure codes have separate codes for aneurysm repair and aortic bypass (e.g. L19X vs.
L21X). The procedure carried out for an aortic aneurysm may sometimes be described as an aortic
bypass, and examination of HES records showed that the codes often coexisted. Even where there was
no code in the OPCS fields for an aortic aneurysm procedure, a significant number of cases in which
there were aortic bypasses included a diagnostic code representing AAA. The aortic bypass procedures
were, therefore, amalgamated and, where the ICD codes included a field containing a code for AAA,
the procedures were categorised as infrarenal aneurysm repair, whereas those without such an ICD
code were categorised as aortic bypass for PAD.
Endovascular aneurysm repair
New OPCS codes for EVAR (stent graft) were introduced in 2005. Prior to this, it is not possible to reliably
separate EVAR from open surgical repair. After the introduction of separate codes for endovascular repair,
it was found that many cases had records including OPCS codes for both non-specific aneurysm repair
and endovascular repair. In some cases, this may be a reflection of multiple procedures within the same
admission; however, this is quite an unusual event and is considered separately in relation to identifying
cases with multiple operations in the same admission. In cases where the coding represents multiple codes
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being used for the same procedure the clinical advice, supported by considering differences in mortality
rates and hospital stay, suggested that the majority of these were instances of a single endovascular
procedure with multiple procedural codes. For this reason, those cases where there were both codes in
the record were classified as endovascular repairs.
Juxtarenal and suprarenal aneurysms
Historically, aneurysms above the renal artery were dealt with in cardiothoracic units or a few
specialist vascular units; however, with the increasing use of fenestrated and branched endovascular
stent grafts, several vascular units are now undertaking significant numbers of these procedures.
Examination of the records suggested that the majority of cases classified with codes representing
these procedures continue to be carried out at specialist cardiothoracic units. However, a proportion
represent juxtarenal aneurysms that fall into the workload of vascular services. In the absence of any
better way to categorise these, they were classified on the basis of treatment specialty or, where this
was not available, on main specialty, including vascular and general surgery and interventional
radiology within the vascular workload. All other cases (most of which were cardiothoracic or
cardiology specialties) were excluded.
Aneurysm-related deaths
A proportion of patients admitted as an emergency with a ruptured AAA die either before or during
surgery. It felt important to try and capture these, as the selection of patients for intervention may
potentially represent a difference owing to different organisational arrangements. We examined the
records of a sample of patients who died in hospital and whose diagnostic codes included AAAs.
This revealed that there were a significant number of cases in which a procedure, such as laparotomy,
a diagnostic procedure or insertion of a venous line, was recorded in the procedure codes or in which
there was a death on the day of admission without a procedure. However, there were also other cases for
which aneurysm was included as a secondary diagnosis and the main reason for admission appeared to be
other than the aneurysm, particularly cardiac or respiratory diagnoses. A vascular group was, therefore,
defined in which the treatment and/or main specialty was vascular or general surgery, the primary
diagnosis field included the code for AAA and the discharge method identified a death in hospital.
Summary
The considerations above gave rise to a final category of AAA-related admissions with the procedures
being grouped as suprarenal and juxtarenal endovascular repair (complex endovascular); suprarenal
and juxtarenal OR (complex open); infrarenal endovascular repair; infrarenal OR (to include aortic
bypasses with a diagnosis of aneurysm); and patients with a diagnosis of an aneurysm who died
without an aortic procedure being recorded.
Peripheral arterial disease
Procedures that were included in the peripheral arterial category covered a wide range of endovascular
and open procedures and amputations carried out for lower limb vascular disease. The procedures
were divided into 12 categories: aortoiliac bypass, extra-anatomical bypass, femoroproximal and
femorodistal bypass, femoral endarterectomy, major and minor amputation, iliac, femoral and unspecified
angioplasty, embolectomy, and investigations. Some of these categories required some further refinement,
particularly where codes were non-specific.
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Aortoiliac bypass
As referred to above, some aortoiliac bypasses were carried out in patients with diagnostic codes
for aneurysm, and these were, therefore, classified above with the infrarenal aneurysm repairs.
The remainder were categorised as PAD procedures; however, there was an additional group that
included non-specific codes for operations on the aorta, such as unspecified bypasses of a segment
of aorta (L219) and endarterectomy of aorta NEC (L252). Where the codes were non-specific, further
investigation showed that the diagnostic and specialty codes suggested that some of these were
carried out for cardiothoracic diagnoses and the cases were, therefore, limited to those with a
treatment specialty or main specialty of general or vascular surgery.
Endovascular treatment
The OPCS codes have been modified in recent years to include a number of different endovascular
procedures, including transluminal placement of stent, transluminal angioplasty, other transluminal
procedures and separate codes for placement of different numbers of bare metallic or drug-eluting
stents. Many of these codes do not specify a site; however, there are additional codes for transluminal
procedures on the femoral or iliac arteries, but not for procedures distal to the knee. The transluminal
procedures were, therefore, divided into three categories of iliac angioplasty, femoral angioplasty and
unspecified angioplasty to include all transluminal therapeutic procedures. The unspecified group were
found to contain a large number of procedures that were carried out under cardiac or cardiothoracic
specialties, and these were, therefore, further filtered on the basis of the treatment or main specialty codes.
Amputation
The majority of lower limb amputations in the UK are carried out for vascular and diabetic disease and,
therefore, fall largely within the remit of vascular services. There are, however, some that are carried
out for malignancy, trauma or orthopaedic problems. The initial intention was, therefore, to limit
amputations on the basis of specialty; however, it became apparent that in some places there is
significant crossover, with orthopaedic surgeons carrying out some amputations on patients with
diagnoses of diabetes or vascular disease, whereas in other areas vascular or general surgeons would
be involved in amputations resulting from non-vascular causes. The amputations were, therefore,
selected on the basis of excluding a set of diagnostic codes for trauma and malignancy, leaving a less
specific group that could be explored further in relation to vascular treatment pathways.
Carotid disease
Carotid treatments were divided into endovascular treatments (codes L311–L319 and L767) and open
procedures that included endarterectomy, carotid body operations and carotid bypass procedures.
Varicose veins
There have been recent changes in the treatments available for VV. Up until 2005/6, the only procedures
for which OPCS codes were available were injection sclerotherapy and open surgical procedures. Since
2006/7, additional codes have been introduced for radiofrequency ablation and laser ablation. Where
available, the category of VV has been split into five separate groups for open surgery, including high
ligation and surgery on the truncal veins, phlebectomy/avulsions, laser treatment, radiofrequency ablation
and sclerotherapy.
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Venous ulceration was originally intended to be defined as a separate category based on ICD codes;
however, sampling of records demonstrated that the codes for leg ulcers were non-specific and
sometimes associated with other codes and procedures that suggested complex venous disease or
mixed arterial disease. It was, therefore, considered that these would be best analysed as part of the
PAD pathway.
Other procedures
There are a large number of other procedures that may potentially fall under the remit of vascular
services. Although these include a large number of codes, many of them are not specific to vascular
services and the overall numbers that appear to have been admitted under the care of vascular services
are relatively small compared with the main diagnostic groups. However, examination of this showed
that some were procedures that may represent complications of other treatments for vascular disease,
they also contain a large number of therapeutic endovascular procedures, many of which may be carried
out by a vascular interventional radiologist, as a service to other specialties and may therefore represent
an important group in respect to potential reconfiguration of services. These were, therefore, identified
and grouped for subsequent analysis; these resulted in a number of different groups that may require
separate consideration.
Arteriovenous malformations
There are separate codes for open and endovascular treatment of arteriovenous malformations;
however, these do not specify the treatment site. Although there is the facility for identifying sites
within the ICD codes, examination of the records showed that these were used inconsistently and
many arteriovenous malformations are treated by other specialties. These were, therefore, divided into
two groups for endovascular and open treatments but restricted to those cases in which the treatment
and/or main specialty was general surgery, vascular surgery or interventional radiology.
Upper limb procedures
Again, these were divided into open and endovascular procedures on the basis of the OPCS codes.
Vascular access procedures
There is considerable variation in practice as to the specialties that undertake vascular access
procedures, particularly those required for cancer treatments and for renal access. In some places
these are carried out by vascular surgeons and there is an increasing use of endovascular placement,
often with the involvement of interventional radiologists. It was, therefore, decided to include these
procedures in the analysis and, for the purpose of categorisation, they were divided into four groups
for renal access and other forms of access, each of which were subdivided into endovascular and
open procedures.
Visceral and renal artery procedures
These are relatively uncommon procedures and, therefore, renal and visceral procedures were grouped
together but subdivided into endovascular and open procedures.
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There are a range of other procedures that may contribute to the workload of vascular services; those
that are open procedures largely relate to unspecified procedures on arteries and veins, which were
found to be unusual on their own, but often combined with another procedure. These were classified as
‘other open vascular procedures’. There is also a wide range of miscellaneous endovascular procedures
including therapeutic occlusion of vessels, procedures relating to thrombolysis, embolisation, embolectomy
and insertion of filters. Some of these may represent a significant workload for vascular radiology services
and they were, therefore, identified as a separate group for further evaluation.
Hierarchy of procedures
To ensure consistency across the entire data set, the first 12 fields containing procedure codes were
checked for relevant OPCS codes that could be assigned to one of the above categories. Because each
episode contains multiple procedure fields and each admission may have multiple episodes, a process
was developed to flag whether or not a specific episode and a specific admission contained codes that
would result in assignment to each of the groups. A hierarchy was then developed on the basis of
consultation with clinicians to assign those cases that contained codes relating to multiple case-mix
groups to the most appropriate primary grouping (see Report Supplementary Material 2).
In general, the rationale was that specific categories were preferred to non-specific ones (e.g. if there
were codes for femoral angioplasty and non-specific codes relating to angioplasty, the case would be
assigned as a femoral angioplasty). There were some specific instances that required value judgements
that were made in consultation with the clinical expert advisers:
l Cases with both aneurysm procedures and peripheral arterial procedures were categorised as aneurysm.
The rationale for this was that when arterial procedures and aneurysm-related procedures are carried
out in the same admission, it is often the case that the arterial procedure either is an aspect of the
aneurysm treatment (e.g. iliac angioplasty or embolisation related to endovascular aneurysm repair)
or might relate to a complication of the aneurysm treatment, such as distal embolisation, bypass or
limb loss following aneurysm surgery.
l In the aneurysm group, those with both endovascular and open procedures were assigned to
endovascular procedures. The basis of this was examination of records, which suggested that codes
for aneurysm repair are sometimes used in conjunction with endovascular procedures and, where an
OR and an endovascular procedure occur separately in the same admission, it was felt most likely
that the OR represented a failure of an intended endovascular procedure. This latter point will be
investigated further when looking at multiple procedures within the same admission.
l In the VV category, episodes often contained multiple codes for procedures and the clinical advice
was that certain surgical procedures or sclerotherapy may be carried out in conjunction with laser
or radiofrequency treatment for truncal veins. Cases where there were codes for the newer
procedures were, therefore, assigned to these, with other open procedures taking precedence over
avulsions or sclerotherapy.
l Where groups within the ‘other’ category were present alongside codes for aneurysm, PAD or
carotid treatments the case was assigned to one of the last two categories.
l Although cases were assigned to a single group and category to allow the development of pathways,
the flags for each of the individual groups were retained to allow subsequent consideration of
patterns of activity in which there were multiple procedures or multiple categories of treatment.
Identification of treatment sites
One of the main aspects of the analysis of HES data was to characterise the relationship between
hospital volume and aspects of practice, resource use and outcome to model the effects of changes in
service configuration. To do this, it is necessary to identify the sites at which procedures are carried out.
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The HES data set contains two fields that identify the provider site. The first is ‘procode’, which should
contain the provider code for the NHS provider under which the episode is categorised, and the
second is ‘sitetret’, which should identify the site at which the treatment takes place. Examination of
these fields showed that there is considerable variation in the way in which the codes are used, and
this is compounded by changes in organisational structures, as a result of which the relationship
between individual sites and NHS providers may have changed over the years.
In theory, all NHS acute trusts should be represented by a three-digit alphanumeric code beginning
with the letter R. NHS trust sites are identified by a five-digit alphanumeric in which the first three
digits are those of the provider trust and the last two digits identify the specific site. There is, however,
considerable inconsistency in the way that these codes are used. In some cases, the full five-digit site
appears in the provider code, whereas in others there is a three-digit code or three digits followed
by non-specific digits, such as 00 or XX. In some cases, the ‘sitetret’ field contains just two digits
representing the site; in others it contains a full five digits. There are some instances of the initials of
the hospital being used rather than the published code and some hospitals have multiple site codes
representing different wards or units within the hospital.
Expert opinion was that it was important to identify the sites in which procedures were carried out
rather than to rely on provider codes alone, as there have been many changes in provider trusts and
the merger of several hospitals into a large single provider for administrative processes may or may
not be accompanied by changes in the sites at which vascular services are delivered. An exercise was,
therefore, carried out to try to identify hospital sites in a consistent way, so that changes in practice
with regard to the sites at which procedures are carried out could be comparable across the years of
the study. It was felt that this was particularly important for major vascular procedures and, therefore,
an attempt was made to identify specifically all sites where elective AAA repair were carried out
during the period of study.
To achieve this, all combinations of provider and site code were identified and all combinations of
codes were examined individually. Where the provider and site codes did not correspond and map to
a consistent specific site, both codes were examined individually to categorise them wherever possible.
In many cases, it was possible to identify the site in this way. A further exercise was carried out to
identify multiple sites that represented different units or wards within the same hospital and to
reclassify sites where the coding had changed owing to organisational codes and to map these onto
the current provider sites.
In this way, a look-up table was produced of all sites at which aortic aneurysm repair had been carried
out. These were identified by a site identifier (ID) consisting of the current three-digit provider code
plus a fourth digit that represented the individual site. Where a provider had only a single site carrying
out aortic surgery or where there was insufficient coding to identify the site beyond the three-digit
provider code this was designated XYZ0 (where XYZ is the three-digit provider code), and where a
specific site was identified these would be numbered XYZ1, XYZ2, etc. In this way, a look-up table was
generated that allowed the concatenated provider and site codes to be used to look-up the specific
four-digit site identifier. In addition, as some sites had changed name and some hospital moves had
taken place, further identification and amalgamation of sites was carried out by matching site postcodes.
Since the introduction of the NAASP, aneurysm services in England have been grouped into 43
screening areas and, based on digitised mapping of these areas, all resident LSOAs and provider sites
were classified to a specific screening area for consideration of geographical variations in configuration
and practice (see Report Supplementary Material 3).
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Identification of admissions
The HES provides records at the level of consultant episode. Where patients are transferred between
consultants or units within a single admission, this may generate multiple episodes within the same
stay in hospital. Each episode may have duplicate or unique information regarding procedures,
diagnoses or other fields within the HES record. To develop patient pathways for specific treatments
and conditions it is necessary to combine the episode-level data into admissions. In the majority of
cases, a single episode is present in an admission so that the episode start and end dates are the same
as the admission and discharge dates; however, where there were multiple episodes it is necessary to
aggregate the relevant information across multiple episodes to produce an admission-level set of data.
A significant proportion of episodes do not contain a discharge date, so the first stage in this
procedure was to identify admissions as being all unique combinations of admission and anonymised
HES ID for the same patient. In some cases, this results in admissions with multiple discharge dates.
This may occur if there is a day-case admission followed by re-admission or transfer to another
hospital on the same day, or if one or more of the episodes contains an incorrect discharge date.
In developing the admission-level data set, all admissions on the same date for an individual patient
were combined while retaining the episode-level data to identify transfers between sites, re-admissions
and multiple procedures within the same admission. To create an overall admission record, the
discharge dates were aggregated to identify the last discharge date, taken as the end of the
full admission.
Examination of the data showed that there are a number of anomalies within the records. For example,
there may be multiple admissions that appear to have the same discharge date for the same patient.
This may occur if, for example, a patient is discharged and then re-admitted and discharged or dies on
the same day. It may also be due to a data entry error. Because the former circumstance in particular is
relevant to the outcome of treatment, these episodes were combined into the same admission record by
creating a minimum admission date for all admissions with the same end date.
Further evaluation of the data showed that there are numerous anomalous situations in which there
appear to be concurrent or overlapping admissions. Theoretically, if the rules for characterising
admissions and discharges are followed, there should not be overlapping episodes, or episodes where
admission and discharge dates are within another admission. However, the HES data show that this is
not uncommon, and examination of records where this occurred suggested different circumstances
where it seems to happen. One is commonly associated with admissions for investigations or dialysis,
where it would appear that patients may remain in the HES data as apparently being an inpatient in
one hospital, while having a separate admission for dialysis or an investigation, often as a day case.
The other situation is where there are apparently discrepancies in the recorded admission or discharge
date for what appear to be episodes within the same admission.
To allow further analysis of these situations, all overlapping and coincident admissions were combined
into a single record based on a combined maximum discharge date and minimum admission date, with
those in which there were multiple sites or conflicting dates being flagged for further consideration.
Identification of outcome measures
There are a number of potential outcome measures that can be identified from within HES data and
different outcome measures are particularly relevant to particular case-mix categories. This section
deals briefly with some of the issues in identifying outcome measures from the routine data set, but
further details are provided in Report Supplementary Material 4 and in published papers.7,11,208
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Mortality
For some high-risk procedures within vascular surgery, mortality is an important outcome measure
but raises a number of issues regarding the different potential ways to measure this and the ability to
correct for differences in case-mix.
The HES records include a field for discharge method that identifies episodes that ended with the death
of the patient. In the past, this was commonly used as a method to identify mortality. As discussed above,
a single hospital admission or spell of treatment may include multiple episodes, which is particularly true
if a patient suffers a complication and is transferred to another specialty or hospital. In view of this, the
use of a crude assessment of mortality based on discharge method of individual episodes is likely to
underestimate overall mortality. For the current analysis, episodes were combined into continuous
impatient spells and in-hospital death was identified if any of the merged episodes included a discharge
method indicating that the patient had died. An alternative that is commonly used for describing
procedure-related mortality is to include deaths within 30 days of a procedure. This was available
through linkage of the episode data to ONS mortality data. Some ambiguity may be created in defining
30-day mortality where there are multiple procedures or no operative procedure during an admission.
In these cases, the 30-day mortality was defined as 30 days from the date of admission for unoperated
cases and as 30 days from the date of the first index procedure where there were multiple procedures
in the same admission. For example, a patient admitted as an emergency may undergo investigative
procedures followed by one or more major vascular reconstructions, and in such a case the index date
would be taken as the date of the first major procedure.
Both in-hospital death and 30-day mortality were used as potential outcome measures and produced
different results, an issue that is discussed further in the results relating to aortic aneurysm repair in
Vascular activity and outcomes from routine data.
Re-admissions
The linkage of data allowed identification of patient pathways and re-admissions to hospital; in particular,
the NHS measure of re-admission to hospital within 30 days of discharge was identified for all case-mix
groups. In some cases, a further categorisation was required, because, for example, it is not uncommon for
a patient to be admitted for investigation and then undergo a further subsequent planned admission for
further treatment. The nature and type of re-admission was, therefore, looked at on a case-by-case basis
for the different categories of admission. Re-admissions for repeat procedures was identified within the full
data set and specific groups were identified that were relevant to particular diagnostic categories. Examples
include re-admissions for repeat of the same procedure, further operative or endovascular procedures
following treatment of PAD, and admissions with a stroke diagnosis following carotid endarterectomy.
These categories are dealt with under the discussion of the results for the individual conditions.
Complications and comorbidities
Although HES records provide a rich source of diagnostic and procedural information, it can be difficult to
distinguish some conditions that may be pre-existing comorbidities from those that occur as complications
of a treatment. A detailed piece of work was carried out to consider complications and comorbidities for
different conditions based on existing published categorisation (see Report Supplementary Material 4), but
modifying this in the light of advice from the clinical consensus group and making use of evidence from
linked episodes prior to the index admission to attempt to separate complications from comorbidities.
Further details of this process are described in Report Supplementary Material 4.
The relevance of different comorbidities or complications varies between the different diagnostic
categories, and is described in more detail below. For example, in the case of the treatment of CAD,
although CVAs are an important complication of the treatment, they may also be a pre-existing condition
and indication for the treatment, in which case they are likely to indicate a higher-risk group of patients.
By identifying those patients in whom a CVA was identified in a prior admission or the same admission
as a cause for emergency admission, some separation of these groups is possible.
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Appendix 2 Qualitative interview topic guide




Confirm consent – complete form
Confirm confidentiality
OK to tape
Can stop any time
History Could you tell me a little bit about why you are attending the vascular clinic?
Symptoms
Diagnosis
Understanding about the disease?
Quality of life Tell me about your experiences of living with your condition
Overall, how would you say your condition affects your quality of life?
Physical symptoms How does your disease affect you physically?
Pain (triggers and relievers, intensity, location)
Mobility (walking distance, stairs)
Sleep/fatigue (getting to sleep, waking up, feeling tired)
Physical functioning What impact does your condition have on your day-to-day functioning?
Ability to get out and about
Daily activities (shopping, self-care, house-hold chores)
Sex life
Exercise
Limited in type of activity you would like to do
What would you say is the most significant impact on your daily life?
Emotional impact How does this impact on how you feel?
Well-being
Mood (emotional, upset, angry, scared)
Health concerns (present, future)
Limitations
Social impact How does your condition impact on your ability to get out and about and see people?
Friends
Family
Work (economic impact, time off work, relationship with colleagues)
Hobbies
Impact on others (support needs)
Self-care What lifestyle advice have you been given – e.g. smoking cessation, exercise, weight
management, etc.?
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Process of care Thinking about your experiences at the hospital – how do you feel about the care you
have received?
Was it a prompt referral?
How are the staff?
Is the clinic easy to get to?
Treatment?
What has gone well/not so well?
What are your views on how long you had to wait in clinic to see medical staff/specialists?
Is there anything you feel could have been improved?
What are your views on the time you had to wait for your procedure following your referral?
Would it have made much difference to you if the waiting time had been shorter?
What about follow-up appointments? Were these at the hospital or at your home?
Did you have far to travel for your procedure?
How big a problem would it have been if you’d have had to travel further for your procedure
and/or follow-up appointments?
Did you see the same people at each follow-up appointment? If yes, is that something you
valued? If no, would you have preferred to see the same people?
Did you have to stay in hospital following your procedure? How long? Would you have
preferred a longer or shorter stay?
Apart from the outcome of the procedure itself, what was the most important thing to you
about the process of care that you’ve undergone?
Which aspect of care would you most like to see improved?
Closing Is there anything else you feel would be useful for other people with your condition to improve
their care?
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Appendix 3 Abdominal aortic aneurysm
trade-off interview booklet
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Appendix 4 Carotid artery disease
trade-off interview booklet
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Appendix 5 Peripheral arterial disease
trade-off interview booklet
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Appendix 6 List of covariates in
volume–outcome regression models
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Covariate Name inhosd_AAA inhosd_CAD inhosd_PAD surv_AAA surv_CAD surv_PAD los_AAA lso_CAD los_PAD cost_AAA cost_CAD cost_PAD amp_PAD
startage Age (years) 1 1 1 1 1 1 1 1 1 1 1 1 1
male Male (vs. female) 1 1 1 1 1 1 1 1 1 1 1 1 1
evar EVAR (vs. OR) 1 1 1 1 1 1 1 1 1 1 1 1 1
imd04 Index of Multiple Deprivation
(2004)
1 1 1 1 1 1 1 1 1 1 1 1 1
elective Admitted as elective 1 1 1 1 1 1 1 1 1 1 1 1 1
weekend Admitted at weekend
(Saturday or Sunday)
em_rup em em ✗ ✗ ✗ em_rup em em em_rup em em em
urban Living in urban area ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗
distml Distance from home to hospital ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗
hesyear200708 hesyear200708 1 1 1 1 1 1 1 1 1 ✗ ✗ ✗ 1
hesyear200809 hesyear200809 1 1 1 1 1 1 1 1 1 1 1 1 1
hesyear200910 hesyear200910 1 1 1 1 1 1 1 1 1 1 1 1 1
hesyear201011 hesyear201011 1 1 1 1 1 1 1 1 1 1 1 1 1
hesyear201112 hesyear201112 1 1 1 1 1 1 1 1 1 1 1 1 1
hesyear201213 hesyear201213 1 1 1 1 1 1 1 1 1 1 1 1 1
hesyear201314 hesyear201314 1 1 1 1 1 1 1 1 1 1 1 1 1
hesyear201415 hesyear201415 1 1 1 1 1 1 1 1 1 1 1 1 1
hesyear201516 hesyear201516 1 1 1 1 1 1 1 1 1 1 1 1 1
hesyear201617 hesyear201617 1 1 1 1 1 1 1 1 1 1 1 1 1
hesyear201718 hesyear201718 1 1 1 1 1 1 1 1 1 1 1 1 1
co1 Coronary artery disease 1 1 1 1 1 1 1 1 1 1 1 1 1
co2 Heart failure 1 1 1 1 1 1 1 1 1 1 1 1 1
co3 Cerebrovascular disease ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗
co4 COPD 1 1 1 1 1 1 1 1 1 1 1 1 1
co5 Peptic ulcer disease ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗
co6 Mild liver disease ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗
co7 Diabetes 1 1 1 1 1 1 1 1 1 1 1 1 1







































Covariate Name inhosd_AAA inhosd_CAD inhosd_PAD surv_AAA surv_CAD surv_PAD los_AAA lso_CAD los_PAD cost_AAA cost_CAD cost_PAD amp_PAD
co9 Renal disease 1 1 1 1 1 1 1 1 1 1 1 1 1
co10 Cancer 1 1 1 1 1 1 1 1 1 1 1 1 1
co11 Moderate or severe liver
disease
1 1 1 1 1 1 1 1 1 1 1 1 1
co12 Smoking ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗
co13 Obesity ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗
co14 Primary hypertension ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗
co15 Dyslipidaemia 1 1 1 1 1 1 1 1 1 1 1 1 1
vol Total annual volume 1 1 1 1 1 1 1 1 1 1 1 1 1
ruptured AAA ruptured 1 ✗ ✗ 1 ✗ ✗ 1 ✗ ✗ 1 ✗ ✗ ✗
cad_b4 Having either TIA, stroke or
I652 (occlusion and stenosis of
the carotid artery) before index
admission
✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗
amaj_c Major amputation in index
admission
✗ ✗ 1 ✗ ✗ 1 ✗ ✗ 1 ✗ ✗ 1 ✗
by_subEb Embolectomy subgroup
(ref: aibip_PAD)
✗ ✗ 1 ✗ ✗ 1 ✗ ✗ 1 ✗ ✗ 1 1
by_subFdisby Femorodistal subgroup
(ref: aibip_PAD)
✗ ✗ 1 ✗ ✗ 1 ✗ ✗ 1 ✗ ✗ 1 1
by_subFmoby Femoroproximal subgroup
(ref: aibip_PAD)
✗ ✗ 1 ✗ ✗ 1 ✗ ✗ 1 ✗ ✗ 1 1
death_c Died in hospital ✗ ✗ ✗ ✗ ✗ ✗ 1 1 1 1 1 1 ✗
vulcer_c Leg ulcer in index admission ✗ ✗ 1 ✗ ✗ 1 ✗ ✗ 1 ✗ ✗ 1 1
los_findex Length of stay in index
admission
✗ ✗ ✗ 1 1 1 ✗ ✗ ✗ ✗ ✗ ✗ ✗
stroke_inad Stroke in index admission ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗
amaj_b4 Major amputation before index
admission
✗ ✗ 1 ✗ ✗ 1 ✗ ✗ 1 ✗ ✗ 1 1


















































































































































































































































































































































































































Appendix 7 List of model parameters
informed by literature searches
vasgroup group sub1 sub2 Mean SD
AA General Under 25 Male 0.94 0.12
AA General Under 25 Female 0.94 0.12
AA General 25 to 34 Male 0.93 0.16
AA General 25 to 34 Female 0.93 0.15
AA General 35 to 44 Male 0.91 0.17
AA General 35 to 44 Female 0.91 0.15
AA General 45 to 54 Male 0.84 0.27
AA General 45 to 54 Female 0.85 0.23
AA General 55 to 64 Male 0.78 0.28
AA General 55 to 64 Female 0.81 0.26
AA General 65 to 74 Male 0.78 0.28
AA General 65 to 74 Female 0.78 0.25
AA General 75 + Male 0.75 0.28
AA General 75 + Female 0.71 0.27
AA Repair OSRvsbase month0to3 –0.0802 0.30
AA Repair OSRvsbase month3to6 –0.0802 0.30
AA Repair evarvsOSR month0to3 0.0599 0.42
AA Reintervention vsbase upto6month –0.0604 0.65
AA Neardeath vsbase before6month –0.149 0.42
CAD Base 0.766 0.25
CAD Stroke_decrement vsperfect Mean 0.243
CAD Stroke_decrement vsperfect Alpha 64
CAD Stroke_decrement vsperfect Beta 200
PAD Base IC 0.7 0.23
PAD Base CLI 0.35 0.23
PAD Amputation 0.48 0.23
AA Surveillance_cost 234
AA Reintervention_cost 8932 893.20
CAD Surveillance_cost Open 458 45.8
CAD Surveillance_cost Endo 533 53.3
CAD Stroke_cost Open Year1 7570 757
CAD Stroke_cost Open Year2onward 1770 177
CAD Stroke_cost Endo Year1 6020 602
CAD Stroke_cost Endo Year2onward 1400 140
PAD IC_cost monthly 115 11.5
PAD CLI_cost monthly 361 36.1
PAD Amputation_folcost monthly 2200 220
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Appendix 8 Reinterventions following
abdominal aortic aneurysm treatment
Reintervention category Severity OPCS codes
Conversion to OR Life-threatening reinterventions
(classed by EVAR 1 group)
Any AAA OPCS code after primary
repair
Reintervention for graft infection –
open
Divide these into open interventions
vs. EVAR re-intervention
Reintervention for graft infection –
endovascular
Reoperation of OR – open
Known aneurysmal extension above
or below original graft – OR
Known aneurysmal extension above




Axillo – bifemoral bypass graft Life-threatening reinterventions
(classed by EVAR 1 group)
PAD (extra-anatomical) only
Staple or ligation (EVAR) Serious reintervention (classed by
EVAR 1 group)
L472 Percutaneous transluminal
embolisation of visceral branch of
abdominal aorta NEC
Embolisation (of endoleak) L713 Percutaneous transluminal
embolisation of artery
Sclerosis of endoleaks L702 Open embolisation of
artery NEC






Reintervention for thrombosis of
graft limb – endovascular
False femoral aneurysm – open
Re-intervention for thrombosis of
graft limb – open procedure
Incisional hernia – open repair T251, T252, T253, T258, T259, T261,
T262, T263, T264, T268, T269
Laparotomy Mentioned in reintervention Y502 Laparotomy approach
T301 Reopening of abdomen and
re-exploration of intra-abdominal
operation site and surgical arrest of
postoperative bleeding
T302 Reopening of abdomen and
re-exploration of intra-abdominal
operation site NEC
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Reintervention category Severity OPCS codes
T303 Reopening of abdomen NEC
T304 Opening of abdomen and
exploration of groin
T308 Other specified opening of
abdomen
T309 Unspecified opening of
abdomen
Lysis of adhesions Mentioned in reintervention T412 Division of band of peritoneum
T413 Freeing of adhesions of
peritoneum
T414 Open removal of foreign body
from peritoneum
T415 Freeing of extensive adhesions
of peritoneum
T418 Other specified other open
operations on peritoneum
T419 Unspecified other open
operations on peritoneum
Bowel resection Mentioned in reintervention H041–H139
NEC, not elsewhere classified.
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Appendix 9 Feedback from the Patient
Advisory Panel
Online Patient Advisory Panel: reviewer form
Please complete this form electronically and return to xxxxxxxxxxxx by the agreed deadline.
We recommend that you read all the information we send you first, before completing the review.
Please have a common sense practical view by ensuring that your comments are meaningful,
considered and informed by your experiences, and where appropriate challenging.
If you have any questions whilst reviewing this information please get in touch with xxx by email or
call xxxxxxxxxxx.
Section 1: comments on the invite letter
Is the invite letter clearly written and easy to understand? (if you feel there are elements of the invite
letter that could be improved, please elaborate on this in your answer).
Reviewer 1 – Yes.
Reviewer 2 – I think that the letter is written in a clearly and easy to understand way mostly, and the
layout is also clear and easy to understand. The part of the letter that mentions types of vascular
problems that you can have could be taken out. This is because there would be very few people that
would know what they were and even less understands them. As the participants of the projects are
healthy therefore don’t suffer from any vascular problems, they probably won’t know what the
conditions are, so the names of some of the problems would just confuse them when they read it.
Reviewer 3 – Is the invite letter clearly written and easy to understand? (if you feel there are elements
of the invite letter that could be improved, please elaborate on this in your answer) Yes it is clearly
written and understandable. It could be improved by defining the terms: vascular, services and vascular
insufficiency, and also by using less medical terminology i.e. talking about blood circulation problems
rather than vascular conditions.
Reviewer 4 – The letter is fairly clearly written, although terms are used that might not be understood
and I wasn’t entirely clear about the purpose of the research from the letter.
It isn’t clear what a ‘healthy’ adult is – whether other conditions are excluded or just vascular
conditions.
Also, it would be better to have the explanation of what ‘vascular problems’ are right at the start as
the term is used in the title and first paragraph without explanation.
What are vascular ‘services’? in-patient/out-patient and/or community services?
I was confused as to how ‘public’ views on ‘vascular’ services could be explored.
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Many people won’t know what ‘aortic aneurysm’ or ‘venous insufficency’ mean and there’s no explanation
of ‘health-care treatments’ and ‘interventions’ ‘patient-focused’ may not be a familiar term to everyone.
Reviewer 5 – Reasonably clear however a description of what ‘Vascular’ services are, is needed. I feel
the word vascular itself is too technical.
Also most of paragraph 3 needs to come before paragraph 2.
Using the phrase general public is condescending ‘public’ is fine.
Reviewer 6 – The letter is brief and to the point. I did however keep rereading to try to understand
why you want the opinion of people who do not need to access this service.
Reviewer 7 – I think you should make it clear at the very beginning that this is an interview study,
not a clinical trial or experiment.
Reviewer 8 – It is a well written, clear, logical and just the right length. This is difficult as not sure
how it could be improved. It’s the correct length and gets right to the point without any unnecesarry
information. I would perhaps want to maybe know a bit more information on how this study would
impact the health service.
Reviewer 9 – The letter is very clearly written in plain English and easy to understand.
Reviewer 10 – It is clear, but I suggest the actual details of the participant’s contribution – the short
interview possibly face to face-could be set out in the first paragraph just to engage them more.
Reviewer 11 – I am very happy that the invite letter is clearly written and easy to understand. It
clearly states that the research is aimed at improving patient-focused care: I feel this is important
when embarking upon a research study.
Reviewer 12 – It is, but where are you getting their name from? I think that needs including as you are
hinting at the fact you know something about them as you know they don’t have a vascular condition.
I think people need to assured that their contribution can make a difference and explain the rationale
for interviewing this group. A lot of people will think they cannot comment on a condition they have
no experience of and a service they have never used. I certainly fall into this category.
Having read the invite letter, do you think it is a project that you would consider taking part in?
Reviewer 1 – Yes.
Reviewer 2 – I would consider it, because it doesn’t sound like it would inconvenience me too much, as
the interview is mostly likely to take place over telephone, and would only take around 20–30 minutes.
Reviewer 3 – Yes. It appears to be a worthwhile project in which to become involved.
Reviewer 4 – Not without more explanation – and I was put off by the technical nature of both
documents and the hypothetical scenario methodology.
Reviewer 5 – Yes.
Reviewer 6 – I see no reason not to take part, it’s a painless half an hour of my time; I would like to
know why you’re seeking the opinions of the general public, people unaffected by the service, to help
shape the service. Why should I be interested?
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Reviewer 7 – Yes.
Reviewer 8 – I would be interested in taking part to see how the services are being changed and from
the letter it would suggest that re-structuring of services are taking place, and the researchers and
clinicians are asking the public what they want and what they would benefit from.
Reviewer 9 – It is a project I would take part in, although there is no direct benefit to myself, it may
help others.
Reviewer 10 – Yes, if I were ‘healthy’!
Reviewer 11 – Yes, I would be keen to take part in this project.
Reviewer 12 – Not currently, I would want the information I have asked for above.
Section 2: comments on the participant information sheet
Does the document clearly describe and explain what will be involved for a patient who wants to
participate in the research?
Reviewer 1 – “Participant interviews will most likely take place over the phone, but some interviews
will be in person”: Better said in Invite Letter: “This will most likely be a telephone interview, but in
some cases could be in person, either at a clinic or hospital”. Why one or the other, and why not
knowing in advance?
Reviewer 2 – Yes, apart from the part that mentions about some of the interviews being in person at
clinic or in hospital. Is there a reason why some people would be interviewed in person, or is that an
option in case some people can’t do the interview by phone? This would need clarifying, as it may put
some people off, as they would find it an inconvenience for them if they would have to go in in person.
Reviewer 3 – Yes I believe so. The use of the term “patient” here is inappropriate I think as it is
addressed to “healthy volunteers”.
Reviewer 4 – No – I don’t think so. It still uses medical terms and I found the interview
structure unclear.
Reviewer 5 – Not really I found it very confusing is it about quality of services or how far I would
travel for the service. Also, as a patient, would I be interviewed over the phone or face to face – why
the difference and who decides? Finally what is described in the structure doesn’t seem like an
interview to me more like a ‘virtual or imaginary game’ and this does need more clarification.
Reviewer 6 – Very clear, easy to read. Describes the process well.
Reviewer 7 – Yes I think it’s very clear.
Reviewer 8 – This document very clearly starts with something I look out for. ‘No obligation to
complete this study’ and ‘contact details can be found at the end’. It then follows into what is expected
and a general example of how the interview will be conducted.
‘The disadvantages and risks involved are minimal’. – I’m not sure about this? How can a phone call be
risky? This is too general, you need to outline the risk clearly or if no, which I suspect, say “there are no
risks involved with the interview”.
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Reviewer 9 – The document is very thorough and clear on what would be involved for the patient.
There is no harm involved in the study and data storage and use was explain clearly and thoroughly.
Reviewer 10 – yes.
Reviewer 11 – The participant information sheet is very clearly written, and explains everything in
good detail. I feel it also sets out the aims of the project very clearly.
Reviewer 12 – It is, but I think it could have more information in it as described for the invitation
letter above. A description of the documents they will be sent would be useful, as it sounds offputting
and bit much like hard work for no benefit. It would be useful to give some examples of where this
type of research has been successful before.
Would you say that the document is written in a language that patients would understand, if not, what
parts need changing?
Reviewer 1 – Definition of “Trade-off techniques”.
Reviewer 2 – It is mainly written in a language that the patients would understand, apart from one
part. The paragraph that talks about the purpose of the study includes a list of vascular problems near
the end, “peripheral arterial disease, aortic aneurysm, carotid arterial disease, varicose veins and
venous insufficiency”. The inclusion of this is confusing and not really that necessary for the patient
information sheet as they won’t understand what they’re reading.
Reviewer 3 – As in my response to Section 1 I would like to see the terms vascular, services,
insufficiency, explained in more everyday language so as to be more readily understood by lay persons.
Reviewer 4 – The ‘purpose’ paragraph is unclear – if this is aimed at the public who don’t have vascular
conditions they are unlikely to understand the medical terms used. Also – it still doesn’t explain how
public views can be related to services they don’t access. Same points as above re letter – use of
‘healthy’ ‘patient-focused’, etc. I found the interview structure unclear – would I be asked entirely
hypothetical questions? And how much explanation would there be of the health states and treatments?
Reviewer 5 – I think a lot of the language is quite technical such as ‘vascular health-care treatments’
and ‘rank them in order of how good or bad’ and ‘trade-off technique’ So they need descriptions in
short and simple sentences. Also what do you mean by good or bad? This is very vague does it mean
‘is this painful or uncomfortable or embarrassing?’ I found a lot of the language quite patronising.
Reviewer 6 – Seems straightforward and easy to understand, clearly laid out. Being picky, I don’t like
the use of ‘so therefore’ in the paragraph about disadvantages and risks. It’s clumsy and unnecessary to
use both words.
Reviewer 7 – Yes but I think it might interest people more if you clarified what ‘vascular services’
comprises. Is it surgery, medicine and radiology? You might also consider encouraging potential
subjects by telling them how their responses will make a difference.
Reviewer 8 – A very clear and logical information sheet. I cannot see anything that would need altering
other than the disadvantages and risks involved section.
Reviewer 9 – Perhaps define ‘vascular’ slightly sooner. The document is understandable and clear.
It is lengthy; however, I believe all the information is necessary.
Reviewer 10 – yes.
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Reviewer 11 – I’m happy that it’s all written in a manner that’s easy to understand.
Reviewer 12 – The language is fine.
If you were given this document in clinic, would you have any questions for the researchers after
reading this document?
Reviewer 1 – No.
Reviewer 2 – It says that they would be sent documents to prepare for the interview.Would they be long
and time consuming to read, as this may not be possible for people who are very busy and wouldn’t have
that much time to read long documents, therefore maybe making it an inconvenience and put them off.
Reviewer 3 – Yes as stated above.
Reviewer 4 – How can questions relating to hypothetical conditions and situations help to inform
provision of a specific set of services for specific conditions? Wouldn’t it be better to ask those patients
who already use them? Where are the locked cabinets for storing transcripts kept?
Reviewer 5 – I would be very worried about confidentiality I don’t find what has been written is
reassuring in any way whatsoever. You need to be very specific about coding procedures and how
all identifiers are removed. You need to state how researchers are monitored and what their access
procedures are. Most patients are happy to give a researcher plenty of information about themselves
just as long as they, the patient, is not identifiable.
Reviewer 6 – I still don’t understand why you want healthy volunteers with no interest in the service,
I know what you want, and how it is carried out, and that it is part of a much larger study, but why
would my opinion be valuable?
Reviewer 7 – I think the main question would be around the arrangements for the interview. Can it be
done at the weekend or in the evening? If the subject has to travel are you facilitating this by paying
their expenses? If I was sitting in a clinic waiting area reading this I’d like to know if the interview
could be done during that visit to the hospital. This would benefit you because as they leave hospital
they’ll forget all about the request to be involved.
Reviewer 8 – Is there a need for this study to decide where certain vascular services will be situated
and structured in Sheffield because there will be some remodeling and moving? What do you expect
to understand from the trade-off technique? How do my details, such as occupation, help the study?
Why are you using healthy volunteers and not people with vascular disease states?
Reviewer 9 – I might wish for the researchers to elaborate on the meaning of ‘trade-off’ technique.
Reviewer 10 – yes, I would want to know more about ‘the broad structure of the interviews will be as
follows:’ as I would be intrigued!
Reviewer 11 – If I have any other health conditions (i.e. not vascular), would this affect my eligibility
to take part in the research? How many participants do you hope to interview? Do you have any links
to the ‘larger research study’ you mention on the first page? Are there any factors that determine
whether a phone interview or a face-to-face interview is conducted? Would I be able to read the
transcript of my interview (after it’s been written up), such that I can confirm that it gives a true
representative view of my interview?
Reviewer 12 – Why me? How can I possibly comment on something I know nothing about?
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Section 3: do you have any other comments you would like to feedback to
the researcher?
Reviewer 1 – None.
Reviewer 2 – None.
Reviewer 3 – None.
Reviewer 4 – None.
Reviewer 5 – You have decided that distance to the vascular service as a key factor, I would suggest
most patients would consider local transport links and parking issues at a site are more important
than distance
Reviewer 6 – None.
Reviewer 7 – None.
Reviewer 8 – None.
Reviewer 9 – The information looks thorough and clear.
Reviewer 10 – If you are going to tease the participant with the last section, either be more specific
with what it entails, or leave it out altogether until the day. If you have any questions that you would
like to ask the researcher regarding their project, please include them here.
Reviewer 11 – I think this is a really important project, especially given the aim is to assess current
vascular treatment provision, and suggest improvements. I’d be very keen to be involved in the study.
I wish you every success.
Reviewer 12 – None.
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Appendix 10 Participant information
sheet and invitation letter
The design, development and commissioning of patient focused vascular
services: public preferences for vascular treatment
Participant information sheet for volunteers from the general public: telephone interviews
We would like to invite you to take part in a research project, which is looking at different ways in
which services for vascular disease could be provided in the UK. The reason for inviting you is that
we are interested in finding out the views of the general public.
Before deciding if you would like to take part, it is important that you understand why the research
is being done, and what taking part would involve for you. Please take the time to read through the
following information carefully, and feel free to discuss it with any family or friends if you wish. If you
have any questions or would like any more information before deciding, please contact the research
team whose details are included at the end of this leaflet.
Please note that taking part is entirely voluntary and you do not have to do so.
What are vascular services?
Vascular services are health-care treatments for people who have vascular disease (problems with
their blood circulation system). Examples of vascular disease include varicose veins, venous leg ulcers,
peripheral arterial disease, carotid arterial disease (which can lead to strokes) and aortic aneurysms.
To take part in the research study you do not need to have any medical knowledge or know anything
about vascular disease.
What is the purpose of the study?
We are interested in finding out what members of the general public think about the way vascular
services are organised. We are particularly interested in your views about how far people have to
travel to be treated for vascular disease. This research study is part of a large 5-year research study,
funded by the Department of Health, to evaluate vascular services in the UK. The results of the study
will be used to make recommendations about how vascular services could be better organised to
produce the most benefit for patients.
Why have I been invited to take part?
You have been asked to take part in this study because you are a member of the general public and do
not suffer from a vascular condition.
What will happen to me if I take part?
If you agree to take part, we will arrange for you to have a one-time only interview with a member of
the research team. This will most likely be a telephone interview, but interviews could be arranged in
person, at either the clinic or hospital, if preferred. The interview will be one-to-one, with just you and
the researcher. One of the research team members will contact you to arrange the interview at a time
that is convenient for you. You will also be sent some documents through the post for you to look at
during the interview.
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The broad structure of the interviews will be as follows:
1. You will be provided with some descriptions of symptoms that are experienced by people with
different vascular conditions, and asked to compare the conditions in terms of how good or bad
you think the conditions are. For instance you could be asked to compare the symptoms of a person
who has had their leg amputated with those of a person who has not had an amputation, but who
has moderate amounts of pain in their leg.
2. You will then be asked to imagine that you are experiencing some of the vascular conditions and
to value them using a technique that is commonly used in this kind of research. For instance you
could be asked to decide whether you would prefer to continue living with some pain or to have
a treatment to reduce the pain but which has some risk attached to it. We will explore how your
choices might change for different levels of risk.
3. You will then be given a description of a typical treatment process for a vascular condition and
asked about how far you would be prepared to travel to be treated if you had that condition.
4. Finally, you will be asked to answer some general questions about yourself, such as where you live
and your occupation. You will also be given the opportunity to make any general comments about
the interview and your experience of it.
The researcher will carefully talk you through each stage of the interview and will clearly explain
all of the information presented to you during the process. The documents posted to you before the
interview will help with this. The interview will be recorded. This will avoid the need for the researcher
to take lots of notes and will help them concentrate on what you are saying. Your responses will be
entered into a database but the information will be made anonymous so you will not be recognised.
This means any names or information that make you identifiable will be removed. The researcher will
check that the recording and the noted responses are the same, and will then erase the recording.
The interviews will last approximately 20–30 minutes.
Do I have to take part?
It is entirely your decision whether or not to take part, and you are under no obligation to do so. If you
do decide to take part you will be asked to give us your consent over the phone before going ahead
with the interview. If the interview takes place in person, you will be asked to sign a consent form.
You will be given a copy of the participant information sheet and consent form to keep. If you decide
to take part, you are still free to withdraw at any time, and you do not have to give a reason.
What are the possible disadvantages and risks of taking part?
The disadvantages and risks involved are very small. The interview may take up to 20–30 minutes to
complete, so may be a little time consuming.
What are the possible benefits of taking part?
The study will not help you directly. However, the information we get from this study will help improve
the treatment and care provision to people with vascular disease.
What if there is a problem?
There is no obvious reason why any problems should arise from you taking part, or that you may be
harmed as a result of participating in the research.
If you have any complaint about the way you have been dealt with during the study, the normal NHS
complaints procedures are available to you. In the first instance you should contact the trust’s patient
services team by telephone XXXX.
Will my taking part in the study be kept confidential?
The recordings and written records of your interview will be kept safely and confidentially. They will
be stored in locked cabinets and on password-protected computers. Only the researchers will have
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access to them. Any information that we use will be anonymised so that you will not be able to be
identified. All information that is collected about you during the course of the research will be kept
strictly confidential.
What will happen to the results of the research study?
The results of the study will be used to make recommendations about how vascular services could
be better organised to produce the most benefit for patients, and written up in reports and other
publications. If you wish, you can provide us with your email or address and we will send you a copy of
the final report of the study.
Who is organising and funding the research?
A team led by Professor Jonathan Michaels, funded by an NIHR Programme Grant, to examine the
provision of vascular services. The research is a collaboration between the University of Sheffield,
Sheffield Teaching Hospitals and the NHS Sheffield Clinical Commissioning Group.
The project lead for this part of the study is Dr Phil Shackley.
Who has reviewed the study?
All research in the NHS is looked at by an independent group of people, called a Research Ethics
Committee, to protect your interests. This study has been reviewed by South East Coast – Brighton
and Sussex Research Ethics Committee.
Contacts for further information
Aoife Howard, Research Associate XXXX.
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